RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Liver Neoplasms
Accession: DOID:9007188
browse the term
Synonyms: exact_synonym: NEOPLASM OF THE LIVER; hepatic neoplasm; hepatic neoplasms; liver neoplasm; neoplasm of liver
primary_id: MESH:D008113
xref: EFO:1001513
GViewer not supported for the selected species.
G
ABL1
ABL proto-oncogene 1, non-receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941
NCBI chr12:7,258,932...7,435,658
Ensembl chr12:7,256,648...7,312,734
G
ABTB3
ankyrin repeat and BTB domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941
NCBI chr11:102,535,469...102,882,227
Ensembl chr11:102,800,591...102,882,388
G
ADAMTS17
ADAM metallopeptidase with thrombospondin type 1 motif 17
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941
NCBI chr29:18,484,341...18,842,210
Ensembl chr29:18,481,449...18,841,568
G
AHR
aryl hydrocarbon receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19996281 PMID:30346592
NCBI chr21:40,778,198...40,826,491
Ensembl chr21:40,778,218...40,826,478
G
ANXA2
annexin A2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941
NCBI chr26:23,100,000...23,147,687
Ensembl chr26:23,099,992...23,145,457
G
ANXA4
annexin A4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941
NCBI chr14:37,297,960...37,384,187
Ensembl chr14:37,297,652...37,344,884
G
ANXA7
annexin A7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25058030
NCBI chr 9:57,863,482...57,900,972
Ensembl chr 9:57,863,546...57,900,324
G
APC
APC regulator of WNT signaling pathway
ISO
ClinVar Annotator: match by term: Neoplasm of the liver
ClinVar
PMID:16569251 PMID:18199528 PMID:21859464 PMID:22703879 PMID:23159591 PMID:24728327 PMID:25186627 PMID:25479140 PMID:25741868 PMID:25980754 PMID:26173098 PMID:26252958 PMID:26467025 PMID:26530882 PMID:26580448 PMID:26837502 PMID:26845104 PMID:26976419 PMID:27121310 PMID:28135048 PMID:28135145 PMID:28195569 PMID:28492532 PMID:32088909 PMID:32390703 PMID:32984025 More...
NCBI chr23:15,992,437...16,135,117
Ensembl chr23:16,042,287...16,137,067
G
APCS
amyloid P component, serum
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20195826
NCBI chr20:4,360,955...4,363,810
Ensembl chr20:4,358,654...4,362,095
G
ASH1L
ASH1 like histone lysine methyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27064257
NCBI chr20:8,290,606...8,499,991
Ensembl chr20:8,322,504...8,500,129
G
ASIP
agouti signaling protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15175105
NCBI chr 2:38,479,328...38,568,756
G
ASNS
asparagine synthetase (glutamine-hydrolyzing)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28108177
NCBI chr21:51,244,514...51,264,694
Ensembl chr21:51,247,742...51,265,241
G
ATP7B
ATPase copper transporting beta
onset
ISO
CTD Direct Evidence: marker/mechanism compared to LEC/Tj;
CTD RGD
PMID:11509115
RGD:1302456
NCBI chr 3:29,817,712...29,899,302
Ensembl chr 3:29,816,860...29,899,077
G
BAP1
BRCA1 associated deubiquitinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231345
NCBI chr22:13,765,510...13,774,866
Ensembl chr22:13,764,686...13,774,740
G
BRAF
B-Raf proto-oncogene, serine/threonine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17514646
NCBI chr21:109,495,525...109,690,261
G
CCDC134
coiled-coil domain containing 134
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941
NCBI chr19:24,332,293...24,358,056
Ensembl chr19:24,332,316...24,357,583
G
CCND1
cyclin D1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27064257
NCBI chr 1:4,909,616...4,922,272
Ensembl chr 1:4,907,353...4,922,357
G
CCNH
cyclin H
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30705370
NCBI chr 4:81,373,812...81,392,454
Ensembl chr 4:81,373,994...81,392,326
G
CCR4
C-C motif chemokine receptor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941
NCBI chr15:77,435,195...77,439,164
Ensembl chr15:77,437,265...77,438,347
G
CDKN1A
cyclin dependent kinase inhibitor 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33010264
NCBI chr17:35,445,668...35,454,334
Ensembl chr17:35,445,223...35,454,342
G
CDKN1B
cyclin dependent kinase inhibitor 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16391232
NCBI chr11:12,612,064...12,617,228
Ensembl chr11:12,612,079...12,617,531
G
CGREF1
cell growth regulator with EF-hand domain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28108177
NCBI chr14:80,500,056...80,516,893
Ensembl chr14:80,513,701...80,516,698
G
CIDEA
cell death inducing DFFA like effector a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25058030 PMID:28108177
NCBI chr18:70,836,188...70,853,917
G
CLSTN2
calsyntenin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941
NCBI chr15:49,996,144...50,622,454
Ensembl chr15:49,999,908...50,151,120
G
CPT1B
carnitine palmitoyltransferase 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25058030
NCBI chr19:33,044,272...33,055,197
Ensembl chr19:33,043,916...33,054,247
G
CRABP1
cellular retinoic acid binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941
NCBI chr26:4,987,927...4,996,431
Ensembl chr26:4,987,882...4,996,343
G
CSF2
colony stimulating factor 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17326190
NCBI chr23:34,906,987...34,911,252
Ensembl chr23:34,908,911...34,911,140
G
CSF3
colony stimulating factor 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:9018096
NCBI chr16:66,162,814...66,166,192
Ensembl chr16:66,163,681...66,165,172
G
CTNNB1
catenin beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10467420 PMID:21047994
NCBI chr22:2,679,488...2,725,034
Ensembl chr22:2,684,022...2,723,949
G
CXCL1
C-X-C motif chemokine ligand 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33010264
NCBI chr 7:22,327,041...22,329,405
Ensembl chr 7:22,569,355...22,569,900 Ensembl chr 7:22,569,355...22,569,900
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17093202
NCBI chr26:53,390,054...53,403,309
Ensembl chr26:53,390,089...53,404,211
G
DACT2
dishevelled binding antagonist of beta catenin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25058030
NCBI chr13:96,141,847...96,152,677
G
DCD
dermcidin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20195826
NCBI chr11:50,760,466...50,765,369
G
DDX54
DEAD-box helicase 54
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941
NCBI chr11:108,407,623...108,437,188
Ensembl chr11:108,404,719...108,437,168
G
DICER1
dicer 1, ribonuclease III
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24478143
NCBI chr24:72,915,550...72,986,658
Ensembl chr24:72,915,499...72,963,006
G
DPP10
dipeptidyl peptidase like 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941
NCBI chr10:14,434,244...15,822,419
G
EFNB2
ephrin B2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941
NCBI chr 3:84,904,421...84,949,292
Ensembl chr 3:84,904,435...84,949,465
G
ESM1
endothelial cell specific molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28108177
NCBI chr 4:51,227,908...51,269,280
Ensembl chr 4:51,227,916...51,235,972
G
ESR1
estrogen receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16712894
NCBI chr13:79,153,418...79,554,552
Ensembl chr13:79,270,265...79,554,549
G
EXOSC2
exosome component 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941
NCBI chr12:7,441,812...7,452,979
Ensembl chr12:7,442,791...7,452,964
G
FHIT
fragile histidine triad diadenosine triphosphatase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12112319
NCBI chr22:21,006,010...22,474,056
G
FLCN
folliculin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941
NCBI chr16:16,245,840...16,271,465
Ensembl chr16:16,245,715...16,267,698
G
FOSB
FosB proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26411935
NCBI chr 6:38,916,039...38,924,129
G
FST
follistatin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12203361
NCBI chr 4:49,773,646...49,780,343
Ensembl chr 4:49,773,980...49,780,333
G
GADL1
glutamate decarboxylase like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941
NCBI chr15:75,237,681...75,407,007
Ensembl chr15:75,237,675...75,405,706
G
GJB1
gap junction protein beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2559087
NCBI chr X:61,013,991...61,019,222
Ensembl chr X:61,017,716...61,018,567
G
GNMT
glycine N-methyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21137059
NCBI chr17:29,196,142...29,199,728
Ensembl chr17:29,196,321...29,198,947
G
GPER1
G protein-coupled estrogen receptor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:30641053
NCBI chr28:20,491,874...20,497,966
Ensembl chr28:20,492,188...20,493,315
G
GPX1
glutathione peroxidase 1
treatment
ISO
RGD
PMID:26147624
RGD:152995453
NCBI chr22:10,754,976...10,756,617
G
GPX2
glutathione peroxidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28108177
NCBI chr24:42,151,205...42,155,335
G
GPX3
glutathione peroxidase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20195826
NCBI chr23:53,576,950...53,585,321
G
GRIK2
glutamate ionotropic receptor kainate type subunit 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30705370
NCBI chr13:71,855,960...72,545,376
Ensembl chr13:71,855,794...72,325,857
G
HCFC1
host cell factor C1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19255062
NCBI chr X:128,371,518...128,395,920
Ensembl chr X:128,371,517...128,394,861
G
HEBP2
heme binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25058030
NCBI chr13:34,985,834...34,995,037
Ensembl chr13:34,986,129...34,994,809
G
HERC3
HECT and RLD domain containing E3 ubiquitin protein ligase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941
NCBI chr 7:36,945,452...37,068,574
Ensembl chr 7:36,958,239...37,066,994
G
HGF
hepatocyte growth factor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:8807143
NCBI chr21:67,118,785...67,193,506
Ensembl chr21:67,120,722...67,193,504
G
HIGD2A
HIG1 hypoxia inducible domain family member 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941
NCBI chr23:78,392,364...78,393,407
G
HMOX1
heme oxygenase 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17002867
NCBI chr19:18,144,466...18,157,944
Ensembl chr19:18,144,545...18,157,971
G
HRAS
HRas proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10874023 PMID:12082015 PMID:12127263 PMID:16410370 PMID:17514646
NCBI chr 1:343,613...345,782
Ensembl chr 1:343,506...346,637
G
HSDL2
hydroxysteroid dehydrogenase like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25058030
NCBI chr12:27,051,287...27,132,884
Ensembl chr12:26,999,960...27,131,914
G
IFT88
intraflagellar transport 88
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9362446
NCBI chr 3:435,649...546,661
Ensembl chr 3:436,207...546,583
G
IGF2
insulin like growth factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12127304
NCBI chr 1:1,937,414...1,951,238
Ensembl chr 1:1,936,830...1,945,388
G
IL12A
interleukin 12A
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17326190
NCBI chr15:30,887,048...30,896,577
Ensembl chr15:30,887,897...30,894,550
G
IL12B
interleukin 12B
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17326190
NCBI chr23:61,714,293...61,731,835
G
IL2
interleukin 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18298334
NCBI chr 7:69,729,635...69,736,279
Ensembl chr 7:69,730,282...69,734,969
G
ITIH1
inter-alpha-trypsin inhibitor heavy chain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17114358
NCBI chr22:14,159,702...14,174,627
Ensembl chr22:14,160,680...14,174,641
G
JUN
Jun proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12127263 PMID:24183702
NCBI chr20:74,204,481...74,207,835
Ensembl chr20:74,205,542...74,206,546
G
KRAS
KRAS proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10629081 PMID:12211074
NCBI chr11:24,963,396...25,010,747
Ensembl chr11:24,973,619...25,005,191
G
KRT18
keratin 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19409407 PMID:19796649
NCBI chr11:49,073,733...49,081,706
G
KRT8
keratin 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19409407 PMID:19796649
NCBI chr11:49,027,879...49,051,753
G
LARGE1
LARGE xylosyl- and glucuronyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941
NCBI chr19:16,080,482...16,704,968
Ensembl chr19:16,080,430...16,549,495
G
LOC103224275
glutathione S-transferase Mu 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21214675
NCBI chr20:23,854,969...23,861,634
G
LOC103243413
signal transducer and activator of transcription 5B
exacerbates
ISO
B6 strain
RGD
PMID:24838184
RGD:153298928
NCBI chr16:63,997,486...64,070,392
Ensembl chr16:63,997,441...64,070,445
G
LTF
lactotransferrin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12079509
NCBI chr22:7,867,332...7,896,403
Ensembl chr22:7,867,286...7,894,521
G
MACIR
macrophage immunometabolism regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30705370
NCBI chr23:6,695,131...6,714,925
Ensembl chr23:6,712,171...6,712,791
G
MACROD2
mono-ADP ribosylhydrolase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27064257
NCBI chr 2:42,891,656...44,973,129
G
MAPK14
mitogen-activated protein kinase 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17468757
NCBI chr17:36,012,164...36,095,542
Ensembl chr17:36,014,454...36,095,138
G
MMP14
matrix metallopeptidase 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33010264
NCBI chr29:23,201,425...23,212,408
Ensembl chr29:23,201,112...23,212,679
G
MYC
MYC proto-oncogene, bHLH transcription factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8807143 PMID:11532874
NCBI chr 8:122,282,989...122,288,392
Ensembl chr 8:122,282,630...122,288,384
G
MYO5B
myosin VB
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25058030
NCBI chr18:30,759,345...31,143,139
Ensembl chr18:30,759,764...31,143,474
G
NAT2
N-acetyltransferase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19666988
NCBI chr 8:16,451,144...16,494,961
Ensembl chr 8:16,493,749...16,494,621
G
NCOR1
nuclear receptor corepressor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27064257
NCBI chr16:15,442,315...15,629,411
Ensembl chr16:15,462,640...15,628,512
G
NDRG1
N-myc downstream regulated 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15341671
NCBI chr 8:127,668,012...127,727,918
Ensembl chr 8:127,667,981...127,719,011
G
NFE2L2
NFE2 like bZIP transcription factor 2
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:20722399 PMID:35523338
NCBI chr10:62,789,647...62,825,651
Ensembl chr10:62,790,124...62,825,339
G
NOP16
NOP16 nucleolar protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941
NCBI chr23:78,387,634...78,392,405
Ensembl chr23:78,387,877...78,392,238
G
NR1H4
nuclear receptor subfamily 1 group H member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23178280 PMID:24091600 PMID:24189133 PMID:29142166 PMID:30556042
NCBI chr11:95,792,428...95,877,989
Ensembl chr11:95,792,996...95,878,293
G
NR1I3
nuclear receptor subfamily 1 group I member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941 PMID:19482888 PMID:22293087 PMID:24449422 PMID:28218408
NCBI chr20:2,724,843...2,752,999
Ensembl chr20:2,744,908...2,756,658
G
NUDCD3
NudC domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941
NCBI chr21:14,177,167...14,283,419
Ensembl chr21:14,177,173...14,284,469
G
NUDT7
nudix hydrolase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25058030
NCBI chr 5:63,212,163...63,231,465
Ensembl chr 5:63,212,226...63,231,650
G
OAT
ornithine aminotransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28108177
NCBI chr 9:117,060,819...117,083,160
Ensembl chr 9:117,060,393...117,083,126
G
PDRG1
p53 and DNA damage regulated 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941
NCBI chr 2:36,334,730...36,342,685
Ensembl chr 2:36,331,198...36,342,179
G
PHGDH
phosphoglycerate dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28108177
NCBI chr20:14,045,395...14,075,935
Ensembl chr20:14,045,346...14,076,177
G
PLS1
plastin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17114358
NCBI chr15:47,919,807...48,031,158
Ensembl chr15:47,919,823...48,003,805
G
PPARA
peroxisome proliferator activated receptor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20143881 PMID:29134746
G
PPARG
peroxisome proliferator activated receptor gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20143881
NCBI chr22:48,262,743...48,407,415
Ensembl chr22:48,275,600...48,407,418
G
PRICKLE2
prickle planar cell polarity protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941
NCBI chr22:25,128,160...25,481,385
Ensembl chr22:25,133,352...25,303,131
G
PRKCE
protein kinase C epsilon
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941
NCBI chr14:61,022,903...61,570,390
Ensembl chr14:61,026,017...61,242,343
G
PSMA4
proteasome 20S subunit alpha 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20195826
NCBI chr26:4,793,046...4,802,098
Ensembl chr26:4,793,307...4,801,886
G
PTER
phosphotriesterase related
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25058030
NCBI chr 9:16,382,479...16,539,382
Ensembl chr 9:16,429,776...16,457,737
G
PTPRO
protein tyrosine phosphatase receptor type O
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941 PMID:20163174
NCBI chr11:15,225,375...15,494,559
Ensembl chr11:15,392,926...15,495,807
G
RAF1
Raf-1 proto-oncogene, serine/threonine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19499222
NCBI chr22:48,560,270...48,643,537
Ensembl chr22:48,561,161...48,618,020
G
RTP3
receptor transporter protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17693185
NCBI chr22:7,925,733...7,930,132
Ensembl chr22:7,926,804...7,931,187
G
SCD
stearoyl-CoA desaturase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12419843
NCBI chr 9:93,380,812...93,398,860
Ensembl chr 9:93,380,914...93,398,912
G
SIX3
SIX homeobox 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941
NCBI chr14:62,278,124...62,292,942
Ensembl chr14:62,278,461...62,281,127
G
SLC11A2
solute carrier family 11 member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941
NCBI chr11:47,190,138...47,238,543
Ensembl chr11:47,197,168...47,235,130
G
SLC2A1
solute carrier family 2 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26943884
NCBI chr20:89,974,567...90,007,977
Ensembl chr20:90,002,030...90,008,033
G
SLC38A9
solute carrier family 38 member 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941
NCBI chr 4:51,876,430...51,961,914
Ensembl chr 4:51,876,268...51,948,012
G
SLC40A1
solute carrier family 40 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21785164
NCBI chr10:75,076,286...75,097,742
Ensembl chr10:75,075,971...75,096,271
G
SLC66A3
solute carrier family 66 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25058030
NCBI chr14:96,446,268...96,469,485
Ensembl chr14:96,447,306...96,469,441
G
SNX10
sorting nexin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28108177
NCBI chr21:31,999,253...32,044,967
Ensembl chr21:31,998,277...32,081,843
G
SPATA21
spermatogenesis associated 21
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941
NCBI chr20:115,889,975...115,933,026
Ensembl chr20:115,891,903...115,929,898
G
SRMS
src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941
NCBI chr 2:657,315...664,883
Ensembl chr 2:657,623...664,064
G
STAC3
SH3 and cysteine rich domain 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28108177
NCBI chr11:53,149,572...53,163,036
Ensembl chr11:53,154,755...53,163,090
G
STAT3
signal transducer and activator of transcription 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12957465
NCBI chr16:63,877,884...63,957,894
Ensembl chr16:63,922,862...63,957,984
G
TCF4
transcription factor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941
NCBI chr18:24,116,595...24,483,037
Ensembl chr18:24,116,547...24,478,228
G
TERT
telomerase reverse transcriptase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27064257
NCBI chr 4:1,082,894...1,119,373
Ensembl chr 4:1,083,384...1,117,468
G
TGFA
transforming growth factor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8807143
NCBI chr14:36,545,641...36,654,213
Ensembl chr14:36,545,875...36,648,237
G
TMEM132D
transmembrane protein 132D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941
NCBI chr11:124,425,472...125,256,613
G
TNF
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24183702
G
TNFSF10
TNF superfamily member 10
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18980244
NCBI chr15:16,934,982...16,953,155
Ensembl chr15:16,934,962...16,954,860
G
TNK2
tyrosine kinase non receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941
NCBI chr15:91,187,702...91,232,391
Ensembl chr15:91,201,008...91,232,399
G
TOP1
DNA topoisomerase I
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30132517
NCBI chr 2:22,655,085...22,751,082
Ensembl chr 2:22,651,995...22,751,102
G
TOP2A
DNA topoisomerase II alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30132517
NCBI chr16:65,761,391...65,792,041
Ensembl chr16:65,761,416...65,792,701
G
TOX3
TOX high mobility group box family member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28108177
NCBI chr 5:38,197,059...38,304,582
Ensembl chr 5:38,197,066...38,304,264
G
TP53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12378512 PMID:16410370
NCBI chr16:7,047,686...7,065,567
Ensembl chr16:7,045,146...7,066,223
G
TRIO
trio Rho guanine nucleotide exchange factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941
NCBI chr 4:13,846,753...14,214,647
Ensembl chr 4:13,847,936...14,215,164
G
TRMT11
tRNA methyltransferase 11 homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30705370
NCBI chr13:47,680,321...47,735,103
Ensembl chr13:47,680,332...47,734,857
G
TTC39A
tetratricopeptide repeat domain 39A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17114358
NCBI chr20:81,608,949...81,668,469
Ensembl chr20:81,625,002...81,668,728
G
TTLL9
tubulin tyrosine ligase like 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941
NCBI chr 2:36,259,106...36,340,711
Ensembl chr 2:36,268,132...36,332,618
G
UGDH
UDP-glucose 6-dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17114358
NCBI chr27:10,781,324...10,810,595
Ensembl chr27:10,781,502...10,810,817
G
WDR17
WD repeat domain 17
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941
NCBI chr 7:122,141,723...122,257,343
Ensembl chr 7:122,169,204...122,257,337
G
WSCD1
WSC domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941
NCBI chr16:5,452,255...5,504,686
Ensembl chr16:5,318,532...5,507,872
G
XPA
XPA, DNA damage recognition and repair factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24084170
NCBI chr12:41,711,872...41,735,024
Ensembl chr12:41,711,943...41,725,698
G
XPC
XPC complex subunit, DNA damage recognition and repair factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24084170
NCBI chr22:50,088,019...50,121,584
Ensembl chr22:50,085,353...50,121,542
G
YIF1A
Yip1 interacting factor homolog A, membrane trafficking protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941
NCBI chr 1:7,977,690...7,982,313
Ensembl chr 1:7,977,867...7,984,211
G
ZDHHC2
zinc finger DHHC-type palmitoyltransferase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25058030 PMID:28108177
NCBI chr 8:15,241,100...15,311,431
Ensembl chr 8:15,270,598...15,303,323
G
ZSCAN22
zinc finger and SCAN domain containing 22
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19233941
NCBI chr 6:50,608,188...50,616,961
Ensembl chr 6:50,608,214...50,619,176
G
EPHX1
epoxide hydrolase 1
ISO
associated with estrogen excess;protein:increased activity;liver (rat)
RGD
PMID:6133380
RGD:152998935
NCBI chr25:3,924,396...3,960,264
Ensembl chr25:3,924,606...3,945,535
G
LOC103223058
glutathione hydrolase light chain 2
ISO
associated with estrogen excess;protein:increased activity;liver (rat)
RGD
PMID:6133380
RGD:152998935
NCBI chr19:7,353,922...7,406,392
G
MET
MET proto-oncogene, receptor tyrosine kinase
ISO
ClinVar Annotator: match by term: Pediatric hepatocellular carcinoma
ClinVar
PMID:9927037 PMID:17483355
NCBI chr21:85,370,574...85,486,405
Ensembl chr21:85,397,645...85,488,093
G
ABCB11
ATP binding cassette subfamily B member 11
ISO
RGD
PMID:15853769
RGD:1598580
NCBI chr10:54,458,283...54,575,943
Ensembl chr10:54,459,377...54,575,059
G
ADSL
adenylosuccinate lyase
ISO
protein:increased activity:liver (rat)
RGD
PMID:2937404
RGD:1598766
NCBI chr19:22,920,971...22,940,468
G
AFP
alpha fetoprotein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24012840 PMID:32961231
NCBI chr 7:21,904,225...21,924,105
Ensembl chr 7:21,905,154...21,924,092
G
AGPS
alkylglycerone phosphate synthase
ISO
RGD
PMID:7407223
RGD:1598794
NCBI chr10:62,943,914...63,101,644
Ensembl chr10:62,946,695...63,096,044
G
ALAS2
5'-aminolevulinate synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr X:51,086,062...51,108,564
Ensembl chr X:51,086,066...51,103,505
G
APOA4
apolipoprotein A4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 1:108,186,627...108,190,508
Ensembl chr 1:108,186,921...108,189,698
G
APOC2
apolipoprotein C2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 6:38,406,829...38,411,239
Ensembl chr 6:38,409,641...38,410,927
G
ARID1A
AT-rich interaction domain 1A
disease_progression
ISO
RGD
PMID:26569409
RGD:11344640
NCBI chr20:105,981,549...106,066,093
Ensembl chr20:105,981,290...106,065,672
G
ARRB2
arrestin beta 2
ISO
mRNA, protein:increased expression:liver (rat)
RGD
PMID:21167192
RGD:5509890
NCBI chr16:4,191,040...4,202,382
Ensembl chr16:4,191,172...4,202,385
G
ATP7A
ATPase copper transporting alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23792645
NCBI chr X:66,843,519...66,985,655
Ensembl chr X:66,843,558...66,985,709
G
ATP7B
ATPase copper transporting beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23792645
NCBI chr 3:29,817,712...29,899,302
Ensembl chr 3:29,816,860...29,899,077
G
BAK1
BCL2 antagonist/killer 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100771
NCBI chr17:38,492,776...38,502,534
Ensembl chr17:38,492,858...38,501,281
G
BBC3
BCL2 binding component 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100771
NCBI chr 6:40,560,550...40,572,428
Ensembl chr 6:40,561,274...40,567,853
G
BCL2
BCL2 apoptosis regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10426811 PMID:28100771
NCBI chr18:16,440,560...16,643,187
Ensembl chr18:16,441,733...16,637,895
G
BCL2L1
BCL2 like 1
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:10426811 PMID:22414765 PMID:28100771
RGD:11353865
NCBI chr 2:36,059,024...36,118,332
Ensembl chr 2:36,058,919...36,116,470
G
BIRC5
baculoviral IAP repeat containing 5
ISO
mRNA, protein:increased expression:liver
RGD
PMID:18246794
RGD:2293125
NCBI chr16:70,226,824...70,237,000
G
CA3
carbonic anhydrase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 8:80,805,296...80,816,127
Ensembl chr 8:80,805,134...80,816,190
G
CAD
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
ISO
protein:increased activity:liver (rat)
RGD
PMID:13618893
RGD:5132586
NCBI chr14:80,371,154...80,399,193
Ensembl chr14:80,371,096...80,398,914
G
CCL20
C-C motif chemokine ligand 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30603057
NCBI chr10:113,815,099...113,836,562
Ensembl chr10:113,832,573...113,835,736
G
CCNB1
cyclin B1
ISO
mRNA:increased expression:liver
RGD
PMID:17342310
RGD:2315991
NCBI chr 4:65,265,798...65,276,465
Ensembl chr 4:65,265,844...65,277,085
G
CCND1
cyclin D1
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17055752 PMID:28100771
RGD:2289139
NCBI chr 1:4,909,616...4,922,272
Ensembl chr 1:4,907,353...4,922,357
G
CCNDBP1
cyclin D1 binding protein 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16501603
NCBI chr26:39,794,572...39,807,919
Ensembl chr26:39,797,083...39,807,827
G
CCNG2
cyclin G2
ISO
RGD
PMID:27982046
RGD:151361200
NCBI chr 7:25,657,548...25,667,464
Ensembl chr 7:25,657,441...25,666,254
G
CD40LG
CD40 ligand
ISO
RGD
PMID:19035311
RGD:5491179
NCBI chr X:111,655,301...111,667,602
Ensembl chr X:111,655,397...111,666,639
G
CD63
CD63 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr11:51,673,402...51,677,075
Ensembl chr11:51,672,740...51,676,301
G
CDKN1A
cyclin dependent kinase inhibitor 1A
ISO
protein:decreased expression:liver:
RGD
PMID:8640740
RGD:8662309
NCBI chr17:35,445,668...35,454,334
Ensembl chr17:35,445,223...35,454,342
G
CDKN1B
cyclin dependent kinase inhibitor 1B
disease_progression
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:19533683
RGD:2315050
NCBI chr11:12,612,064...12,617,228
Ensembl chr11:12,612,079...12,617,531
G
CDKN1C
cyclin dependent kinase inhibitor 1C
disease_progression
ISO
protein:decreased expression:liver (rat) protein:increased expression:liver (rat) mRNA:increased expression:liver (rat)
RGD
PMID:3965145 PMID:19533683 PMID:26606000
RGD:11354707 RGD:152998958 RGD:2315050
NCBI chr 1:2,696,382...2,699,054
Ensembl chr 1:2,696,233...2,699,028
G
COPS5
COP9 signalosome subunit 5
ISO
protein:increased expression:liver (rat)
RGD
PMID:26606000
RGD:11354707
NCBI chr 8:62,905,924...62,925,205
Ensembl chr 8:62,905,906...62,925,201
G
CPS1
carbamoyl-phosphate synthase 1
severity
ISO
mRNA:decreased expression:liver
RGD
PMID:3387993
RGD:2303406
NCBI chr10:96,267,890...96,392,393
Ensembl chr10:96,267,889...96,392,206
G
CTNNB1
catenin beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11280770 PMID:20118494 PMID:21147764
NCBI chr22:2,679,488...2,725,034
Ensembl chr22:2,684,022...2,723,949
G
CXCL9
C-X-C motif chemokine ligand 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 7:24,507,121...24,513,830
Ensembl chr 7:24,507,130...24,513,121
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
ISO
mRNA:increased expression:liver
RGD
PMID:22687991
RGD:7296954
NCBI chr26:8,753,236...8,759,378
Ensembl chr26:8,753,327...8,759,384
G
CYP1A2
cytochrome P450 family 1 subfamily A member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11376689 PMID:21147764
NCBI chr26:8,727,996...8,733,254
G
CYP2C8
cytochrome P450 family 2 subfamily C member 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 9:88,154,131...88,183,915
Ensembl chr 9:88,154,134...88,183,458
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18056438
NCBI chr26:53,390,054...53,403,309
Ensembl chr26:53,390,089...53,404,211
G
DHODH
dihydroorotate dehydrogenase (quinone)
ISO
protein:increased activity:liver (rat)
RGD
PMID:6331524
RGD:5132618
NCBI chr 5:55,161,788...55,177,383
Ensembl chr 5:55,161,916...55,180,896
G
DTYMK
deoxythymidylate kinase
ISO
protein:increased activity:tumor (rat)
RGD
PMID:6244089
RGD:5133686
NCBI chr10:127,722,091...127,733,662
Ensembl chr10:127,721,784...127,733,476
G
ENO2
enolase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2910524
NCBI chr11:6,945,243...6,954,959
Ensembl chr11:6,945,413...6,957,304
G
EPHX1
epoxide hydrolase 1
ISO
RGD
PMID:7260898
RGD:11252158
NCBI chr25:3,924,396...3,960,264
Ensembl chr25:3,924,606...3,945,535
G
ESR1
estrogen receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35044086
NCBI chr13:79,153,418...79,554,552
Ensembl chr13:79,270,265...79,554,549
G
F12
coagulation factor XII
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr23:79,414,074...79,438,896
Ensembl chr23:79,414,225...79,432,298
G
FOXM1
forkhead box M1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15082532
NCBI chr11:2,920,903...2,941,011
Ensembl chr11:2,920,663...2,940,823
G
GJB1
gap junction protein beta 1
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:1336494 PMID:18308698
RGD:7349398
NCBI chr X:61,013,991...61,019,222
Ensembl chr X:61,017,716...61,018,567
G
GJB2
gap junction protein beta 2
ISO
RGD
PMID:1336494
RGD:7349398
NCBI chr 3:801,786...808,165
Ensembl chr 3:807,379...808,059
G
GLUL
glutamate-ammonia ligase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20118494 PMID:21147764
NCBI chr25:46,988,853...46,998,112
Ensembl chr25:46,989,205...47,000,555
G
GRP
gastrin releasing peptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2910524
NCBI chr18:20,496,201...20,508,551
Ensembl chr18:20,496,516...20,507,153
G
GSTP1
glutathione S-transferase pi 1
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:liver (rat)
CTD RGD
PMID:2563599 PMID:3124819 PMID:3965145 PMID:7585603 PMID:12016164 PMID:20188851 More...
RGD:152998958 RGD:2317823
NCBI chr 1:6,676,897...6,679,936
G
HAT1
histone acetyltransferase 1
ISO
protein:increased expression:liver
RGD
PMID:17182829
RGD:2316578
NCBI chr10:57,412,916...57,482,682
Ensembl chr10:57,412,910...57,482,351
G
HGF
hepatocyte growth factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11896611
NCBI chr21:67,118,785...67,193,506
Ensembl chr21:67,120,722...67,193,504
G
HRAS
HRas proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7955063 PMID:20118494 PMID:21147764 PMID:27517622
NCBI chr 1:343,613...345,782
Ensembl chr 1:343,506...346,637
G
HTR2C
5-hydroxytryptamine receptor 2C
ISO
protein:increased expression:brainstem, cerebral cortex
RGD
PMID:17258772
RGD:1624998
NCBI chr X:102,190,355...102,499,928
Ensembl chr X:102,325,731...102,497,278
G
IGF2
insulin like growth factor 2
treatment
ISO
RGD
PMID:22425635
RGD:10402567
NCBI chr 1:1,937,414...1,951,238
Ensembl chr 1:1,936,830...1,945,388
G
IGF2R
insulin like growth factor 2 receptor
ISO
RGD
PMID:9652747 PMID:15057872
RGD:2311623 RGD:2311630
NCBI chr13:87,587,717...87,723,795
Ensembl chr13:87,587,907...87,724,116
G
IKBKG
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30737368
NCBI chr X:128,781,975...128,816,039
Ensembl chr X:128,787,785...128,806,083
G
IL6
interleukin 6
disease_progression
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:blood serum (mouse)
CTD RGD
PMID:26297436 PMID:26569409
RGD:11344640
NCBI chr21:35,577,513...35,582,385
Ensembl chr21:35,577,939...35,582,237
G
INSR
insulin receptor
disease_progression
ISO
associated with Diabetes Mellitus, Experimental;protein:increased expression:cytoplasm,liver (rat)
RGD
PMID:15520221
RGD:2306052
NCBI chr 6:6,625,951...6,803,610
Ensembl chr 6:6,630,777...6,803,592
G
JAK2
Janus kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100771
NCBI chr12:74,421,243...74,566,766
Ensembl chr12:74,421,016...74,566,710
G
KAT6A
lysine acetyltransferase 6A
ISO
protein:increased expression:liver (rat)
RGD
PMID:17083329
RGD:2312274
NCBI chr 8:39,912,120...40,035,776
Ensembl chr 8:39,911,776...39,962,735
G
KDR
kinase insert domain receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11956651
NCBI chr 7:13,435,059...13,482,236
Ensembl chr 7:13,435,096...13,482,771
G
KRAS
KRAS proto-oncogene, GTPase
disease_progression
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver (rat)
CTD RGD
PMID:8603461 PMID:19533683
RGD:2315050
NCBI chr11:24,963,396...25,010,747
Ensembl chr11:24,973,619...25,005,191
G
LOC103233229
cadherin-1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20118494 PMID:25319454
NCBI chr 5:58,578,244...58,679,677
Ensembl chr 5:58,578,146...58,679,541
G
LOC103235509
cytochrome P450 2F1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 6:35,270,229...35,286,326
G
LOC103244924
cyclin-G1
ISO
RGD
PMID:27982046
RGD:151361200
NCBI chr23:65,709,759...65,716,913
Ensembl chr23:65,709,786...65,714,711
G
MAP2K1
mitogen-activated protein kinase kinase 1
ISO
associated with Diabetes Mellitus, Experimental;protein:increased expression:liver
RGD
PMID:15520221
RGD:2306052
NCBI chr26:17,059,122...17,168,787
Ensembl chr26:17,060,054...17,168,782
G
MAPK1
mitogen-activated protein kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100771
NCBI chr19:4,246,144...4,352,648
Ensembl chr19:4,246,122...4,353,325
G
MAPK3
mitogen-activated protein kinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100771
NCBI chr 5:26,536,471...26,545,666
Ensembl chr 5:26,536,532...26,546,461
G
MET
MET proto-oncogene, receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11956651
NCBI chr21:85,370,574...85,486,405
Ensembl chr21:85,397,645...85,488,093
G
MFGE8
milk fat globule EGF and factor V/VIII domain containing
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
G
MMP2
matrix metallopeptidase 2
ISO
mRNA, protein:increased expression, increased activity:liver CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:19528495 PMID:19539802 PMID:30603057
RGD:2325734 RGD:2325736
NCBI chr 5:41,264,382...41,291,657
Ensembl chr 5:41,264,354...41,291,004
G
MMP9
matrix metallopeptidase 9
ISO
mRNA, protein:increased expression, increased activity:liver
RGD
PMID:19528495 PMID:19539802
RGD:2325734 RGD:2325736
NCBI chr 2:17,867,267...17,874,757
Ensembl chr 2:17,867,177...17,874,712
G
MYC
MYC proto-oncogene, bHLH transcription factor
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver (rat)
CTD RGD
PMID:3335218 PMID:9079223 PMID:11280770 PMID:18560566
RGD:10059623
NCBI chr 8:122,282,989...122,288,392
Ensembl chr 8:122,282,630...122,288,384
G
NOS2
nitric oxide synthase 2
ISO
protein:increased expression:liver
RGD
PMID:10383909
RGD:2325277
NCBI chr16:21,533,011...21,576,645
Ensembl chr16:21,533,484...21,574,257
G
NOTCH1
notch receptor 1
ISO
protein:increased expression:liver
RGD
PMID:18942116
RGD:2325310
NCBI chr12:1,656,815...1,707,566
Ensembl chr12:1,656,918...1,709,585
G
NQO1
NAD(P)H quinone dehydrogenase 1
ISO
mRNA, protein:increased expression:liver (rat)
RGD
PMID:27867096
RGD:13442478
NCBI chr 5:57,676,547...57,695,434
Ensembl chr 5:57,675,981...57,716,599
G
NR1H4
nuclear receptor subfamily 1 group H member 4
susceptibility
ISO
RGD
PMID:17283114
RGD:14701032
NCBI chr11:95,792,428...95,877,989
Ensembl chr11:95,792,996...95,878,293
G
NR1I3
nuclear receptor subfamily 1 group I member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17172636 PMID:24769335 PMID:25656644
NCBI chr20:2,724,843...2,752,999
Ensembl chr20:2,744,908...2,756,658
G
NRAS
NRAS proto-oncogene, GTPase
ISO
human gene in mouse model
RGD
PMID:16286660
RGD:14975105
NCBI chr20:18,953,273...18,966,002
Ensembl chr20:18,953,883...18,961,931
G
PEMT
phosphatidylethanolamine N-methyltransferase
ISO
protein:decreased expression:liver
RGD
PMID:7929120
RGD:1642378
NCBI chr16:16,540,096...16,626,251
Ensembl chr16:16,539,985...16,611,279
G
PLCL1
phospholipase C like 1 (inactive)
disease_progression
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:19533683
RGD:2315050
NCBI chr10:83,291,683...83,640,634
Ensembl chr10:83,574,894...83,642,768
G
PML
PML nuclear body scaffold
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20377131
NCBI chr26:9,441,998...9,494,949
Ensembl chr26:9,451,112...9,494,931
G
PPAT
phosphoribosyl pyrophosphate amidotransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:761203
NCBI chr 7:12,201,434...12,242,418
Ensembl chr 7:12,191,784...12,243,488
G
PPP2CA
protein phosphatase 2 catalytic subunit alpha
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:2562181
RGD:8693574
NCBI chr23:36,999,110...37,028,916
Ensembl chr23:36,997,078...37,029,280
G
PRDX1
peroxiredoxin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27517622
NCBI chr20:87,267,026...87,277,634
Ensembl chr20:87,267,044...87,279,978
G
PTGR1
prostaglandin reductase 1
ISO
mRNA, protein:increased expression:liver
RGD
PMID:24853774
RGD:14401713
NCBI chr12:27,918,990...27,999,736
G
RAD51
RAD51 recombinase
ISO
protein:decreased expression:liver
RGD
PMID:17219426
RGD:2292638
NCBI chr26:42,281,085...42,319,394
Ensembl chr26:42,279,608...42,318,169
G
RB1
RB transcriptional corepressor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17854601
NCBI chr 3:26,220,783...26,393,671
Ensembl chr 3:26,220,803...26,394,546
G
RGN
regucalcin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr X:44,282,825...44,299,027
Ensembl chr X:44,285,601...44,299,258
G
RIDA
reactive intermediate imine deaminase A homolog
ISO
protein:increased expression:liver (rat)
RGD
PMID:12939504
RGD:9685719
NCBI chr 8:93,014,986...93,031,499
G
RRAS2
RAS related 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147764
NCBI chr 1:50,527,669...50,607,208
Ensembl chr 1:50,527,699...50,607,871
G
RRM1
ribonucleotide reductase catalytic subunit M1
ISO
RGD
PMID:15224347
RGD:2316863
NCBI chr 1:62,606,112...62,649,979
Ensembl chr 1:62,604,486...62,650,200
G
RXRA
retinoid X receptor alpha
ISO
mRNA, protein:decreased expression:liver
RGD
PMID:17786350
RGD:1643105
NCBI chr12:3,704,129...3,814,707
Ensembl chr12:3,699,923...3,814,678
G
SERPINA1
serpin family A member 1
ISO
RGD
PMID:10569800
RGD:1626391
NCBI chr24:72,158,521...72,171,139
Ensembl chr24:72,156,784...72,163,500
G
SLC31A1
solute carrier family 31 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23792645
NCBI chr12:26,307,308...26,348,701
Ensembl chr12:26,311,334...26,348,694
G
SLC7A5
solute carrier family 7 member 5
ISO
mRNA:increased expression:liver
RGD
PMID:17498859
RGD:151357003
NCBI chr 5:73,229,953...73,269,801
Ensembl chr 5:73,229,951...73,269,754
G
SNX27
sorting nexin 27
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36029209
NCBI chr20:11,997,768...12,083,929
Ensembl chr20:11,998,527...12,083,528
G
SOCS1
suppressor of cytokine signaling 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15197228
NCBI chr 5:10,731,866...10,733,745
Ensembl chr 5:10,732,350...10,732,991
G
SPP1
secreted phosphoprotein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 7:36,337,165...36,344,927
Ensembl chr 7:36,338,386...36,344,407
G
SQLE
squalene epoxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 8:119,586,639...119,610,980
Ensembl chr 8:119,586,659...119,611,142
G
STAT3
signal transducer and activator of transcription 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26297436 PMID:28100771
NCBI chr16:63,877,884...63,957,894
Ensembl chr16:63,922,862...63,957,984
G
TGFA
transforming growth factor alpha
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:liver
CTD RGD
PMID:9079223 PMID:16734725
RGD:2317490
NCBI chr14:36,545,641...36,654,213
Ensembl chr14:36,545,875...36,648,237
G
TGFB1
transforming growth factor beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100771
NCBI chr 6:35,651,583...35,674,387
Ensembl chr 6:35,648,677...35,674,365
G
TK1
thymidine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr16:70,186,103...70,200,689
Ensembl chr16:70,186,767...70,200,610
G
TNF
tumor necrosis factor
treatment disease_progression
ISO
Morris hepatoma protein:increased expression:blood serum (mouse) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:9063767 PMID:26569409 PMID:28100771
RGD:11344640 RGD:14696818
G
TNFRSF10B
TNF receptor superfamily member 10b
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18079962
NCBI chr 8:21,101,945...21,150,362
Ensembl chr 8:21,102,267...21,150,267
G
TP53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10626228 PMID:28100771
NCBI chr16:7,047,686...7,065,567
Ensembl chr16:7,045,146...7,066,223
G
TSC22D1
TSC22 domain family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15833021 PMID:17533171
NCBI chr 3:22,529,552...22,673,495
G
VIM
vimentin
ISO
RGD
PMID:19199359
RGD:6480440
NCBI chr 9:17,183,466...17,191,771
Ensembl chr 9:17,183,388...17,191,829
G
XDH
xanthine dehydrogenase
ISO
protein:decreased expression:liver
RGD
PMID:3460692
RGD:13210515
NCBI chr14:76,084,693...76,162,840
Ensembl chr14:76,085,368...76,163,936
G
HNF1A
HNF1 homeobox A
ISO
ClinVar Annotator: match by term: Hepatic adenomas, familial | ClinVar Annotator: match by term: LIVER CELL ADENOMAS, FAMILIAL
OMIM ClinVar
PMID:8866553 PMID:8945470 PMID:9032114 PMID:9045858 PMID:9075818 PMID:9166684 PMID:9313763 PMID:9392505 PMID:9439666 PMID:9754819 PMID:10333057 PMID:10447526 PMID:10754480 PMID:10966642 PMID:11058894 PMID:11296231 PMID:11315851 PMID:11393552 PMID:12050210 PMID:12355088 PMID:12530534 PMID:12574234 PMID:12618559 PMID:14747304 PMID:15649945 PMID:15883474 PMID:15928245 PMID:17054605 PMID:17407387 PMID:17440016 PMID:17573900 PMID:17937063 PMID:17989309 PMID:18003757 PMID:18672310 PMID:19169489 PMID:19929997 PMID:21051477 PMID:21628466 PMID:21696527 PMID:22348187 PMID:22432108 PMID:23348805 PMID:23551881 PMID:23607861 PMID:24097065 PMID:25174781 PMID:25555642 PMID:25741868 PMID:26059258 PMID:26431509 PMID:26467025 PMID:27148439 PMID:28395978 PMID:28492532 PMID:28862987 PMID:29417725 PMID:30293189 PMID:30455330 PMID:30814848 PMID:31264968 PMID:31365591 PMID:31517624 PMID:31576961 PMID:31638168 PMID:32238361 PMID:32395877 PMID:32741144 PMID:32910913 PMID:34373539 PMID:35328643 PMID:35673428 More...
NCBI chr11:116,334,935...116,358,582
Ensembl chr11:116,335,675...116,357,751
G
CA12
carbonic anhydrase 12
ISO
mRNA:increased expression:liver
RGD
PMID:28304380
RGD:153352326
NCBI chr26:20,162,706...20,221,680
Ensembl chr26:20,162,926...20,224,502
G
CTNNB1
catenin beta 1
ISO
protein:increased tyrosine phosphorylation:exon:
RGD
PMID:19101982
RGD:14402052
NCBI chr22:2,679,488...2,725,034
Ensembl chr22:2,684,022...2,723,949
G
FGFR1
fibroblast growth factor receptor 1
ISO
protein:increased expression:liver:
RGD
PMID:24925055
RGD:11055933
NCBI chr 8:36,426,116...36,485,683
Ensembl chr 8:36,427,110...36,485,508
G
PRKACA
protein kinase cAMP-activated catalytic subunit alpha
ISO
mRNA,protein:increased expression:liver (human)
RGD
PMID:27027723
RGD:151347845
NCBI chr 6:12,743,752...12,759,155
G
GJA4
gap junction protein alpha 4
ISO
ClinVar Annotator: match by term: Hepatic hemangioma
ClinVar
PMID:33912852
NCBI chr20:98,092,282...98,095,036
Ensembl chr20:98,092,785...98,093,786
G
TSC2
TSC complex subunit 2
ISO
DNA:mutations:multiple associated with tuberous sclerosis;DNA:mutations:multiple
RGD
PMID:22251200 PMID:29512829
RGD:21079730 RGD:21079732
NCBI chr 5:1,946,534...1,985,168
Ensembl chr 5:1,946,927...1,987,682
G
APC
APC regulator of WNT signaling pathway
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
PMID:1316610 PMID:8381579 PMID:8764128 PMID:9824584 PMID:15311282 PMID:17293347 PMID:20685668 PMID:22135120 PMID:27081525 PMID:28492532 PMID:35495172 More...
NCBI chr23:15,992,437...16,135,117
Ensembl chr23:16,042,287...16,137,067
G
APOA1
apolipoprotein A1
ISO
mRNA, protein:decreased expression:serum (human)
RGD
PMID:27974108
RGD:25671440
NCBI chr 1:108,201,967...108,203,902
Ensembl chr 1:108,201,439...108,203,609
G
ARID1A
AT-rich interaction domain 1A
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
PMID:26822237
NCBI chr20:105,981,549...106,066,093
Ensembl chr20:105,981,290...106,065,672
G
ATM
ATM serine/threonine kinase
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
PMID:11756177 PMID:16832357 PMID:17333338 PMID:19781682 PMID:20305132 PMID:21665257 PMID:24728327 PMID:25085752 PMID:25186627 PMID:25741868 PMID:26467025 PMID:26689913 PMID:26787654 PMID:26837699 PMID:27913932 PMID:28492532 PMID:28779002 PMID:29522266 PMID:29659569 PMID:30256826 PMID:30303537 PMID:30995915 PMID:31780696 PMID:32325837 PMID:33128190 PMID:33359728 PMID:33436325 PMID:33471991 PMID:34262154 PMID:34646395 PMID:35264596 PMID:35495172 PMID:35980532 PMID:37436117 More...
NCBI chr 1:99,653,208...99,786,889
Ensembl chr 1:99,653,139...99,791,520
G
AXIN2
axin 2
ISO
protein:increased expression:liver:
RGD
PMID:11809809
RGD:151356508
NCBI chr16:55,874,043...55,906,739
Ensembl chr16:55,874,072...55,907,281
G
BARD1
BRCA1 associated RING domain 1
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
PMID:25741868 PMID:26467025 PMID:26580448 PMID:28492532 PMID:35264596 PMID:35495172 PMID:36187937 More...
NCBI chr10:100,539,827...100,627,718
Ensembl chr10:100,539,527...100,627,675
G
BRCA2
BRCA2 DNA repair associated
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
PMID:9971877 PMID:10717622 PMID:15937982 PMID:17826769 PMID:19941162 PMID:21120943 PMID:21769658 PMID:23056405 PMID:23893897 PMID:24884479 PMID:25085752 PMID:25348012 PMID:25741868 PMID:26467025 PMID:26933808 PMID:27741520 PMID:28492532 PMID:30212499 PMID:31131967 PMID:31911673 PMID:33471991 PMID:33643918 PMID:35039564 PMID:35495172 PMID:35980532 More...
NCBI chr 3:11,070,086...11,155,257
Ensembl chr 3:11,071,682...11,155,213
G
CLDN1
claudin 1
severity
ISO
mRNA,protein:decreased expression:liver, embryonic tissue (human)
RGD
PMID:16647953
RGD:26884349
NCBI chr15:84,518,464...84,533,587
Ensembl chr15:84,516,478...84,532,969
G
COL7A1
collagen type VII alpha 1 chain
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
PMID:25741868 PMID:28492532
NCBI chr22:9,964,652...9,996,785
Ensembl chr22:9,964,651...9,996,626
G
CTNNB1
catenin beta 1
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
PMID:9500465 PMID:9927029 PMID:10192393 PMID:10398436 PMID:10435629 PMID:10655994 PMID:23265383 PMID:25157968 PMID:25741868 PMID:26619011 PMID:26822237 More...
NCBI chr22:2,679,488...2,725,034
Ensembl chr22:2,684,022...2,723,949
G
CUNH11orf65
chromosome unknown C11orf65 homolog
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
PMID:21665257 PMID:25085752 PMID:25186627 PMID:25741868 PMID:26787654 PMID:28492532 PMID:29522266 PMID:33471991 More...
NCBI chr 1:99,804,191...99,879,834
Ensembl chr 1:99,804,218...99,827,182
G
DHCR7
7-dehydrocholesterol reductase
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
PMID:12270273 PMID:15670717 PMID:16207203 PMID:16392899 PMID:23042628 PMID:24813812 PMID:25741868 PMID:27401223 PMID:28250423 PMID:28492532 PMID:29300326 More...
NCBI chr 1:3,243,263...3,257,332
Ensembl chr 1:3,243,313...3,257,487
G
DIS3L2
DIS3 like 3'-5' exoribonuclease 2
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
PMID:28492532 PMID:35495172
NCBI chr10:117,959,396...118,350,728
Ensembl chr10:117,960,326...118,352,176
G
DOCK8
dedicator of cytokinesis 8
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
PMID:28492532
NCBI chr12:79,060,579...79,298,145
Ensembl chr12:79,060,425...79,298,164
G
DPEP1
dipeptidase 1
ameliorates
ISO
human cells in mouse model
RGD
PMID:31541079
RGD:153344539
G
DROSHA
drosha ribonuclease III
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
NCBI chr 4:30,665,759...30,807,047
Ensembl chr 4:30,665,131...30,795,442
G
EP300
E1A binding protein p300
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
PMID:28492532
NCBI chr19:23,634,132...23,726,095
Ensembl chr19:23,634,571...23,724,979
G
ERCC2
ERCC excision repair 2, TFIIH core complex helicase subunit
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
PMID:24728327 PMID:25741868 PMID:28492532 PMID:29178624
NCBI chr 6:38,804,296...38,823,229
Ensembl chr 6:38,801,423...38,823,073
G
ERCC5
ERCC excision repair 5, endonuclease
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
NCBI chr 3:81,406,103...81,441,422
Ensembl chr 3:81,405,872...81,436,040
G
EXT2
exostosin glycosyltransferase 2
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
NCBI chr 1:21,077,159...21,282,317
Ensembl chr 1:21,119,987...21,281,635
G
FAH
fumarylacetoacetate hydrolase
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
NCBI chr26:3,223,327...3,259,367
Ensembl chr26:3,223,079...3,258,657
G
FANCA
FA complementation group A
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
PMID:24728327 PMID:25741868 PMID:26467025 PMID:28492532
NCBI chr 5:75,073,161...75,149,110
Ensembl chr 5:75,073,358...75,148,591
G
FANCD2
FA complementation group D2
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
PMID:25741868 PMID:28492532 PMID:28678401 PMID:30306255
NCBI chr22:46,072,797...46,141,107
Ensembl chr22:46,072,761...46,140,713
G
FANCD2OS
FANCD2 opposite strand
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
PMID:28492532
NCBI chr22:46,144,575...46,150,638
Ensembl chr22:46,144,859...46,145,392
G
FANCM
FA complementation group M
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
PMID:25741868 PMID:26467025 PMID:28492532 PMID:28678401 PMID:28881617 PMID:29351780 PMID:32522261 PMID:35495172 More...
NCBI chr24:22,255,750...22,327,191
Ensembl chr24:22,256,236...22,329,609
G
FGFR3
fibroblast growth factor receptor 3
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
PMID:28492532 PMID:35495172
NCBI chr27:46,958,444...46,974,032
Ensembl chr27:46,957,254...46,973,392
G
FH
fumarate hydratase
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
PMID:25741868 PMID:28492532
NCBI chr25:78,576,931...78,599,998
Ensembl chr25:78,575,300...78,599,972
G
FLCN
folliculin
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
PMID:25741868 PMID:26467025 PMID:28492532 PMID:35495172
NCBI chr16:16,245,840...16,271,465
Ensembl chr16:16,245,715...16,267,698
G
FLNA
filamin A
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
PMID:28492532
NCBI chr X:128,657,580...128,683,812
Ensembl chr X:128,657,393...128,680,531
G
FRMPD1
FERM and PDZ domain containing 1
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
NCBI chr12:42,835,352...42,981,017
Ensembl chr12:42,835,350...42,980,486
G
GBA1
glucosylceramidase beta 1
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
PMID:12204005 PMID:21228398 PMID:23430543 PMID:25741868
NCBI chr20:8,598,110...8,631,517
Ensembl chr20:8,598,628...8,630,990
G
GLI3
GLI family zinc finger 3
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
PMID:25741868 PMID:28492532
NCBI chr21:16,386,700...16,665,648
Ensembl chr21:16,549,789...16,662,238
G
GPC3
glypican 3
ISO
protein:increased expression:liver (human)
RGD
PMID:23530909
RGD:243065128
NCBI chr X:108,688,706...109,143,653
G
IGF2
insulin like growth factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23958494
NCBI chr 1:1,937,414...1,951,238
Ensembl chr 1:1,936,830...1,945,388
G
JAG1
jagged canonical Notch ligand 1
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
PMID:25741868 PMID:36965188
NCBI chr 2:27,484,699...27,521,108
Ensembl chr 2:27,484,760...27,522,504
G
JMJD1C
jumonji domain containing 1C
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
PMID:28492532
NCBI chr 9:67,913,062...68,135,555
G
KDR
kinase insert domain receptor
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 7:13,435,059...13,482,236
Ensembl chr 7:13,435,096...13,482,771
G
LOC103233229
cadherin-1
ISO
protein:increased expression:liver
RGD
PMID:16465411
RGD:14402053
NCBI chr 5:58,578,244...58,679,677
Ensembl chr 5:58,578,146...58,679,541
G
MET
MET proto-oncogene, receptor tyrosine kinase
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
PMID:25741868 PMID:27666373 PMID:28492532
NCBI chr21:85,370,574...85,486,405
Ensembl chr21:85,397,645...85,488,093
G
MKI67
marker of proliferation Ki-67
ameliorates
ISO
human cells in mouse model
RGD
PMID:31541079
RGD:153344539
NCBI chr 9:120,697,183...120,727,039
Ensembl chr 9:120,698,834...120,726,866
G
MSH2
mutS homolog 2
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
PMID:28492532
NCBI chr14:59,730,101...59,802,857
Ensembl chr14:59,729,789...59,802,819
G
MSH6
mutS homolog 6
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
PMID:25741868 PMID:28492532 PMID:35264596
NCBI chr14:59,375,602...59,400,252
Ensembl chr14:59,375,691...59,400,174
G
MUTYH
mutY DNA glycosylase
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
NCBI chr20:87,449,480...87,462,329
Ensembl chr20:87,448,986...87,462,265
G
NAP1L1
nucleosome assembly protein 1 like 1
ISO
mRNA:increased expression:liver (human)
RGD
PMID:12935928
RGD:9590075
NCBI chr11:71,639,965...71,679,131
Ensembl chr11:71,522,837...71,678,825
G
NDRG4
NDRG family member 4
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
NCBI chr 5:44,402,021...44,452,829
Ensembl chr 5:44,402,453...44,455,245
G
NYNRIN
NYN domain and retroviral integrase containing
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
NCBI chr24:1,380,864...1,401,710
Ensembl chr24:1,381,483...1,401,750
G
PCNA
proliferating cell nuclear antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11560253
NCBI chr 2:32,936,600...32,953,635
Ensembl chr 2:32,948,196...32,953,991
G
RECQL
RecQ like helicase
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
NCBI chr11:21,334,601...21,366,943
Ensembl chr11:21,331,584...21,366,979
G
RECQL4
RecQ like helicase 4
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
PMID:28492532
NCBI chr 8:138,725,494...138,732,286
Ensembl chr 8:138,725,633...138,732,096
G
REN
renin
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
PMID:28492532
NCBI chr25:25,159,816...25,193,620
Ensembl chr25:25,183,037...25,193,420
G
RHBDF2
rhomboid 5 homolog 2
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
NCBI chr16:45,176,152...45,205,464
Ensembl chr16:45,194,852...45,204,761
G
RPS19
ribosomal protein S19
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
PMID:12586610 PMID:25741868 PMID:28492532
NCBI chr 6:36,067,959...36,085,581
G
SALL1
spalt like transcription factor 1
ISO
embryonal subtype;protein:increased expression:liver, nucleus (human)
RGD
PMID:23822878
RGD:11556217
NCBI chr 5:36,928,711...36,944,158
Ensembl chr 5:36,927,990...36,943,630
G
SALL4
spalt like transcription factor 4
ISO
Embryonal Hepatoblastoma;protein:increased expression:liver (human)
RGD
PMID:23822878
RGD:11556217
NCBI chr 2:12,179,721...12,199,629
Ensembl chr 2:12,182,357...12,199,321
G
SH2B3
SH2B adaptor protein 3
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
PMID:20404132 PMID:25741868
NCBI chr11:106,657,601...106,703,940
Ensembl chr11:106,670,685...106,700,619
G
SLX4
SLX4 structure-specific endonuclease subunit
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 5:3,281,468...3,308,296
G
SMO
smoothened, frizzled class receptor
ISO
protein:increased expression:liver
RGD
PMID:21159571
RGD:150521618
NCBI chr21:97,788,955...97,814,549
Ensembl chr21:97,788,624...97,814,709
G
SPOP
speckle type BTB/POZ protein
ISO
mRNA:decreased expression:liver (human)
RGD
PMID:24912477
RGD:153298925
NCBI chr16:69,990,554...70,073,241
G
STK11
serine/threonine kinase 11
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 6:973,033...996,857
Ensembl chr 6:974,144...995,136
G
TGFA
transforming growth factor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11560253
NCBI chr14:36,545,641...36,654,213
Ensembl chr14:36,545,875...36,648,237
G
TGFBR2
transforming growth factor beta receptor 2
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
NCBI chr15:75,112,903...75,200,263
Ensembl chr15:75,112,561...75,197,711
G
TP53
tumor protein p53
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
PMID:1565143 PMID:8401536 PMID:8633021 PMID:12826609 PMID:17606709 PMID:19556618 PMID:20128691 PMID:20586629 PMID:21343334 PMID:22887876 PMID:23031740 PMID:23259501 PMID:25584008 PMID:25741868 PMID:26467025 PMID:26585234 PMID:26619011 PMID:26911350 PMID:27189670 PMID:28279309 PMID:28492532 PMID:28975465 PMID:29070607 PMID:29979965 PMID:30224644 PMID:31775759 PMID:32475984 PMID:32817165 PMID:33087929 More...
NCBI chr16:7,047,686...7,065,567
Ensembl chr16:7,045,146...7,066,223
G
VHL
von Hippel-Lindau tumor suppressor
ISO
ClinVar Annotator: match by term: Hepatoblastoma
ClinVar
PMID:7563486 PMID:8634692 PMID:8707293 PMID:8772572 PMID:8956040 PMID:9829911 PMID:9829912 PMID:10567493 PMID:10612827 PMID:10761708 PMID:11106358 PMID:11257211 PMID:11739384 PMID:12202531 PMID:12414898 PMID:15300849 PMID:19228690 PMID:19574279 PMID:19906784 PMID:20447124 PMID:22234250 PMID:23990664 PMID:23990666 PMID:24033266 PMID:24055113 PMID:25157968 PMID:25637381 PMID:25741868 PMID:26211615 PMID:27527340 PMID:28492532 PMID:28503092 PMID:29790589 PMID:30877234 More...
NCBI chr22:46,184,621...46,203,065
Ensembl chr22:46,184,756...46,204,428
G
ZFHX3
zinc finger homeobox 3
ISO
protein:increased expression:liver (human)
RGD
PMID:33368532
RGD:151361168
NCBI chr 5:55,912,325...56,174,010
Ensembl chr 5:55,907,983...56,085,112
G
CARM1
coactivator associated arginine methyltransferase 1
ISO
mRNA,protein:increased expression:liver:
RGD
PMID:23912631
RGD:9586718
NCBI chr 6:9,866,715...9,915,655
Ensembl chr 6:9,866,534...9,914,682
G
CDKN1B
cyclin dependent kinase inhibitor 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17620307
NCBI chr11:12,612,064...12,617,228
Ensembl chr11:12,612,079...12,617,531
G
CTNNB1
catenin beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147764
NCBI chr22:2,679,488...2,725,034
Ensembl chr22:2,684,022...2,723,949
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
treatment
ISO
RGD
PMID:23543859
RGD:14700918
NCBI chr26:53,390,054...53,403,309
Ensembl chr26:53,390,089...53,404,211
G
HNF1A
HNF1 homeobox A
susceptibility exacerbates
ISO
DNA:loss of heterozygosity, mutations:multiple DNA:mutation: (human) DNA:frameshift mutation, non-sense mutation:cds:R229X, G55fsX57 (human)
RGD
PMID:12355088 PMID:14598263 PMID:17663417
RGD:14700683 RGD:14700774 RGD:150530291
NCBI chr11:116,334,935...116,358,582
Ensembl chr11:116,335,675...116,357,751
G
HRAS
HRas proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8200073
NCBI chr 1:343,613...345,782
Ensembl chr 1:343,506...346,637
G
KRAS
KRAS proto-oncogene, GTPase
induced
ISO
aflatoxin B1 induced:DNA:transversion,transition mutations:cds:
RGD
PMID:8446626
RGD:11568697
NCBI chr11:24,963,396...25,010,747
Ensembl chr11:24,973,619...25,005,191
G
LOC103241760
ubiquitin-conjugating enzyme E2 E2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27914986
NCBI chr15:67,885,721...68,263,924
G
MAP3K8
mitogen-activated protein kinase kinase kinase 8
ameliorates
ISO
RGD
PMID:26560698
RGD:11342977
G
MKI67
marker of proliferation Ki-67
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31939706
NCBI chr 9:120,697,183...120,727,039
Ensembl chr 9:120,698,834...120,726,866
G
NR1H4
nuclear receptor subfamily 1 group H member 4
ISO
RGD
PMID:17183066
RGD:14696794
NCBI chr11:95,792,428...95,877,989
Ensembl chr11:95,792,996...95,878,293
G
NR1I3
nuclear receptor subfamily 1 group I member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25656644
NCBI chr20:2,724,843...2,752,999
Ensembl chr20:2,744,908...2,756,658
G
PTEN
phosphatase and tensin homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15199412 PMID:27022031
RGD:1302555
NCBI chr 9:81,308,058...81,412,386
Ensembl chr 9:81,309,099...81,409,146
G
PTPN11
protein tyrosine phosphatase non-receptor type 11
ISO
MouseDO
NCBI chr11:107,658,495...107,754,457
Ensembl chr11:107,658,453...107,752,637
G
TMEM70
transmembrane protein 70
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27914986
NCBI chr 8:69,576,786...69,582,478
Ensembl chr 8:69,576,808...69,583,308
G
AADAT
aminoadipate aminotransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 7:116,268,241...116,299,509
Ensembl chr 7:116,268,253...116,298,336
G
ABCA1
ATP binding cassette subfamily A member 1
severity
ISO
mRNA:decreased expression:liver (human)
RGD
PMID:16941710 PMID:30580964
RGD:1598532 RGD:24922199
NCBI chr12:34,587,123...34,734,936
Ensembl chr12:34,587,118...34,731,642
G
ABCB1
ATP binding cassette subfamily B member 1
susceptibility
ISO
DNA:polymorphism: :c.3751G>A(human) DNA:polymorphism: : c.1465C > T(human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17510421 PMID:23488625 PMID:24175826 PMID:25625052
RGD:11041138 RGD:14700904 RGD:14700905
NCBI chr21:61,211,044...61,430,691
Ensembl chr21:61,322,748...61,529,274
G
ABCB4
ATP binding cassette subfamily B member 4
ISO
CTD Direct Evidence: marker/mechanism OMIM:114550
CTD MouseDO
PMID:22022477
NCBI chr21:61,459,344...61,529,017
G
ABCC3
ATP binding cassette subfamily C member 3
ISO
mRNA:increased expression:liver
RGD
PMID:25842354
RGD:11535155
NCBI chr16:42,646,316...42,703,124
Ensembl chr16:42,646,812...42,702,852
G
ABCE1
ATP binding cassette subfamily E member 1
ISO
mRNA:increased expression:liver (human)
RGD
PMID:21932399
RGD:11041873
NCBI chr 7:91,673,359...91,704,774
G
ABL1
ABL proto-oncogene 1, non-receptor tyrosine kinase
ISO
RGD
PMID:32171747
RGD:126907997
NCBI chr12:7,258,932...7,435,658
Ensembl chr12:7,256,648...7,312,734
G
ACACA
acetyl-CoA carboxylase alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147110
NCBI chr16:30,374,166...30,704,635
Ensembl chr16:30,452,343...30,705,004
G
ACER3
alkaline ceramidase 3
disease_progression
ISO
RGD
PMID:30097213
RGD:35673325
NCBI chr 1:68,072,323...68,228,036
Ensembl chr 1:68,072,544...68,227,736
G
ACLY
ATP citrate lyase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147110
NCBI chr16:64,343,175...64,392,011
G
ACO2
aconitase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr19:24,008,602...24,068,346
Ensembl chr19:24,008,667...24,071,356
G
ACOX1
acyl-CoA oxidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12771043 PMID:15565109
NCBI chr16:45,706,009...45,745,564
Ensembl chr16:45,706,360...45,740,247
G
ACSL4
acyl-CoA synthetase long chain family member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144
NCBI chr X:97,488,414...97,575,251
G
ACTB
actin beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144 PMID:21472284
NCBI chr28:16,195,676...16,197,161
Ensembl chr12:52,426,752...52,427,879
G
ADAMTS1
ADAM metallopeptidase with thrombospondin type 1 motif 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19514085
NCBI chr 2:65,376,288...65,385,398
Ensembl chr 2:65,376,310...65,385,918
G
ADAMTS13
ADAM metallopeptidase with thrombospondin type 1 motif 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr12:4,677,237...4,718,825
Ensembl chr12:4,677,229...4,714,386
G
ADD1
adducin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144
NCBI chr27:45,811,611...45,901,277
Ensembl chr27:45,813,496...45,900,778
G
ADGRG7
adhesion G protein-coupled receptor G7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr22:80,202,524...80,275,281
Ensembl chr22:80,203,710...80,273,248
G
ADH4
alcohol dehydrogenase 4 (class II), pi polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 7:47,226,787...47,248,518
Ensembl chr 7:47,226,191...47,248,234
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
susceptibility
ISO
DNA:SNP:intron:+276T>G (rs1501299) (human)
RGD
PMID:23740135
RGD:14401720
NCBI chr15:81,128,427...81,142,779
Ensembl chr15:81,129,795...81,147,391
G
ADRA1A
adrenoceptor alpha 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 8:24,884,187...24,985,824
Ensembl chr 8:24,885,741...24,983,125
G
ADRA2B
adrenoceptor alpha 2B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr14:558,876...562,959
Ensembl chr14:561,057...562,400
G
AFP
alpha fetoprotein
treatment disease_progression severity
ISO
protein:increased expression:serum (human) associated with hepatitis B CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:9029167 PMID:15276417 PMID:22147961 PMID:22392353 PMID:24012840 PMID:25968302 PMID:25999787 PMID:28284560 PMID:28611981 PMID:32961231 More...
RGD:125097525 RGD:126790579 RGD:126790583 RGD:14401581 RGD:152177911
NCBI chr 7:21,904,225...21,924,105
Ensembl chr 7:21,905,154...21,924,092
G
AICDA
activation induced cytidine deaminase
ISO
RGD
PMID:18997814
RGD:127285629
NCBI chr11:8,426,920...8,438,331
Ensembl chr11:8,428,922...8,431,641
G
AK3
adenylate kinase 3
ISO
protein:decreased expression:liver
RGD
PMID:17203974
RGD:13842477
NCBI chr12:74,801,673...74,832,838
Ensembl chr12:74,801,671...74,835,475
G
AKR1A1
aldo-keto reductase family 1 member A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32805337
NCBI chr20:87,228,348...87,245,511
Ensembl chr20:87,228,189...87,245,466
G
AKT1
AKT serine/threonine kinase 1
treatment exacerbates
ISO
mRNA:increased expression:liver ClinVar Annotator: match by term: Hepatocellular cancer
RGD ClinVar
PMID:17611497 PMID:18256540 PMID:18392055 PMID:18504432 PMID:18611285 PMID:18954143 PMID:19418217 PMID:19487299 PMID:19853286 PMID:20233444 PMID:20453058 PMID:21464312 PMID:21512767 PMID:21793738 PMID:22538770 PMID:22610119 PMID:22722201 PMID:22722839 PMID:22980975 PMID:23237847 PMID:23348505 PMID:23700467 PMID:23728071 PMID:23934607 PMID:24190505 PMID:24657128 PMID:25157968 PMID:25741868 PMID:25999787 PMID:26619011 PMID:28492532 PMID:31801250 PMID:37460115 More...
RGD:151893509 RGD:152177911 RGD:408364960
NCBI chr24:82,704,087...82,730,711
Ensembl chr24:82,704,068...82,727,698
G
AKT2
AKT serine/threonine kinase 2
ISO
protein:increased phosphorylation:liver (mouse) protein:increased phosphorylation:liver cancer cell (rat)
RGD
PMID:19309364 PMID:28100771
RGD:127285675 RGD:2313299
NCBI chr 6:34,688,585...34,740,458
Ensembl chr 6:34,690,462...34,720,781
G
ALB
albumin
susceptibility
ISO
associated with hepatitis C;protein:decreased expression:serum protein:decreased expression:serum (human)
RGD
PMID:22392353 PMID:23892757 PMID:29040987
RGD:11035269 RGD:125097525 RGD:14694841
NCBI chr 7:21,872,036...21,890,095
Ensembl chr 7:21,876,132...21,891,407
G
ALDH2
aldehyde dehydrogenase 2 family member
susceptibility severity no_association
ISO
associated with alcohol use disorder;DNA:missense mutation:cds: (human) protein:decreased expression: liver (human) DNA:missense mutation:cds, exon 12:p.E487K (human) DNA:missense mutation:cds: (rs671) (human) mRNA, protein:decreased expression:liver (human) associated with alcoholic liver cirrhosis;DNA:missense mutation:cds:p.E487K (human) associated with hepatitis B;DNA;missense mutation, haplotype:cds: (rs671) (human) DNA:missense mutation:exon 12: (human) associated with hepatitis C:DNA:SNP:exon 12 (human)
RGD
PMID:1916152 PMID:10737710 PMID:12940444 PMID:18439068 PMID:25778454 PMID:26150517 PMID:26827895 PMID:28027570 PMID:29765251 More...
RGD:11054822 RGD:14696699 RGD:14696778 RGD:14696779 RGD:14700899 RGD:15036809 RGD:15042857 RGD:15042859 RGD:15042862
NCBI chr11:107,019,015...107,060,784
Ensembl chr11:107,019,111...107,060,374
G
ALDH7A1
aldehyde dehydrogenase 7 family member A1
severity
ISO
mRNA:altered expression:liver tumor (human)
RGD
PMID:30901224
RGD:152995286
NCBI chr23:29,539,897...29,589,004
G
ALDOC
aldolase, fructose-bisphosphate C
ISO
mRNA:increased expression:liver
RGD
PMID:3830170
RGD:2301136
NCBI chr16:22,342,750...22,346,811
Ensembl chr16:22,341,318...22,346,620
G
ALX4
ALX homeobox 4
ameliorates
ISO
mRNA, protein:decreased expression:liver
RGD
PMID:28081728 PMID:31132711
RGD:153323329 RGD:153323330
NCBI chr 1:21,051,413...21,099,159
Ensembl chr 1:21,051,580...21,097,605
G
ANGPTL6
angiopoietin like 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:9,162,219...9,175,163
G
ANK3
ankyrin 3
ISO
protein:decreased expression:liver
RGD
PMID:26652480
RGD:153344559
NCBI chr 9:70,549,665...71,253,928
Ensembl chr 9:70,893,260...71,254,245
G
ANLN
anillin actin binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr21:22,034,213...22,099,207
Ensembl chr21:22,034,259...22,099,158
G
ANTXR1
ANTXR cell adhesion molecule 1
treatment
ISO
RGD
PMID:20650339
RGD:9684932
NCBI chr14:37,849,911...38,116,339
Ensembl chr14:37,877,436...38,115,938
G
ANXA10
annexin A10
disease_progression
ISO
mRNA:decreased expression:liver (human)
RGD
PMID:35693827
RGD:153344586
NCBI chr 7:114,287,291...114,449,532
Ensembl chr 7:114,388,038...114,449,277
G
ANXA2
annexin A2
ISO
mRNA, protein:increased expression:liver (human)
RGD
PMID:33675609
RGD:152999436
NCBI chr26:23,100,000...23,147,687
Ensembl chr26:23,099,992...23,145,457
G
ANXA4
annexin A4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr14:37,297,960...37,384,187
Ensembl chr14:37,297,652...37,344,884
G
ANXA6
annexin A6
disease_progression
ISO
associated with tumor vascularization; protein:decreased expression:liver tumor (human)
RGD
PMID:30901224
RGD:152995286
NCBI chr23:53,657,377...53,714,828
Ensembl chr23:53,657,718...53,714,850
G
APC
APC regulator of WNT signaling pathway
ISO
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma
OMIM ClinVar
PMID:1316610 PMID:8381579 PMID:8381580 PMID:9536098 PMID:9585611 PMID:9824584 PMID:10713886 PMID:11001924 PMID:11247896 PMID:11317365 PMID:11466687 PMID:11748858 PMID:15311282 PMID:15459959 PMID:16461775 PMID:17293347 PMID:17411426 PMID:17489848 PMID:17576681 PMID:17963004 PMID:18199528 PMID:19531215 PMID:19793053 PMID:20223039 PMID:20685668 PMID:21859464 PMID:21901162 PMID:22135120 PMID:22425061 PMID:22431159 PMID:22447671 PMID:22703879 PMID:23159591 PMID:23460355 PMID:23484150 PMID:24033266 PMID:24448499 PMID:24573554 PMID:24599579 PMID:24728327 PMID:25186627 PMID:25479140 PMID:25559809 PMID:25590978 PMID:25637381 PMID:25741868 PMID:25925381 PMID:25980754 PMID:26207792 PMID:26447891 PMID:26467025 PMID:26530882 PMID:26580448 PMID:26690363 PMID:26845104 PMID:26900293 PMID:26976419 PMID:27028212 PMID:27081525 PMID:27150160 PMID:27600092 PMID:27852271 PMID:28051113 PMID:28127413 PMID:28135048 PMID:28135145 PMID:28195569 PMID:28492532 PMID:28526081 PMID:29641532 PMID:29684080 PMID:30267214 PMID:30374176 PMID:30458888 PMID:31428572 PMID:32390703 PMID:32658311 PMID:33294277 PMID:34426522 PMID:35189564 PMID:35264596 More...
NCBI chr23:15,992,437...16,135,117
Ensembl chr23:16,042,287...16,137,067
G
APCS
amyloid P component, serum
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144
NCBI chr20:4,360,955...4,363,810
Ensembl chr20:4,358,654...4,362,095
G
APEX1
apurinic/apyrimidinic endodeoxyribonuclease 1
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25109342 PMID:33841550
RGD:152998960
NCBI chr29:20,978,878...20,981,393
G
APLN
apelin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr X:104,885,639...104,896,371
Ensembl chr X:104,888,996...104,895,014
G
APOA1
apolipoprotein A1
disease_progression
ISO
CTD Direct Evidence: marker/mechanism associated with hepatitis B; protein:decreased expression:plasma (human)
CTD RGD
PMID:21472284 PMID:23935864 PMID:31211449
RGD:153350082 RGD:25671438
NCBI chr 1:108,201,967...108,203,902
Ensembl chr 1:108,201,439...108,203,609
G
APOA2
apolipoprotein A2
ISO
associated with hepatitis B; mRNA:increased expression:liver
RGD
PMID:31211449
RGD:153350082
NCBI chr20:2,757,939...2,760,356
Ensembl chr20:2,759,237...2,760,686
G
APOA4
apolipoprotein A4
disease_progression
ISO
associated with hepatitis B;
RGD
PMID:31211449
RGD:153350082
NCBI chr 1:108,186,627...108,190,508
Ensembl chr 1:108,186,921...108,189,698
G
APOC2
apolipoprotein C2
ISO
associated with hepatitis B; mRNA:increased expression:liver
RGD
PMID:31211449
RGD:153350082
NCBI chr 6:38,406,829...38,411,239
Ensembl chr 6:38,409,641...38,410,927
G
APOC3
apolipoprotein C3
susceptibility disease_progression
ISO
associated with Chronic Hepatitis B;DNA:SNP: :rs2854116(human) associated with hepatitis B;
RGD
PMID:27547913 PMID:31211449
RGD:153344620 RGD:153350082
NCBI chr 1:108,196,283...108,199,274
Ensembl chr 1:108,196,939...108,199,342
G
APOC4
apolipoprotein C4
disease_progression
ISO
associated with hepatitis B;
RGD
PMID:31211449
RGD:153350082
NCBI chr 6:38,391,454...38,406,692
Ensembl chr 6:38,398,471...38,406,697
G
APOE
apolipoprotein E
ISO
protein:increased expression:liver, serum (mouse)
RGD
PMID:21644509
RGD:6903288
NCBI chr 6:38,377,154...38,381,219
Ensembl chr 6:38,376,887...38,381,438
G
APOF
apolipoprotein F
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr11:52,316,413...52,318,956
Ensembl chr11:52,316,800...52,318,659
G
APRT
adenine phosphoribosyltransferase
ISO
protein:increased activity:hepatoma (rat)
RGD
PMID:6327016
RGD:5135035
NCBI chr 5:74,196,858...74,199,789
Ensembl chr 5:74,194,013...74,199,891
G
AR
androgen receptor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18639551
NCBI chr X:57,380,587...57,553,613
Ensembl chr X:57,380,611...57,546,776
G
ARG1
arginase 1
disease_progression
ISO
associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human)
RGD
PMID:17210712 PMID:30901224
RGD:152995286 RGD:4140476
NCBI chr13:41,971,955...41,983,372
Ensembl chr13:41,971,802...41,983,049
G
ARHGAP44
Rho GTPase activating protein 44
exacerbates
ISO
protein:decreased expression:liver (human)
RGD
PMID:31136984
RGD:401901276
NCBI chr16:12,125,543...12,328,203
Ensembl chr16:12,125,574...12,330,501
G
ARHGEF39
Rho guanine nucleotide exchange factor 39
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr12:44,937,488...44,941,708
Ensembl chr12:44,937,923...44,944,842
G
ARID1A
AT-rich interaction domain 1A
exacerbates treatment
ISO
associated with non-alcoholic steatohepatitis mRNA, protein:decreased expression:liver (human) CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:liver (human) human gene in mouse model
RGD CTD
PMID:22561517 PMID:22634756 PMID:22922871 PMID:25975202 PMID:26569409 PMID:26589513 PMID:29113912 PMID:29136504 More...
RGD:11344640 RGD:125097485 RGD:125097495 RGD:125097519 RGD:126790634
NCBI chr20:105,981,549...106,066,093
Ensembl chr20:105,981,290...106,065,672
G
ARID1B
AT-rich interaction domain 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22634756
NCBI chr13:84,351,298...84,799,691
G
ARID2
AT-rich interaction domain 2
exacerbates disease_progression
ISO
CTD Direct Evidence: marker/mechanism associated with hepatitis B;protein:decreased expression:liver
RGD CTD
PMID:21822264 PMID:22634756 PMID:25701229 PMID:27351279 PMID:28498550 PMID:32071245 More...
RGD:150340708 RGD:150340711 RGD:150340712 RGD:150429631
NCBI chr11:41,933,650...42,117,495
Ensembl chr11:42,028,083...42,118,892
G
ARID3A
AT-rich interaction domain 3A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35179300
NCBI chr 6:667,426...727,987
Ensembl chr 6:680,965...727,843
G
ARRB2
arrestin beta 2
treatment
ISO
RGD
PMID:33841550
RGD:152998960
NCBI chr16:4,191,040...4,202,382
Ensembl chr16:4,191,172...4,202,385
G
ASF1B
anti-silencing function 1B histone chaperone
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:12,760,865...12,773,423
G
ASL
argininosuccinate lyase
disease_progression
ISO
associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human)
RGD
PMID:30901224
RGD:152995286
NCBI chr28:1,782,434...1,800,581
Ensembl chr28:1,782,553...1,802,517
G
ASNS
asparagine synthetase (glutamine-hydrolyzing)
ISO
protein:increased activity:serum (rat)
RGD
PMID:10081
RGD:2316006
NCBI chr21:51,244,514...51,264,694
Ensembl chr21:51,247,742...51,265,241
G
ASPG
asparaginase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr24:82,021,590...82,049,281
Ensembl chr24:82,021,726...82,049,355
G
ASPM
assembly factor for spindle microtubules
disease_progression
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18676753 PMID:28284560
RGD:13439743
NCBI chr25:32,269,518...32,334,617
Ensembl chr25:32,281,424...32,334,977
G
ASS1
argininosuccinate synthase 1
disease_progression
ISO
associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human)
RGD
PMID:12359751 PMID:30901224
RGD:152995286 RGD:4140479
NCBI chr12:7,643,484...7,701,334
G
ATG101
autophagy related 101
disease_progression
ISO
RGD
PMID:35592424
RGD:153350091
NCBI chr11:48,243,200...48,251,129
Ensembl chr11:48,243,216...48,251,371
G
ATG7
autophagy related 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29191453
NCBI chr22:47,187,305...47,571,309
Ensembl chr22:47,325,614...47,571,070
G
ATM
ATM serine/threonine kinase
exacerbates
ISO
protein:increased expression:liver (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:12866955 PMID:19919837
RGD:126781750
NCBI chr 1:99,653,208...99,786,889
Ensembl chr 1:99,653,139...99,791,520
G
ATP5PB
ATP synthase peripheral stalk-membrane subunit b
ISO
associated with hepatitis C
RGD
PMID:18932288
RGD:14696822
NCBI chr20:22,150,488...22,162,740
Ensembl chr20:22,150,239...22,162,312
G
ATP5PD
ATP synthase peripheral stalk subunit d
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr16:46,625,512...46,630,613
G
AURKA
aurora kinase A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:7,730,060...7,753,167
Ensembl chr 2:7,734,128...7,752,395
G
AURKB
aurora kinase B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr16:7,571,255...7,583,034
Ensembl chr16:7,570,538...7,582,959
G
AXIN1
axin 1
disease_progression
ISO
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma protein:decreased expression:liver (human) associated with Hepatitis B, Chronic,DNA:SNP, haplotype:exon:(rs1805105) T>C (human)
OMIM ClinVar RGD
PMID:10700176 PMID:25741868 PMID:26968103 PMID:28492532 PMID:31514071 PMID:37582359 More...
RGD:14402039 RGD:150530482
NCBI chr 5:233,520...295,134
Ensembl chr 5:234,060...290,575
G
AXIN2
axin 2
ISO
protein:increased expression:liver:
RGD
PMID:11809809
RGD:151356508
NCBI chr16:55,874,043...55,906,739
Ensembl chr16:55,874,072...55,907,281
G
AZGP1
alpha-2-glycoprotein 1, zinc-binding
disease_progression
ISO
associated with hepatitis B;mRNA:decreased expression:liver
RGD
PMID:22625427 PMID:26902423 PMID:27993894
RGD:153350130 RGD:153350132 RGD:153350133
NCBI chr28:13,104,262...13,120,329
Ensembl chr28:13,104,323...13,120,363
G
AZIN1
antizyme inhibitor 1
disease_progression
ISO
RNA:increased editing:liver
RGD
PMID:23291631
RGD:14700705
NCBI chr 8:97,679,775...97,717,486
Ensembl chr 8:97,679,468...97,696,928
G
BANF1
barrier to autointegration nuclear assembly factor 1
treatment
ISO
mRNA, protein:increased expression:liver (rat) mRNA, protein:increased expression:liver (human)
RGD
PMID:29059470
RGD:155791679
NCBI chr 1:8,254,186...8,255,571
Ensembl chr 1:8,253,884...8,255,572
G
BAX
BCL2 associated X, apoptosis regulator
treatment
ISO
RGD
PMID:33841550
RGD:152998960
NCBI chr 6:42,186,028...42,193,105
G
BCL2
BCL2 apoptosis regulator
treatment
ISO
mRNA:increased expression:liver (mouse)
RGD
PMID:28100771 PMID:33841550
RGD:127285675 RGD:152998960
NCBI chr18:16,440,560...16,643,187
Ensembl chr18:16,441,733...16,637,895
G
BCL2L1
BCL2 like 1
treatment
ISO
CTD Direct Evidence: marker/mechanism|therapeutic mRNA:increased expression:liver (mouse)
CTD RGD
PMID:10629087 PMID:11509945 PMID:28100771 PMID:33841550
RGD:127285675 RGD:152998960
NCBI chr 2:36,059,024...36,118,332
Ensembl chr 2:36,058,919...36,116,470
G
BCORL1
BCL6 corepressor like 1
disease_progression
ISO
RGD
PMID:26879601 PMID:29679906
RGD:11556159 RGD:150340705
NCBI chr X:105,238,616...105,314,326
Ensembl chr X:105,240,043...105,314,553
G
BHMT
betaine--homocysteine S-methyltransferase
disease_progression
ISO
associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human)
RGD
PMID:30901224
RGD:152995286
NCBI chr 4:73,331,551...73,352,259
Ensembl chr 4:73,332,259...73,352,434
G
BHMT2
betaine--homocysteine S-methyltransferase 2
severity
ISO
mRNA:altered expression:liver tumor (human)
RGD
PMID:30901224
RGD:152995286
NCBI chr 4:73,289,836...73,310,312
Ensembl chr 4:73,289,652...73,312,358
G
BIRC3
baculoviral IAP repeat containing 3
exacerbates treatment ameliorates
ISO
mRNA, protein:increased expression:liver (human) human cell line in a mouse model associated with hepatitis B;mRNA, protein:increased expression:liver (human)
RGD
PMID:22682366 PMID:22820591 PMID:30210622 PMID:30368883 PMID:33310033
RGD:152998937 RGD:152998984 RGD:152998986 RGD:152998988 RGD:152999010
NCBI chr 1:93,692,239...93,711,905
G
BIRC5
baculoviral IAP repeat containing 5
disease_progression
ISO
CTD Direct Evidence: marker/mechanism|therapeutic mRNA:increased expression:liver (human)
CTD RGD
PMID:16086872 PMID:20514400 PMID:31964418
RGD:153344516
NCBI chr16:70,226,824...70,237,000
G
BIRC7
baculoviral IAP repeat containing 7
exacerbates
ISO
mRNA:increased expression:liver (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr 2:965,811...970,983
G
BLZF1
basic leucine zipper nuclear factor 1
disease_progression
ISO
RGD
PMID:26342799
RGD:14398326
NCBI chr25:59,665,035...59,685,304
Ensembl chr25:59,664,280...59,685,376
G
BMI1
BMI1 proto-oncogene, polycomb ring finger
treatment
ISO
RGD
PMID:26919246
RGD:14928318
NCBI chr 9:22,095,592...22,104,894
G
BMPER
BMP binding endothelial regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr21:24,255,857...24,500,790
Ensembl chr21:24,255,866...24,500,720
G
BRAF
B-Raf proto-oncogene, serine/threonine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27222248
NCBI chr21:109,495,525...109,690,261
G
BSG
basigin (Ok blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36574092
NCBI chr 6:309,579...320,209
Ensembl chr 6:309,506...321,785
G
BTG2
BTG anti-proliferation factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18393292
NCBI chr25:26,032,404...26,036,500
Ensembl chr25:26,034,632...26,036,538
G
BUB1
BUB1 mitotic checkpoint serine/threonine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr14:13,647,342...13,698,061
Ensembl chr14:13,647,462...13,697,932
G
BUB1B
BUB1 mitotic checkpoint serine/threonine kinase B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr26:42,769,955...42,855,353
Ensembl chr26:42,792,830...42,855,306
G
C3
complement C3
ISO
RGD
PMID:23245919
RGD:11040806
NCBI chr 6:6,250,422...6,289,264
G
C9
complement C9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144 PMID:28284560
NCBI chr 4:38,082,751...38,165,886
Ensembl chr 4:38,082,457...38,164,164
G
CA12
carbonic anhydrase 12
ameliorates disease_progression
ISO
mRNA:altered expression:liver
RGD
PMID:29900055 PMID:31934040 PMID:35362480
RGD:153352325 RGD:153352328 RGD:155226869
NCBI chr26:20,162,706...20,221,680
Ensembl chr26:20,162,926...20,224,502
G
CA2
carbonic anhydrase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 8:80,830,963...80,848,245
Ensembl chr 8:80,830,939...80,848,707
G
CA9
carbonic anhydrase 9
ISO
mRNA:altered expression:liver
RGD
PMID:29900055
RGD:155226869
NCBI chr12:44,921,530...44,929,504
Ensembl chr12:44,921,665...44,928,831
G
CAB39
calcium binding protein 39
disease_progression
ISO
RGD
PMID:28605041
RGD:14398832
NCBI chr10:116,749,173...116,860,814
Ensembl chr10:116,798,825...116,861,332
G
CAD
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
ISO
DNA:amplification:cds (rat) mRNA:increased expression:liver
RGD
PMID:2888462 PMID:2914957 PMID:7053379
RGD:10755426 RGD:2303530 RGD:5132587
NCBI chr14:80,371,154...80,399,193
Ensembl chr14:80,371,096...80,398,914
G
CADM1
cell adhesion molecule 1
ISO
DNA, mRNA, protein:hypermethylation, decreased expression:promoter:liver
RGD
PMID:17428255
RGD:2289095
NCBI chr 1:106,539,262...106,876,397
Ensembl chr 1:106,539,136...106,606,637
G
CADM2
cell adhesion molecule 2
disease_progression
ISO
mRNA, protein:decreased expression:liver
RGD
PMID:24240726
RGD:15092075
NCBI chr22:90,879,537...91,994,144
G
CALML3
calmodulin like 3
severity
ISO
protein:decreased expression:liver (human)
RGD
PMID:29445139
RGD:151665319
NCBI chr 9:5,634,739...5,636,634
Ensembl chr 9:5,635,456...5,635,905
G
CALR
calreticulin
treatment exacerbates
ISO
human cells and recombinant gene in a mouse model protein:increased expression:liver (human)
RGD
PMID:12096119 PMID:24997628 PMID:27055635
RGD:150521681 RGD:150521690 RGD:150521691
NCBI chr 6:11,618,691...11,624,299
Ensembl chr 6:11,618,396...11,623,792
G
CAMK2N1
calcium/calmodulin dependent protein kinase II inhibitor 1
ISO
RGD
PMID:23651211
RGD:18337283
NCBI chr20:112,064,718...112,068,505
Ensembl chr20:112,065,581...112,067,256
G
CAP2
cyclase associated actin cytoskeleton regulatory protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr17:54,575,289...54,742,565
Ensembl chr17:54,574,145...54,742,757
G
CAPN3
calpain 3
ISO
mRNA:decreased expression:skeletal muscle
RGD
PMID:10806331
RGD:1600777
NCBI chr26:40,568,320...40,657,443
Ensembl chr26:40,568,885...40,625,597
G
CARM1
coactivator associated arginine methyltransferase 1
ISO
mRNA,protein:increased expression:liver:
RGD
PMID:23912631
RGD:9586718
NCBI chr 6:9,866,715...9,915,655
Ensembl chr 6:9,866,534...9,914,682
G
CASP3
caspase 3
treatment
ISO
RGD
PMID:29133031 PMID:33841550
RGD:13782296 RGD:152998960
NCBI chr 7:130,589,592...130,610,845
Ensembl chr 7:130,591,166...130,610,899
G
CASP8
caspase 8
treatment severity
ISO
associated with hepatitis B;DNA:insertion/deletion:promoter: (rs3834129) (human)
OMIM RGD
PMID:28643196 PMID:29133031
RGD:13782296 RGD:14695027
NCBI chr10:86,888,654...86,944,159
Ensembl chr10:86,916,527...86,943,829
G
CASP9
caspase 9
treatment
ISO
RGD
PMID:29133031
RGD:13782296
NCBI chr20:116,772,819...116,798,402
Ensembl chr20:116,772,155...116,798,930
G
CAT
catalase
disease_progression
ISO
associated with liver cirrhosis with Hepatitis C;DNA:SNP:promoter:-262T>C (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:21907168 PMID:33010264
RGD:27095879
NCBI chr 1:30,792,533...30,828,920
Ensembl chr 1:30,792,399...30,829,592
G
CBFB
core-binding factor subunit beta
ISO
mRNA:decreased expression:liver
RGD
PMID:17094378
RGD:126775147
NCBI chr 5:60,356,303...60,445,793
Ensembl chr 5:60,356,272...60,445,729
G
CBL
Cbl proto-oncogene
disease_progression
ISO
RGD
PMID:26474280
RGD:11536137
NCBI chr 1:110,581,049...110,679,284
Ensembl chr 1:110,581,143...110,674,481
G
CBX2
chromobox 2
disease_progression
ISO
mRNA:increased expression:liver (human)
RGD
PMID:35693827
RGD:153344586
NCBI chr16:71,741,476...71,749,234
Ensembl chr16:71,741,500...71,751,817
G
CBX4
chromobox 4
disease_progression
ISO
protein:increased expression:cytoplasm:
RGD
PMID:23943028 PMID:24838576
RGD:9586738 RGD:9586739
NCBI chr16:71,795,919...71,802,184
Ensembl chr16:71,795,862...71,802,051
G
CBX7
chromobox 7
ISO
mRNA:decreased expression:liver
RGD
PMID:22041561
RGD:9587355
NCBI chr19:21,776,618...21,798,525
Ensembl chr19:21,775,931...21,798,309
G
CCBE1
collagen and calcium binding EGF domains 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr18:20,054,281...20,363,024
Ensembl chr18:20,271,874...20,309,784
G
CCL1
C-C motif chemokine ligand 1
ISO
mRNA:increased expression:liver (mouse)
RGD
PMID:26569409
RGD:11344640
NCBI chr16:27,868,925...27,890,143
G
CCL13
C-C motif chemokine ligand 13
ISO
mRNA:increased expression:liver (mouse)
RGD
PMID:26569409
RGD:11344640
NCBI chr16:27,864,260...27,867,457
Ensembl chr16:27,865,318...27,867,415
G
CCL2
C-C motif chemokine ligand 2
treatment
ISO
RNA:increased expression:liver
RGD
PMID:12679798 PMID:22402625 PMID:27980102
RGD:14995459 RGD:14995468 RGD:14995927
NCBI chr16:27,763,354...27,765,437
Ensembl chr16:27,763,555...27,765,416
G
CCL5
C-C motif chemokine ligand 5
susceptibility treatment
ISO
associated with alcoholic liver cirrhosis;DNA:SNP:promoter:-403G>A(human) DNA:polymorphisms:promoter:-403G>A,-28C>G (human)
RGD
PMID:21610221 PMID:22374185 PMID:28011329
RGD:14995306 RGD:14995333 RGD:14995338
NCBI chr16:29,351,214...29,361,317
G
CCN1
cellular communication network factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17699798
NCBI chr20:47,783,270...47,786,216
Ensembl chr20:47,783,935...47,785,997
G
CCNA1
cyclin A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12029619
NCBI chr 3:14,979,775...14,992,609
Ensembl chr 3:14,982,392...14,993,562
G
CCNB1
cyclin B1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 4:65,265,798...65,276,465
Ensembl chr 4:65,265,844...65,277,085
G
CCNB2
cyclin B2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr26:24,389,654...24,408,976
Ensembl chr26:24,389,642...24,409,346
G
CCND1
cyclin D1
susceptibility
ISO
mRNA:increased expression:liver (mouse) CTD Direct Evidence: marker/mechanism associated with Hepatitis B, Chronic;DNA:SNP:splice-site mutation:870G>A (human)
RGD CTD
PMID:12029619 PMID:19919837 PMID:22649188 PMID:25822088 PMID:25851350 PMID:26189965 PMID:28100771 More...
RGD:127285675 RGD:14401586
NCBI chr 1:4,909,616...4,922,272
Ensembl chr 1:4,907,353...4,922,357
G
CCND2
cyclin D2
disease_progression susceptibility severity
ISO
associated with hepatitis B associated with Chronic Hepatitis C;DNA:SNP: :rs1049606(human) DNA:hypermethylation:CpG site
RGD
PMID:22004425 PMID:31059558 PMID:33320844
RGD:151664743 RGD:151665109 RGD:151665169
NCBI chr11:4,307,419...4,339,003
Ensembl chr11:4,307,401...4,333,661
G
CCNE1
cyclin E1
ameliorates
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:12029619 PMID:17196522 PMID:22634754 PMID:28100771 PMID:29551768
RGD:127285675 RGD:153297807 RGD:2289277
NCBI chr 6:24,879,923...24,888,985
G
CCNF
cyclin F
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 5:2,302,249...2,336,188
Ensembl chr 5:2,302,341...2,335,270
G
CCNG2
cyclin G2
ISO
RGD
PMID:27982046
RGD:151361200
NCBI chr 7:25,657,548...25,667,464
Ensembl chr 7:25,657,441...25,666,254
G
CCR1
C-C motif chemokine receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16284949
NCBI chr22:7,634,205...7,641,380
G
CD163
CD163 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr11:7,501,562...7,536,332
Ensembl chr11:7,501,150...7,536,295
G
CD274
CD274 molecule
disease_progression
ISO
associated with hepatitis B CTD Direct Evidence: marker/mechanism associated with hepatitis B
RGD CTD
PMID:21912640 PMID:22396772 PMID:30267213
RGD:40818240 RGD:41410800
NCBI chr12:74,038,844...74,060,662
Ensembl chr12:74,041,767...74,056,806
G
CD276
CD276 molecule
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16217749
NCBI chr26:9,772,948...9,794,395
G
CD34
CD34 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr25:21,534,969...21,559,951
Ensembl chr25:21,534,983...21,561,215
G
CD40LG
CD40 ligand
ISO
RGD
PMID:19016771
RGD:2313413
NCBI chr X:111,655,301...111,667,602
Ensembl chr X:111,655,397...111,666,639
G
CD5L
CD5 molecule like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr20:6,059,103...6,074,657
Ensembl chr20:6,065,620...6,070,904
G
CD68
CD68 molecule
severity
ISO
protein:increased expression:liver (human)
RGD
PMID:28656201
RGD:40924686
NCBI chr16:6,956,633...6,959,645
Ensembl chr16:6,957,212...6,959,042
G
CDC20
cell division cycle 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr20:89,449,008...89,453,263
Ensembl chr20:89,444,165...89,453,044
G
CDC25C
cell division cycle 25C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr23:40,960,154...41,013,016
Ensembl chr23:40,960,572...41,006,984
G
CDC27
cell division cycle 27
ISO
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma
ClinVar
NCBI chr16:59,497,731...59,564,298
Ensembl chr16:59,497,713...59,564,480
G
CDC45
cell division cycle 45
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr19:6,232,610...6,275,743
Ensembl chr19:6,231,591...6,275,294
G
CDC6
cell division cycle 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr16:65,873,341...65,888,180
Ensembl chr16:65,871,627...65,888,217
G
CDCA2
cell division cycle associated 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 8:23,582,062...23,631,590
Ensembl chr 8:23,582,744...23,632,045
G
CDCA3
cell division cycle associated 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr11:6,882,125...6,885,311
Ensembl chr11:6,881,504...6,885,118
G
CDCA5
cell division cycle associated 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:9,151,503...9,157,412
Ensembl chr 1:9,151,712...9,157,456
G
CDCA8
cell division cycle associated 8
disease_progression
ISO
mRNA:increased expression:liver (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:28284560 PMID:35693827
RGD:153344586
NCBI chr20:95,151,814...95,169,111
Ensembl chr20:95,151,752...95,169,033
G
CDH13
cadherin 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18425332 PMID:18553387 PMID:28284560
NCBI chr 5:68,048,655...69,213,102
Ensembl chr 5:68,451,894...69,211,534
G
CDK1
cyclin dependent kinase 1
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:liver (human)
CTD RGD
PMID:19136513 PMID:28284560
RGD:2316317
NCBI chr 9:70,475,736...70,492,947
G
CDK12
cyclin dependent kinase 12
exacerbates
ISO
mRNA, protein:increased expression:liver (human)
RGD
PMID:31519701
RGD:151361172
NCBI chr16:66,612,238...66,709,437
Ensembl chr16:66,623,785...66,708,755
G
CDK13
cyclin dependent kinase 13
onset
ISO
DNA:amplification: :
RGD
PMID:22912832
RGD:155641228
NCBI chr21:18,551,273...18,688,889
Ensembl chr21:18,553,446...18,688,525
G
CDK14
cyclin dependent kinase 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22922871
NCBI chr21:57,752,126...58,434,621
Ensembl chr21:57,751,721...58,335,258
G
CDK4
cyclin dependent kinase 4
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:26189965 PMID:33841550
RGD:152998960
NCBI chr11:53,661,877...53,665,688
Ensembl chr11:53,659,336...53,664,861
G
CDKN1A
cyclin dependent kinase inhibitor 1A
ISO
OMIM:114550
MouseDO
NCBI chr17:35,445,668...35,454,334
Ensembl chr17:35,445,223...35,454,342
G
CDKN1B
cyclin dependent kinase inhibitor 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20698225
NCBI chr11:12,612,064...12,617,228
Ensembl chr11:12,612,079...12,617,531
G
CDKN1C
cyclin dependent kinase inhibitor 1C
severity
ISO
protein:decreased expression:liver (human)
RGD
PMID:26606000
RGD:11354707
NCBI chr 1:2,696,382...2,699,054
Ensembl chr 1:2,696,233...2,699,028
G
CDKN2C
cyclin dependent kinase inhibitor 2C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr20:81,964,164...81,970,891
Ensembl chr20:81,963,562...81,968,450
G
CDKN3
cyclin dependent kinase inhibitor 3
severity treatment
ISO
associated with alcoholism; protein:increased expression:liver protein:decreased expression:liver mRNA:increased expression:liver CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:22390936 PMID:23292002 PMID:27314282 PMID:28284560
RGD:15090800 RGD:15090801 RGD:15090802
NCBI chr24:31,554,461...31,578,916
Ensembl chr24:31,554,510...31,579,664
G
CDT1
chromatin licensing and DNA replication factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 5:74,190,409...74,196,589
Ensembl chr 5:74,190,947...74,195,972
G
CEBPA
CCAAT enhancer binding protein alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16288022 PMID:21785164
NCBI chr 6:28,342,506...28,345,759
Ensembl chr 6:28,343,907...28,344,977
G
CEBPB
CCAAT enhancer binding protein beta
ISO
mRNA:increased expression:liver (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:14563831 PMID:30659195
RGD:40903042
NCBI chr 2:13,780,538...13,782,639
Ensembl chr 2:13,781,160...13,782,194
G
CEBPD
CCAAT enhancer binding protein delta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14563831
NCBI chr 8:43,873,075...43,874,375
G
CELSR3
cadherin EGF LAG seven-pass G-type receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr22:10,046,361...10,073,689
Ensembl chr22:10,045,900...10,072,395
G
CENPA
centromere protein A
ISO
protein:increased expression:liver (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:21956590 PMID:28284560
RGD:36947377
NCBI chr14:80,838,049...80,847,609
Ensembl chr14:80,839,335...80,846,608
G
CENPE
centromere protein E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 7:51,212,266...51,300,153
G
CENPF
centromere protein F
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr25:14,914,805...14,972,811
Ensembl chr25:14,914,809...14,972,796
G
CENPM
centromere protein M
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr19:24,471,420...24,481,271
Ensembl chr19:24,471,178...24,481,239
G
CENPU
centromere protein U
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 7:130,653,805...130,697,329
Ensembl chr 7:130,653,967...130,697,233
G
CENPW
centromere protein W
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr13:47,363,726...47,372,472
Ensembl chr13:47,363,717...47,372,164
G
CEP131
centrosomal protein 131
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr16:73,138,784...73,172,677
Ensembl chr16:73,139,683...73,170,339
G
CEP164
centrosomal protein 164
susceptibility
ISO
associated with Chronic Hepatitis C;DNA:SNP: :rs573455 (human)
RGD
PMID:22004425
RGD:151665169
NCBI chr 1:108,690,196...108,787,175
Ensembl chr 1:108,701,884...108,790,678
G
CEP55
centrosomal protein 55
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:86,746,658...86,772,052
Ensembl chr 9:86,749,730...86,771,115
G
CETP
cholesteryl ester transfer protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 5:42,909,994...42,936,277
Ensembl chr 5:42,910,226...42,936,277
G
CHAF1B
chromatin assembly factor 1 subunit B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:80,379,637...80,409,626
Ensembl chr 2:80,380,425...80,409,687
G
CHD4
chromodomain helicase DNA binding protein 4
exacerbates
ISO
mRNA:increased expression:liver (human) protein:increased expression:liver (human)
RGD
PMID:26095183 PMID:28486105 PMID:32070428
RGD:11571740 RGD:153323299 RGD:153323308
NCBI chr11:6,603,820...6,641,278
Ensembl chr11:6,602,694...6,640,351
G
CHD5
chromodomain helicase DNA binding protein 5
ISO
mRNA:decreased expression:liver
RGD
PMID:26517514
RGD:11537550
NCBI chr20:125,558,640...125,635,748
Ensembl chr20:125,558,713...125,631,277
G
CKAP2L
cytoskeleton associated protein 2 like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr14:15,753,596...15,780,051
Ensembl chr14:15,751,721...15,779,994
G
CKAP4
cytoskeleton associated protein 4
disease_progression
ISO
associated with tumor vascularization; mRNA,protein:increased expression:liver tumor (human)
RGD
PMID:30901224
RGD:152995286
NCBI chr11:101,460,989...101,471,104
Ensembl chr11:101,460,759...101,471,474
G
CLDN1
claudin 1
severity
ISO
protein:decreased expression:liver (human) protein:increased expression:liver (human) associated with liver cirrhosis;protein:increased expression:liver (human)
RGD
PMID:17270214 PMID:24696415 PMID:24815833
RGD:26884345 RGD:26884348 RGD:26884352
NCBI chr15:84,518,464...84,533,587
Ensembl chr15:84,516,478...84,532,969
G
CLEC1B
C-type lectin domain family 1 member B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr11:9,869,686...9,875,998
Ensembl chr11:9,869,768...9,875,707
G
CLPTM1L
CLPTM1 like
susceptibility disease_progression
ISO
DNA:SNPs::rs401681(human) DNA:SNP: :rs401681(human)
RGD
PMID:25339005 PMID:29042796
RGD:150530496 RGD:150537100
NCBI chr 4:1,140,272...1,162,663
Ensembl chr 4:1,140,132...1,162,898
G
CLTRN
collectrin, amino acid transport regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr X:14,103,046...14,154,936
Ensembl chr X:14,102,497...14,154,123
G
CNDP1
carnosine dipeptidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr18:5,317,101...5,364,323
Ensembl chr18:5,317,542...5,364,277
G
CNOT9
CCR4-NOT transcription complex subunit 9
ISO
ClinVar Annotator: match by term: Hepatocellular carcinoma
ClinVar
PMID:26619011
NCBI chr10:104,473,215...104,502,321
Ensembl chr10:104,473,216...104,503,007
G
CNTNAP4
contactin associated protein family member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 5:61,706,427...61,984,656
Ensembl chr 5:61,706,444...61,982,587
G
COL15A1
collagen type XV alpha 1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr12:40,355,643...40,483,794
G
COL18A1
collagen type XVIII alpha 1 chain
severity
ISO
Protein:increased expression
RGD
PMID:15739185
RGD:1600906
NCBI chr 2:89,129,674...89,186,490
G
COLEC10
collectin subfamily member 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 8:113,663,768...113,704,070
Ensembl chr 8:113,664,263...113,702,720
G
COMT
catechol-O-methyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15341023
NCBI chr19:5,775,829...5,803,260
Ensembl chr19:5,773,225...5,785,422
G
COPS5
COP9 signalosome subunit 5
severity
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:liver (human)
CTD RGD
PMID:20698225 PMID:26606000
RGD:11354707
NCBI chr 8:62,905,924...62,925,205
Ensembl chr 8:62,905,906...62,925,201
G
COX7B2
cytochrome c oxidase subunit 7B2, mitochondrial
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr27:3,353,319...3,503,408
Ensembl chr27:3,503,043...3,503,285
G
CPEB3
cytoplasmic polyadenylation element binding protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:85,325,768...85,569,192
Ensembl chr 9:85,331,466...85,525,688
G
CPS1
carbamoyl-phosphate synthase 1
disease_progression
ISO
associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human)
RGD
PMID:30901224
RGD:152995286
NCBI chr10:96,267,890...96,392,393
Ensembl chr10:96,267,889...96,392,206
G
CREBBP
CREB binding protein
ISO
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: LIVER CELL CARCINOMA
ClinVar
PMID:21390126 PMID:21680795 PMID:21796119 PMID:22832583 PMID:23334668 PMID:23685749 PMID:23778141 PMID:25741868 PMID:26087898 PMID:26619011 PMID:27257180 PMID:28492532 PMID:28970362 PMID:29551561 PMID:33560380 More...
NCBI chr 5:3,415,548...3,570,030
Ensembl chr 5:3,415,412...3,540,943
G
CRHBP
corticotropin releasing hormone binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 4:71,203,335...71,223,179
Ensembl chr 4:71,205,932...71,223,172
G
CRP
C-reactive protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144
NCBI chr20:4,232,262...4,235,826
Ensembl chr20:4,232,913...4,235,377
G
CSF1R
colony stimulating factor 1 receptor
exacerbates severity
ISO
mRNA:increased expression:liver (human) protein:increased expression: liver (human) protein:increased expression:liver (human) DNA:hypomethylation:promoter (human)
RGD
PMID:11412385 PMID:14969845 PMID:20551429 PMID:32724427 PMID:32760707
RGD:150524279 RGD:150524282 RGD:150524286 RGD:150524301 RGD:150524302
NCBI chr23:52,663,290...52,723,652
Ensembl chr23:52,664,076...52,697,304
G
CSF2
colony stimulating factor 2
treatment
ISO
RGD
PMID:12731087
RGD:10450243
NCBI chr23:34,906,987...34,911,252
Ensembl chr23:34,908,911...34,911,140
G
CSK
C-terminal Src kinase
ISO
protein:decreased expression:liver
RGD
PMID:9918913
RGD:5134372
NCBI chr26:8,667,657...8,688,850
Ensembl chr26:8,667,655...8,688,824
G
CSMD1
CUB and Sushi multiple domains 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 8:2,806,358...4,821,568
G
CSPG4
chondroitin sulfate proteoglycan 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr26:7,735,972...7,761,355
Ensembl chr26:7,694,014...7,761,342
G
CSRNP1
cysteine and serine rich nuclear protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr15:262,329...274,003
Ensembl chr15:262,382...276,505
G
CTLA4
cytotoxic T-lymphocyte associated protein 4
susceptibility
ISO
DNA:SNPs: :rs231775,rs231725(human) protein:increased expression:CD4+ and CD8+ T cells:
RGD
PMID:23432218 PMID:28648905
RGD:14398741 RGD:14398742
NCBI chr10:89,637,176...89,644,436
Ensembl chr10:89,638,314...89,642,344
G
CTNNB1
catenin beta 1
severity exacerbates susceptibility
ISO
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma | ClinVar Annotator: match by term: LIVER CELL CARCINOMA DNA:Mutations:exon: DNA:missense mutations:exon 3:multiple (human) associated with hepatitis B;DNA:SNPs: :rs3864004,rs11564475(human) associated with Hepatitis B, Chronic,DNA:SNP, haplotype: :rs3864004 (human)
OMIM ClinVar RGD
PMID:9065402 PMID:9065403 PMID:9294210 PMID:9500465 PMID:9927029 PMID:10027390 PMID:10192393 PMID:10391090 PMID:10398436 PMID:10435629 PMID:10655994 PMID:10666372 PMID:11351304 PMID:11930117 PMID:11950921 PMID:12124804 PMID:15133491 PMID:19101982 PMID:19234609 PMID:21903672 PMID:23033978 PMID:23265383 PMID:24614104 PMID:24728327 PMID:24788118 PMID:25157968 PMID:25326635 PMID:25326669 PMID:25741868 PMID:26350204 PMID:26502894 PMID:26619011 PMID:26822237 PMID:26968103 PMID:27276713 PMID:27915094 PMID:27959697 PMID:28328801 PMID:28333917 PMID:28492532 PMID:28575650 PMID:29682453 PMID:30640974 PMID:31526516 More...
RGD:14402039 RGD:14402040 RGD:14402052 RGD:150429592
NCBI chr22:2,679,488...2,725,034
Ensembl chr22:2,684,022...2,723,949
G
CTSB
cathepsin B
ISO
RGD
PMID:15641152
RGD:2315605
NCBI chr 8:7,246,076...7,269,655
Ensembl chr 8:7,246,013...7,268,854
G
CTSD
cathepsin D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 1:1,570,163...1,581,857
Ensembl chr 1:1,570,069...1,581,833
G
CTSL
cathepsin L
ISO
RGD
PMID:15641152
RGD:2315605
NCBI chr12:98,347,770...98,353,426
Ensembl chr12:98,347,800...98,353,467
G
CUNH14orf180
chromosome unknown C14orf180 homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr24:82,509,386...82,522,929
Ensembl chr24:82,513,692...82,522,935
G
CUX1
cut like homeobox 1
ISO
mRNA:increased expression:liver (human)
RGD
PMID:30561038
RGD:152985541
NCBI chr28:10,901,529...11,370,834
Ensembl chr28:10,937,512...11,370,702
G
CXCL10
C-X-C motif chemokine ligand 10
treatment disease_progression
ISO
RGD
PMID:27245433 PMID:28592115 PMID:28638480
RGD:27095889 RGD:27095898 RGD:27095899
NCBI chr 7:24,526,657...24,529,193
Ensembl chr 7:24,526,680...24,529,130
G
CXCL11
C-X-C motif chemokine ligand 11
ISO
mRNA:increased expression:liver (mouse)
RGD
PMID:26569409
RGD:11344640
NCBI chr 7:24,540,401...24,543,456
Ensembl chr 7:24,541,767...24,542,832
G
CXCL12
C-X-C motif chemokine ligand 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144 PMID:28284560
NCBI chr 9:40,005,580...40,020,513
Ensembl chr 9:40,011,439...40,020,494
G
CXCL14
C-X-C motif chemokine ligand 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr23:38,355,340...38,363,905
Ensembl chr23:38,355,341...38,363,680
G
CXCL8
C-X-C motif chemokine ligand 8
disease_progression susceptibility
ISO
protein:increased expression:liver (human) CTD Direct Evidence: marker/mechanism|therapeutic mRNA:increased expression:liver (human) DNA:SNPs, haplotype:multiple
RGD CTD
PMID:12432545 PMID:24381110 PMID:26078356 PMID:30523154 PMID:35776891
RGD:11526468 RGD:26884364 RGD:26884366
NCBI chr 7:22,202,497...22,205,730
Ensembl chr 7:22,202,527...22,204,068
G
CXCR4
C-X-C motif chemokine receptor 4
severity treatment
ISO
protein:increased expression:liver (human) human cells in mouse model
RGD
PMID:30034941 PMID:33574707
RGD:151665327 RGD:151665331
NCBI chr10:20,336,470...20,340,308
Ensembl chr10:20,336,247...20,340,309
G
CYLD
CYLD lysine 63 deubiquitinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21109933
NCBI chr 5:36,541,022...36,600,874
Ensembl chr 5:36,541,764...36,595,417
G
CYP17A1
cytochrome P450 family 17 subfamily A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15341023
NCBI chr 9:95,870,098...95,877,345
Ensembl chr 9:95,866,908...95,877,180
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15341023
NCBI chr26:8,753,236...8,759,378
Ensembl chr26:8,753,327...8,759,384
G
CYP1A2
cytochrome P450 family 1 subfamily A member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr26:8,727,996...8,733,254
G
CYP26B1
cytochrome P450 family 26 subfamily B member 1
disease_progression
ISO
mRNA:increased expression:liver (human)
RGD
PMID:35693827
RGD:153344586
NCBI chr14:35,030,011...35,057,164
Ensembl chr14:35,038,654...35,057,176
G
CYP2B6
cytochrome P450 family 2 subfamily B member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:35,392,699...35,418,171
Ensembl chr 6:35,393,342...35,418,106
G
CYP2C19
cytochrome P450 family 2 subfamily C member 19
susceptibility
ISO
associated with hepatitis C; DNA:polymorphisms: :
RGD
PMID:11021356
RGD:124713413
NCBI chr 9:87,981,300...88,025,007
G
CYP2C8
cytochrome P450 family 2 subfamily C member 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:88,154,131...88,183,915
Ensembl chr 9:88,154,134...88,183,458
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
ISO
DNA, mRNA:SNP, Decreased expression:liver: rs2031920 (human) associated with alcohol dependence CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:15162526 PMID:20364586 PMID:29765251
RGD:14700882 RGD:14700899
NCBI chr26:53,390,054...53,403,309
Ensembl chr26:53,390,089...53,404,211
G
CYP39A1
cytochrome P450 family 39 subfamily A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr17:25,621,297...25,726,055
Ensembl chr17:25,621,305...25,728,617
G
DAB2IP
DAB2 interacting protein
severity
ISO
protein:decreased expression:liver (human) mRNA:decreased expression:liver (human)
RGD
PMID:22168621 PMID:31176165
RGD:151665110 RGD:151665148
NCBI chr12:17,802,030...18,017,648
Ensembl chr12:17,801,831...17,830,890
G
DBH
dopamine beta-hydroxylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr12:4,474,041...4,498,942
Ensembl chr12:4,474,958...4,498,910
G
DCAF4L2
DDB1 and CUL4 associated factor 4 like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 8:82,966,415...82,968,829
G
DCN
decorin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr11:86,552,392...86,590,229
Ensembl chr11:86,551,072...86,586,891
G
DDR1
discoidin domain receptor tyrosine kinase 1
severity
ISO
mRNA:increased expression:liver (human)
RGD
PMID:33173221
RGD:151347691
NCBI chr17:41,564,271...41,583,404
Ensembl chr17:41,564,992...41,575,682
G
DDR2
discoidin domain receptor tyrosine kinase 2
disease_progression treatment
ISO
RGD
PMID:26362312 PMID:33969575
RGD:11086753 RGD:150429748
NCBI chr20:1,298,636...1,451,872
Ensembl chr20:1,299,574...1,359,674
G
DDX3X
DEAD-box helicase 3 X-linked
exacerbates sexual_dimorphism
ISO
associated with hepatitis B; mRNA,protein:decreased expression:liver (human)
RGD
PMID:16301996 PMID:30297359
RGD:151356499 RGD:151356660
NCBI chr X:38,513,251...38,539,982
Ensembl chr Y:689,380...706,092
G
DEPDC1
DEP domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr20:64,615,693...64,639,088
Ensembl chr20:64,615,866...64,636,294
G
DEPDC1B
DEP domain containing 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 4:56,770,728...56,882,062
Ensembl chr 4:56,770,727...56,863,006
G
DEPDC5
DEP domain containing 5, GATOR1 subcomplex subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21725309
NCBI chr19:14,634,836...14,798,050
Ensembl chr19:14,635,947...14,787,591
G
DHFR
dihydrofolate reductase
ISO
ClinVar Annotator: match by term: Hepatocellular cancer
ClinVar
PMID:28492532
NCBI chr 4:74,787,292...74,811,196
Ensembl chr 4:74,787,629...74,810,960
G
DICER1
dicer 1, ribonuclease III
susceptibility
ISO
associated with hepatitis B; DNA:SNP: :rs1057035 T>C (human)
RGD
PMID:23868705
RGD:149735346
NCBI chr24:72,915,550...72,986,658
Ensembl chr24:72,915,499...72,963,006
G
DIPK2B
divergent protein kinase domain 2B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr X:42,336,140...42,382,863
G
DIRAS3
DIRAS family GTPase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr20:65,060,391...65,065,165
Ensembl chr20:65,063,822...65,064,511
G
DLGAP5
DLG associated protein 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr24:32,338,023...32,374,522
G
DLK1
delta like non-canonical Notch ligand 1
ISO
mRNA:increased expression:liver (mouse)
RGD
PMID:26569409
RGD:11344640
NCBI chr24:78,687,542...78,695,782
Ensembl chr24:78,687,668...78,695,607
G
DMGDH
dimethylglycine dehydrogenase
disease_progression
ISO
associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human)
RGD
PMID:30901224
RGD:152995286
NCBI chr 4:73,217,523...73,339,646
Ensembl chr 4:73,216,579...73,290,268
G
DNAJC6
DnaJ heat shock protein family (Hsp40) member C6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr20:67,661,187...67,824,822
Ensembl chr20:67,660,680...67,809,086
G
DNASE1L3
deoxyribonuclease 1L3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr22:19,487,767...19,496,019
Ensembl chr22:19,487,596...19,496,129
G
DNMT1
DNA methyltransferase 1
ISO
mRNA, protein:increased expression:liver
RGD
PMID:11844796
RGD:2289670
NCBI chr 6:9,199,006...9,263,890
Ensembl chr 6:9,199,003...9,263,607
G
DNMT3A
DNA methyltransferase 3 alpha
ISO
protein:increased expression:liver: mRNA, protein:increased expression:liver
RGD
PMID:11844796 PMID:15885882
RGD:2289670 RGD:9588598
NCBI chr14:82,313,414...82,427,170
Ensembl chr14:82,402,826...82,420,819
G
DNMT3B
DNA methyltransferase 3 beta
ISO
mRNA, protein:increased expression:liver mRNA:increased expression:liver:
RGD
PMID:11844796 PMID:15885882
RGD:2289670 RGD:9588598
NCBI chr 2:37,128,635...37,176,033
Ensembl chr 2:37,146,538...37,174,570
G
DPYD
dihydropyrimidine dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18019677
NCBI chr20:35,376,738...36,215,388
Ensembl chr20:35,377,266...36,215,679
G
DSN1
DSN1 component of MIS12 kinetochore complex
disease_progression
ISO
RGD
PMID:30136646
RGD:27372884
NCBI chr 2:57,511,171...57,525,241
Ensembl chr 2:57,511,366...57,527,088
G
DTL
denticleless E3 ubiquitin protein ligase homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr25:17,418,078...17,485,320
Ensembl chr25:17,418,090...17,485,164
G
DYNLRB1
dynein light chain roadblock-type 1
ISO
RGD
PMID:11750132
RGD:13208527
NCBI chr 2:38,813,852...38,839,905
Ensembl chr 2:38,825,574...38,839,903
G
DYNLRB2
dynein light chain roadblock-type 2
ISO
RGD
PMID:11750132
RGD:13208527
NCBI chr 5:65,994,915...66,009,154
Ensembl chr 5:65,995,228...66,004,804
G
E2F1
E2F transcription factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12029619 PMID:15565109 PMID:28284560
NCBI chr 2:37,968,541...37,980,461
Ensembl chr 2:37,968,556...37,980,326
G
E2F8
E2F transcription factor 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:45,751,937...45,772,698
Ensembl chr 1:45,756,301...45,772,632
G
EAF2
ELL associated factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20564326
NCBI chr22:58,966,640...59,025,158
Ensembl chr22:58,974,409...59,025,143
G
ECM1
extracellular matrix protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
G
ECT2
epithelial cell transforming 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr15:16,612,738...16,685,455
Ensembl chr15:16,612,443...16,685,386
G
EEF2
eukaryotic translation elongation factor 2
exacerbates
ISO
protein:increased expression, increased phosphorylation:liver (human)
RGD
PMID:28060762
RGD:153298915
NCBI chr 6:3,733,056...3,742,526
Ensembl chr 6:3,732,425...3,742,826
G
EFEMP1
EGF containing fibulin extracellular matrix protein 1
disease_progression
ISO
protein:decreased expression:liver:
RGD
PMID:23936443
RGD:10401793
NCBI chr14:50,989,553...51,048,149
Ensembl chr14:50,989,795...51,048,708
G
EFTUD2
elongation factor Tu GTP binding domain containing 2
severity ameliorates
ISO
RGD
PMID:34282556
RGD:155791664
NCBI chr16:61,505,796...61,549,720
Ensembl chr16:61,505,825...61,551,890
G
EGF
epidermal growth factor
susceptibility
ISO
associated with liver cirrhosis;DNA:SNP:5'UTR: (rs4444903) (human) CTD Direct Evidence: marker/mechanism associated with hepatitis B;DNA:SNP:exon: (rs11569017) (human)
RGD CTD
PMID:9029167 PMID:18167406 PMID:23790025
RGD:14695013 RGD:14695014
NCBI chr 7:57,810,110...57,911,361
Ensembl chr 7:57,811,728...57,911,516
G
EGFR
epidermal growth factor receptor
disease_progression
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:9029167 PMID:11355950
RGD:126781769
NCBI chr21:3,664,622...3,853,492
Ensembl chr21:3,666,339...3,853,239
G
EGR1
early growth response 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr23:41,139,636...41,143,598
Ensembl chr23:41,140,065...41,142,374
G
EGR2
early growth response 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:68,472,640...68,479,612
Ensembl chr 9:68,475,102...68,479,595
G
EHD3
EH domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr14:76,237,345...76,271,557
Ensembl chr14:76,236,246...76,271,546
G
EIF3H
eukaryotic translation initiation factor 3 subunit H
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14578863
NCBI chr 8:111,283,184...111,390,835
G
ENAH
ENAH actin regulator
disease_progression
ISO
mRNA:increased expression:liver (human)
RGD
PMID:35030977
RGD:155791678
NCBI chr25:4,134,853...4,264,392
Ensembl chr25:4,134,852...4,260,928
G
ENG
endoglin
ISO
protein:increased expression:liver (rat)
RGD
PMID:20368095
RGD:7257538
NCBI chr12:10,274,705...10,315,715
Ensembl chr12:10,275,064...10,315,040
G
ENO1
enolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr20:122,884,846...122,902,669
Ensembl chr20:122,884,727...122,903,372
G
EP300
E1A binding protein p300
ISO
protein:increased expression:liver (rat)
RGD
PMID:17083329
RGD:2312274
NCBI chr19:23,634,132...23,726,095
Ensembl chr19:23,634,571...23,724,979
G
EPAS1
endothelial PAS domain protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26735578
NCBI chr14:60,823,110...60,912,804
Ensembl chr14:60,822,815...60,912,785
G
EPCAM
epithelial cell adhesion molecule
severity
ISO
protein:increased expression:liver
RGD
PMID:24616575
RGD:14695007
NCBI chr14:59,815,128...59,832,360
Ensembl chr14:59,815,064...59,832,229
G
EPHB1
EPH receptor B1
ISO
protein:increased phosphorylation:liver (mouse)
RGD
PMID:28100771
RGD:127285675
NCBI chr15:55,144,178...55,592,252
Ensembl chr15:55,143,630...55,589,862
G
EPHX1
epoxide hydrolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7892276
NCBI chr25:3,924,396...3,960,264
Ensembl chr25:3,924,606...3,945,535
G
EPO
erythropoietin
disease_progression
ISO
mRNA:increased expression:liver (human)
RGD
PMID:35693827
RGD:153344586
NCBI chr28:12,487,222...12,491,986
Ensembl chr28:12,489,766...12,491,908
G
EPS8L3
EPS8 signaling adaptor L3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr20:23,780,116...23,795,946
Ensembl chr20:23,781,999...23,795,989
G
ERBB3
erb-b2 receptor tyrosine kinase 3
disease_progression
ISO
RGD
PMID:11355950
RGD:126781769
NCBI chr11:52,020,912...52,043,809
Ensembl chr11:52,021,058...52,044,028
G
ERBB4
erb-b2 receptor tyrosine kinase 4
ISO
DNA:insertion/deletion:3'UTR:rs6147150 (human)
RGD
PMID:22294845
RGD:126781763
NCBI chr10:97,099,090...98,281,697
G
ERCC1
ERCC excision repair 1, endonuclease non-catalytic subunit
ISO
mRNA, protein:increased expression:liver (human)
RGD
PMID:15922480
RGD:155598683
NCBI chr 6:38,857,067...38,900,177
Ensembl chr 6:38,854,803...38,872,967
G
ERCC2
ERCC excision repair 2, TFIIH core complex helicase subunit
susceptibility disease_progression
ISO
DNA:SNPs:exon 23: p.K751Q (human) DNA:SNP:cd: 312A>G (human) DNA:SNPs:exon 23: p.K751Q (human) DNA:SNPs:exon 23: p.K751Q (rs13181) (human)
RGD
PMID:19919686 PMID:25531380 PMID:28598207 PMID:28927037
RGD:150530503 RGD:25671459 RGD:25671460 RGD:25671461
NCBI chr 6:38,804,296...38,823,229
Ensembl chr 6:38,801,423...38,823,073
G
EREG
epiregulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35776891
NCBI chr 7:22,898,998...22,924,922
Ensembl chr 7:22,901,862...22,920,678
G
ERN1
endoplasmic reticulum to nucleus signaling 1
ISO
DNA:hypomethylation: CpG islands:
RGD
PMID:20165882
RGD:14694974
NCBI chr16:57,145,080...57,233,757
Ensembl chr16:57,145,191...57,236,230
G
ERP29
endoplasmic reticulum protein 29
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr11:107,244,359...107,255,293
Ensembl chr11:107,244,335...107,256,499
G
ESM1
endothelial cell specific molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 4:51,227,908...51,269,280
Ensembl chr 4:51,227,916...51,235,972
G
ESR1
estrogen receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144 PMID:28284560
NCBI chr13:79,153,418...79,554,552
Ensembl chr13:79,270,265...79,554,549
G
ETFA
electron transfer flavoprotein subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr26:6,970,593...7,075,077
Ensembl chr26:6,970,584...7,076,049
G
EXO1
exonuclease 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr25:78,934,337...78,976,346
Ensembl chr25:78,934,459...78,976,219
G
EZH2
enhancer of zeste 2 polycomb repressive complex 2 subunit
susceptibility
ISO
mRNA:increased expression:liver (human) CTD Direct Evidence: marker/mechanism DNA:SNPs: :multiple
RGD CTD
PMID:24040354 PMID:24211739 PMID:25226601 PMID:26517514 PMID:28284560 PMID:34545456 More...
RGD:10755339 RGD:11537550 RGD:126779595 RGD:126779608
NCBI chr21:117,380,518...117,515,224
Ensembl chr21:117,380,361...117,421,573
G
FABP5
fatty acid binding protein 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 8:76,696,899...76,701,459
G
FAM180A
family with sequence similarity 180 member A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr21:104,411,934...104,428,708
Ensembl chr21:104,412,351...104,427,540
G
FAM83D
family with sequence similarity 83 member D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:24,800,558...24,828,048
G
FANCD2
FA complementation group D2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr22:46,072,797...46,141,107
Ensembl chr22:46,072,761...46,140,713
G
FANCI
FA complementation group I
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr29:7,788,983...7,864,505
Ensembl chr29:7,790,458...7,855,552
G
FASLG
Fas ligand
ISO
protein:increased expression:liver:
RGD
PMID:11274632
RGD:14700677
NCBI chr25:56,488,572...56,496,469
Ensembl chr25:56,489,417...56,496,251
G
FASN
fatty acid synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14563831 PMID:15543204 PMID:21147110
NCBI chr16:73,988,410...74,008,374
Ensembl chr16:73,982,899...74,006,551
G
FAT1
FAT atypical cadherin 1
disease_progression
ISO
mRNA,protein:increased expression:liver (human)
RGD
PMID:24590895
RGD:151347630
NCBI chr 7:132,475,689...132,616,151
Ensembl chr 7:132,483,032...132,616,112
G
FATE1
fetal and adult testis expressed 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15580283
NCBI chr X:126,269,120...126,275,053
Ensembl chr X:126,269,555...126,275,052
G
FBP1
fructose-bisphosphatase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22039417
NCBI chr12:108,452,856...108,484,052
Ensembl chr12:108,453,156...108,483,775
G
FBXL18
F-box and leucine rich repeat protein 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr28:16,216,102...16,249,262
Ensembl chr28:16,216,176...16,248,409
G
FBXO11
F-box protein 11
exacerbates ameliorates
ISO
mRNA:increased expression:liver (human) protein:increased expression:liver (human)
RGD
PMID:29518611 PMID:29603830 PMID:32657545
RGD:152025259 RGD:152025263 RGD:152025266
NCBI chr14:59,276,380...59,375,635
Ensembl chr14:59,276,447...59,374,442
G
FCN2
ficolin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr12:3,255,810...3,264,561
G
FCN3
ficolin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr20:105,414,626...105,420,684
Ensembl chr20:105,414,650...105,420,558
G
FDFT1
farnesyl-diphosphate farnesyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147110
NCBI chr 8:7,272,580...7,306,859
Ensembl chr 8:7,271,509...7,306,760
G
FES
FES proto-oncogene, tyrosine kinase
exacerbates
ISO
DNA:hypermethylation:promoter (human)
RGD
PMID:31038805
RGD:153323297
NCBI chr29:8,967,542...8,979,475
Ensembl chr29:8,965,997...8,979,361
G
FGF19
fibroblast growth factor 19
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25822088
NCBI chr 1:4,852,289...4,860,139
Ensembl chr 1:4,854,363...4,859,102
G
FGF3
fibroblast growth factor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25822088
NCBI chr 1:4,746,195...4,755,654
Ensembl chr 1:4,746,696...4,754,924
G
FGF4
fibroblast growth factor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25822088
NCBI chr 1:4,786,296...4,791,441
Ensembl chr 1:4,789,203...4,791,036
G
FGFR1
fibroblast growth factor receptor 1
treatment
ISO
ClinVar Annotator: match by term: Hepatocellular carcinoma
RGD ClinVar
PMID:21573021 PMID:25705862 PMID:26619011 PMID:26942290 PMID:33448156
RGD:25440476
NCBI chr 8:36,426,116...36,485,683
Ensembl chr 8:36,427,110...36,485,508
G
FGFR2
fibroblast growth factor receptor 2
severity
ISO
associated with hepatitis B;DNA:SNPs: promoter, intron:rs308379, rs1219648 (human)
RGD
PMID:30952770
RGD:38501096
NCBI chr 9:114,234,344...114,354,736
Ensembl chr 9:114,234,250...114,354,704
G
FGFR4
fibroblast growth factor receptor 4
treatment
ISO
RGD
PMID:32677805
RGD:150520166
NCBI chr23:79,095,031...79,106,018
Ensembl chr23:79,097,429...79,105,456
G
FH
fumarate hydratase
ISO
ClinVar Annotator: match by term: Hepatocellular carcinoma
ClinVar
PMID:10896297 PMID:15221078 PMID:16876016 PMID:17182618 PMID:18313410 PMID:19151755 PMID:20301679 PMID:21445611 PMID:25637381 PMID:25741868 PMID:28492532 PMID:28747166 More...
NCBI chr25:78,576,931...78,599,998
Ensembl chr25:78,575,300...78,599,972
G
FHIT
fragile histidine triad diadenosine triphosphatase
ISO
RGD
PMID:12112319
RGD:632723
NCBI chr22:21,006,010...22,474,056
G
FLT3
fms related receptor tyrosine kinase 3
ameliorates
ISO
human cells in mouse model
RGD
PMID:27511526
RGD:149735514
NCBI chr 3:7,117,579...7,222,600
Ensembl chr 3:7,116,947...7,222,849
G
FLVCR1
FLVCR choline and heme transporter 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr25:16,656,219...16,688,397
Ensembl chr25:16,652,246...16,688,376
G
FOS
Fos proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9029167 PMID:28284560
NCBI chr24:52,497,465...52,501,161
Ensembl chr24:52,497,521...52,501,514
G
FOSB
FosB proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:38,916,039...38,924,129
G
FOSL2
FOS like 2, AP-1 transcription factor subunit
ISO
mRNA:increased expression:liver (human)
RGD
PMID:30086463 PMID:32048611
RGD:153344517 RGD:153344521
NCBI chr14:79,201,128...79,222,363
Ensembl chr14:79,201,649...79,222,373
G
FOXA1
forkhead box A1
disease_progression sexual_dimorphism susceptibility
ISO
protein:decreased expression:liver DNA:VNTR, SNPs, haplotypes:multiple:
RGD
PMID:25965836 PMID:29208003 PMID:31400761
RGD:11054501 RGD:151665752 RGD:151665820
NCBI chr24:14,397,759...14,403,078
Ensembl chr24:14,396,702...14,403,094
G
FOXM1
forkhead box M1
ISO
CTD Direct Evidence: marker/mechanism OMIM:114550
CTD MouseDO
PMID:15082532 PMID:17173139 PMID:28284560
NCBI chr11:2,920,903...2,941,011
Ensembl chr11:2,920,663...2,940,823
G
FOXO1
forkhead box O1
ISO
mRNA:decreased expression:liver
RGD
PMID:28972178
RGD:14401599
NCBI chr 3:18,916,849...19,027,776
Ensembl chr 3:18,920,651...19,027,707
G
FOXP1
forkhead box P1
treatment
ISO
RGD
PMID:25156538
RGD:9587823
NCBI chr22:31,907,941...32,538,294
Ensembl chr22:31,912,460...32,154,502
G
FOXP3
forkhead box P3
ISO
protein:increased expression:liver
RGD
PMID:21086571
RGD:38548919
NCBI chr X:46,349,890...46,365,133
G
FST
follistatin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12203361 PMID:19363144
NCBI chr 4:49,773,646...49,780,343
Ensembl chr 4:49,773,980...49,780,333
G
FTH1
ferritin heavy chain 1
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:9054589
RGD:632698
NCBI chr 1:11,837,533...11,840,926
G
FUBP1
far upstream element binding protein 1
exacerbates ameliorates
ISO
mRNA:increased expression:liver (human) associated with Chronic Hepatitis C;mRNA:increased expression:liver (human) human cell line in a mouse model
RGD
PMID:19637194 PMID:25995247 PMID:31587040
RGD:151361188 RGD:151361194 RGD:151361196
NCBI chr20:55,194,681...55,233,666
Ensembl chr20:55,194,743...55,230,277
G
G6PC1
glucose-6-phosphatase catalytic subunit 1
treatment
ISO
associated with Glycogen Storage Disease IA, human gene in a mouse model
RGD
PMID:28096054
RGD:14695537
NCBI chr16:63,380,921...63,392,122
Ensembl chr16:63,381,382...63,391,540
G
G6PD
glucose-6-phosphate dehydrogenase
disease_progression
ISO
mRNA:increased expression:liver (human)
RGD
PMID:25473368 PMID:35693827
RGD:10449118 RGD:153344586
NCBI chr X:128,768,028...128,788,366
Ensembl chr X:128,770,268...128,786,961
G
GABRD
gamma-aminobutyric acid type A receptor subunit delta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr20:129,530,049...129,541,437
Ensembl chr20:129,529,108...129,541,580
G
GAPDH
glyceraldehyde-3-phosphate dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16767786 PMID:21472284
NCBI chr11:6,569,029...6,572,877
G
GC
GC vitamin D binding protein
susceptibility
ISO
associated with Hepatitis B, Chronic;DNA:SNP: :rs7041(human) protein:increased expression:liver
RGD
PMID:21683810 PMID:25541958
RGD:14402025 RGD:5509919
NCBI chr 7:20,254,604...20,298,384
Ensembl chr 7:20,253,879...20,298,265
G
GDF15
growth differentiation factor 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20512989
NCBI chr 6:16,853,397...16,861,924
Ensembl chr 6:16,852,971...16,861,964
G
GDF2
growth differentiation factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23936038 PMID:28284560
NCBI chr 9:44,087,502...44,092,975
Ensembl chr 9:44,089,358...44,092,484
G
GGT1
gamma-glutamyltransferase 1
disease_progression
ISO
RNA,protein:increased expression, activity:liver: HBV associated
RGD
PMID:10572675 PMID:11940314 PMID:27793641
RGD:14701040 RGD:14701041 RGD:14701048
G
GHR
growth hormone receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 4:41,171,038...41,464,474
Ensembl chr 4:41,285,712...41,464,666
G
GJB1
gap junction protein beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17978847
NCBI chr X:61,013,991...61,019,222
Ensembl chr X:61,017,716...61,018,567
G
GJB2
gap junction protein beta 2
ISO
DNA, mRNA:promoter hypermethylation, decreased expression:liver
RGD
PMID:17295234
RGD:2289638
NCBI chr 3:801,786...808,165
Ensembl chr 3:807,379...808,059
G
GLI1
GLI family zinc finger 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26189965
NCBI chr11:53,371,929...53,384,339
Ensembl chr11:53,375,558...53,385,269
G
GLUL
glutamate-ammonia ligase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144
NCBI chr25:46,988,853...46,998,112
Ensembl chr25:46,989,205...47,000,555
G
GMNN
geminin DNA replication inhibitor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr17:47,462,647...47,474,445
Ensembl chr17:47,461,645...47,474,417
G
GMPS
guanine monophosphate synthase
ISO
protein:increased activity:hepatoma (rat)
RGD
PMID:6861338
RGD:5135537
NCBI chr15:34,817,603...34,885,363
Ensembl chr15:34,815,066...34,885,228
G
GNAO1
G protein subunit alpha o1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 5:42,105,295...42,272,573
Ensembl chr 5:42,105,334...42,273,059
G
GNAZ
G protein subunit alpha z
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr19:2,758,097...2,812,306
Ensembl chr19:2,757,819...2,788,076
G
GNMT
glycine N-methyltransferase
ISO
CTD Direct Evidence: marker/mechanism OMIM:114550
CTD MouseDO
PMID:19146867 PMID:31086990
NCBI chr17:29,196,142...29,199,728
Ensembl chr17:29,196,321...29,198,947
G
GOLM1
golgi membrane protein 1
severity
ISO
protein:increased expression:serum mRNA, protein:increased expression:liver
RGD
PMID:21140449 PMID:21443671
RGD:401827118 RGD:401827119
NCBI chr12:96,706,865...96,778,687
Ensembl chr12:96,708,548...96,779,065
G
GPC1
glypican 1
disease_progression
ISO
mRNA:increased expression:liver (human)
RGD
PMID:35693827
RGD:153344586
NCBI chr10:126,464,383...126,496,686
Ensembl chr10:126,464,801...126,497,897
G
GPC3
glypican 3
severity exacerbates disease_progression treatment
ISO
protein:increased expression:liver protein:increased expression:liver (human) protein:increased expression:blood serum (human) mRNA,protein:increased expression:peripheral blood mononuclear cell,blood serum, liver (human) mRNA:increased expression:Peripheral Blood (human) protein:increased expression:serum CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:16698587 PMID:19496787 PMID:21438004 PMID:22883669 PMID:23558072 PMID:25449037 PMID:27286460 PMID:28284560 PMID:28801286 More...
RGD:14695019 RGD:14695020 RGD:243065125 RGD:243065131 RGD:243065134 RGD:243065135 RGD:243065139
NCBI chr X:108,688,706...109,143,653
G
GPM6A
glycoprotein M6A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 7:121,715,329...122,082,175
Ensembl chr 7:121,714,770...121,894,739
G
GPR158
G protein-coupled receptor 158
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:24,903,263...25,310,817
G
GPR182
G protein-coupled receptor 182
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr11:52,904,691...52,908,786
Ensembl chr11:52,905,582...52,906,796
G
GPX1
glutathione peroxidase 1
severity no_association susceptibility
ISO
associated with hepatitis C;DNA:missense mutation:CDS:p.P198L (rs1050450) (human) DNA:missense mutation:CDS:p.P198L (human) associated with alcoholic liver cirrhosis;DNA:missense mutation:CDS:p.P198L (human)
RGD
PMID:16510607 PMID:19929244 PMID:25894370 PMID:26990426
RGD:11533013 RGD:151708729 RGD:152995483 RGD:152998906
NCBI chr22:10,754,976...10,756,617
G
GPX3
glutathione peroxidase 3
severity disease_progression
ISO
mRNA,protein:decreased expression:liver, blood plasma (human) DNA:hypermethylation
RGD
PMID:25333265 PMID:25445749 PMID:27570561
RGD:151665355 RGD:151665509 RGD:401827855
NCBI chr23:53,576,950...53,585,321
G
GRB7
growth factor receptor bound protein 7
exacerbates
ISO
protein:increased expression:liver (human)
RGD
PMID:17634422
RGD:151347655
NCBI chr16:66,416,978...66,427,035
Ensembl chr16:66,416,904...66,426,300
G
GSTP1
glutathione S-transferase pi 1
ISO
CTD Direct Evidence: marker/mechanism DNA:increased methylation:promoter
CTD RGD
PMID:9029167 PMID:22536438
RGD:14401712
NCBI chr 1:6,676,897...6,679,936
G
GTSE1
G2 and S-phase expressed 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr19:28,776,515...28,811,712
Ensembl chr19:28,777,821...28,811,035
G
GYS2
glycogen synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr11:21,400,582...21,464,438
Ensembl chr11:21,398,869...21,463,277
G
HAMP
hepcidin antimicrobial peptide
ISO
mRNA:decreased expression:liver (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:28284560 PMID:29235098
RGD:15042879
NCBI chr 6:30,214,820...30,218,100
Ensembl chr 6:30,215,563...30,217,996
G
HAO2
hydroxyacid oxidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr20:14,376,096...14,408,753
Ensembl chr20:14,374,543...14,407,992
G
HAVCR1
hepatitis A virus cellular receptor 1
disease_progression
ISO
mRNA:increased expression:liver (human)
RGD
PMID:35693827
RGD:153344586
NCBI chr23:59,422,769...59,454,183
Ensembl chr23:59,423,334...59,453,531
G
HAVCR2
hepatitis A virus cellular receptor 2
disease_progression
ISO
associated with hepatitis B;DNA:SNP: : ���1516 G>T (human)
RGD
PMID:27034168
RGD:40818257
NCBI chr23:59,479,794...59,501,532
Ensembl chr23:59,475,826...59,500,836
G
HDAC2
histone deacetylase 2
disease_progression
ISO
mRNA:increased expression:liver:
RGD
PMID:24448241
RGD:9590206
NCBI chr13:59,873,248...59,904,542
Ensembl chr13:59,873,767...59,905,742
G
HDAC4
histone deacetylase 4
ISO
mRNA:increased expression:liver:
RGD
PMID:21837748
RGD:9681451
NCBI chr10:125,098,375...125,450,524
Ensembl chr10:125,098,366...125,403,227
G
HERC5
HECT and RLD domain containing E3 ubiquitin protein ligase 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28919514
NCBI chr 7:36,817,118...36,867,712
Ensembl chr 7:36,819,708...36,867,933
G
HFE
homeostatic iron regulator
disease_progression
ISO
associated with Liver Cirrhosis;DNA:missense mutation:cds:p.C282Y (human)
RGD
PMID:20019189 PMID:29642405
RGD:14746967 RGD:2317357
NCBI chr17:46,159,770...46,168,831
Ensembl chr17:46,156,685...46,164,649
G
HGF
hepatocyte growth factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9932610 PMID:11896611
NCBI chr21:67,118,785...67,193,506
Ensembl chr21:67,120,722...67,193,504
G
HGFAC
HGF activator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144
NCBI chr27:45,283,213...45,290,922
Ensembl chr27:45,283,206...45,290,644
G
HHIP
hedgehog interacting protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18559595
NCBI chr 7:91,216,874...91,311,392
Ensembl chr 7:91,216,955...91,310,387
G
HIF1A
hypoxia inducible factor 1 subunit alpha
disease_progression treatment
ISO
protein:increased expression:liver (human)
RGD
PMID:19335982 PMID:26078356 PMID:31321740
RGD:11526468 RGD:155882550 RGD:9068886
NCBI chr24:38,873,830...38,927,657
Ensembl chr24:38,873,861...38,928,288
G
HILPDA
hypoxia inducible lipid droplet associated
disease_progression
ISO
mRNA:increased expression:liver (human) human cells in mouse model mRNA, protein:increased expression:liver (human)
RGD
PMID:30205391 PMID:31142329 PMID:35693827
RGD:153344574 RGD:153344577 RGD:153344586
NCBI chr21:97,254,246...97,257,186
G
HJURP
Holliday junction recognition protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr10:119,857,118...119,885,945
Ensembl chr10:119,868,303...119,885,783
G
HMGB2
high mobility group box 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20851854
NCBI chr 7:119,440,089...119,442,806
Ensembl chr 7:119,440,468...119,443,578
G
HMGCR
3-hydroxy-3-methylglutaryl-CoA reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9207284 PMID:21147110
NCBI chr 4:69,664,784...69,690,343
Ensembl chr 4:69,665,417...69,688,686
G
HMGCS2
3-hydroxy-3-methylglutaryl-CoA synthase 2
disease_progression
ISO
RGD
PMID:28867541
RGD:14975299
NCBI chr20:14,018,669...14,040,934
Ensembl chr20:14,019,692...14,041,016
G
HNF1A
HNF1 homeobox A
treatment
ISO
human cell line in mouse model
RGD
PMID:29466992
RGD:14700664
NCBI chr11:116,334,935...116,358,582
Ensembl chr11:116,335,675...116,357,751
G
HNF4A
hepatocyte nuclear factor 4 alpha
ISO
protein:decreased expression:liver:
RGD
PMID:20876809
RGD:12904747
NCBI chr 2:19,390,870...19,466,300
Ensembl chr 2:19,388,891...19,421,664
G
HNRNPA1
heterogeneous nuclear ribonucleoprotein A1
ISO
protein:increased expression:liver (human)
RGD
PMID:23633480
RGD:9685423
NCBI chr11:50,397,173...50,403,192
Ensembl chr11:50,396,888...50,400,802
G
HNRNPA2B1
heterogeneous nuclear ribonucleoprotein A2/B1
ISO
protein:increased expression:liver (human) mRNA:increased expression:liver (rat)
RGD
PMID:20604928 PMID:23633480
RGD:9685422 RGD:9685423
NCBI chr21:32,167,126...32,178,031
Ensembl chr21:32,167,337...32,176,980
G
HNRNPAB
heterogeneous nuclear ribonucleoprotein A/B
severity
ISO
mRNA:increased expression:liver (human)
RGD
PMID:24638979
RGD:10059322
NCBI chr23:79,891,942...79,903,289
G
HNRNPD
heterogeneous nuclear ribonucleoprotein D
ISO
protein:increased expression:liver (human) protein:increased expression:liver (rat)
RGD
PMID:20102719 PMID:22318685
RGD:10042969 RGD:10042977
NCBI chr 7:30,729,697...30,749,793
Ensembl chr 7:30,731,175...30,749,876
G
HNRNPH1
heterogeneous nuclear ribonucleoprotein H1
ISO
protein:increased expression:liver (human)
RGD
PMID:23633480
RGD:9685423
NCBI chr23:81,330,777...81,340,470
Ensembl chr23:81,330,351...81,339,882
G
HNRNPL
heterogeneous nuclear ribonucleoprotein L
ISO
associated with Hepatitis B
RGD
PMID:24125732
RGD:9999429
NCBI chr 6:33,452,705...33,469,070
Ensembl chr 6:33,452,852...33,466,284
G
HOXA10
homeobox A10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr21:31,189,240...31,198,244
G
HOXA13
homeobox A13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr21:31,168,239...31,175,960
Ensembl chr21:31,168,793...31,173,056
G
HOXD9
homeobox D9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr10:61,695,065...61,699,936
Ensembl chr10:61,697,271...61,699,933
G
HPRT1
hypoxanthine phosphoribosyltransferase 1
ISO
protein:increased activity:hepatoma (rat)
RGD
PMID:6327016
RGD:5135035
NCBI chr X:109,629,674...109,671,409
G
HRAS
HRas proto-oncogene, GTPase
treatment
ISO
human cells in a mouse model ClinVar Annotator: match by term: Hepatocellular cancer ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma
RGD ClinVar
PMID:10791191 PMID:11150980 PMID:12835555 PMID:16155195 PMID:16170316 PMID:16329078 PMID:16372351 PMID:16443854 PMID:16835863 PMID:16881968 PMID:16969868 PMID:17054105 PMID:17211612 PMID:17384584 PMID:17412879 PMID:17601930 PMID:17979197 PMID:18039947 PMID:18042262 PMID:18247425 PMID:18978862 PMID:19206176 PMID:19213030 PMID:19255327 PMID:19371735 PMID:19382114 PMID:19669404 PMID:19773371 PMID:20301680 PMID:20660566 PMID:20859122 PMID:20937837 PMID:20979192 PMID:21438134 PMID:21495179 PMID:21686750 PMID:21834037 PMID:21850009 PMID:22087699 PMID:22256804 PMID:22317973 PMID:22420426 PMID:22495892 PMID:22499344 PMID:22683711 PMID:22726224 PMID:22926243 PMID:23093928 PMID:23096712 PMID:23406027 PMID:23429430 PMID:23751039 PMID:23884457 PMID:24006476 PMID:24033266 PMID:24129065 PMID:24169525 PMID:24224811 PMID:24390138 PMID:24803665 PMID:25157968 PMID:25326635 PMID:25741868 PMID:25815234 PMID:25914166 PMID:26467025 PMID:26619011 PMID:26778095 PMID:27195699 PMID:27283355 PMID:27444071 PMID:27589201 PMID:28027064 PMID:28139825 PMID:28492532 PMID:29493581 PMID:30055033 PMID:30138938 PMID:30191474 PMID:31222966 PMID:31394527 PMID:31560489 PMID:31564432 PMID:31775759 PMID:32371413 PMID:32732226 PMID:33027564 PMID:33372952 PMID:34008892 PMID:34958143 PMID:168335863 More...
RGD:14688055
NCBI chr 1:343,613...345,782
Ensembl chr 1:343,506...346,637
G
HSPA5
heat shock protein family A (Hsp70) member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284 PMID:29698666
NCBI chr12:12,920,705...12,925,888
Ensembl chr12:12,920,710...12,927,431
G
HSPA9
heat shock protein family A (Hsp70) member 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr23:41,230,675...41,251,177
Ensembl chr23:41,231,364...41,251,150
G
HSPB1
heat shock protein family B (small) member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr28:10,442,530...10,443,804
Ensembl chr28:10,442,398...10,443,855
G
HTATIP2
HIV-1 Tat interactive protein 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16799960
NCBI chr 1:44,624,782...44,643,188
Ensembl chr 1:44,624,734...44,643,121
G
HTRA1
HtrA serine peptidase 1
disease_progression exacerbates
ISO
mRNA:decreased expression:liver (human) protein:decreased expression:liver (human)
RGD
PMID:20943460 PMID:26403966
RGD:152985524 RGD:152985529
NCBI chr 9:115,197,543...115,250,092
Ensembl chr 9:115,197,566...115,253,919
G
ICAM1
intercellular adhesion molecule 1
severity
ISO
protein:increased expression:serum
RGD
PMID:26109813
RGD:11056752
NCBI chr 6:9,320,991...9,338,125
Ensembl chr 6:9,322,550...9,338,263
G
IDH1
isocitrate dehydrogenase (NADP(+)) 1
ISO
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma
ClinVar
PMID:18772396 PMID:19657110 PMID:19798509 PMID:19818334 PMID:20946881 PMID:21352804 PMID:21446021 PMID:22160010 PMID:22397365 PMID:22417203 PMID:22898539 PMID:23558169 PMID:24606448 PMID:25043048 PMID:25157968 PMID:25741868 PMID:26619011 PMID:27993330 PMID:30231226 PMID:36201590 More...
NCBI chr10:94,021,002...94,039,997
Ensembl chr10:94,020,818...94,039,975
G
IER2
immediate early response 2
ISO
mRNA, protein:decreased expression:liver (human)
RGD
PMID:32009420
RGD:153323326
NCBI chr 6:11,834,998...11,838,421
Ensembl chr 6:11,836,706...11,837,377
G
IFNA2
interferon alpha 2
susceptibility
ISO
associated with hepatitis B; DNA:SNP:enhancer: (rs649053) (human)
RGD
PMID:29080269
RGD:21406429
NCBI chr12:58,468,018...58,469,825
G
IFNG
interferon gamma
ISO
mRNA:increased expression:liver (mouse)
RGD
PMID:26569409
RGD:11344640
NCBI chr11:63,785,493...63,791,071
Ensembl chr11:63,786,041...63,790,473
G
IGBP1
immunoglobulin binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21339737
NCBI chr X:59,970,740...60,008,066
Ensembl chr X:59,971,234...60,008,047
G
IGF1
insulin like growth factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr11:97,624,498...97,708,730
Ensembl chr11:97,631,189...97,707,308
G
IGF1R
insulin like growth factor 1 receptor
susceptibility
ISO
DNA:SNPs, haplotype: : CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17441810 PMID:23958494 PMID:24758241
RGD:14985227
NCBI chr29:17,212,206...17,534,036
Ensembl chr29:17,459,404...17,526,930
G
IGF2
insulin like growth factor 2
susceptibility
ISO
CTD Direct Evidence: marker/mechanism associated with hepatitis B;DNA:SNPs:intron, 3'utr:+2482A>C, +820A>G (human)
RGD CTD
PMID:12532445 PMID:16092956 PMID:16750516 PMID:17554210
RGD:14401723 RGD:2311523
NCBI chr 1:1,937,414...1,951,238
Ensembl chr 1:1,936,830...1,945,388
G
IGF2BP1
insulin like growth factor 2 mRNA binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr16:69,405,923...69,461,613
Ensembl chr16:69,406,549...69,459,175
G
IGF2BP3
insulin like growth factor 2 mRNA binding protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr21:34,846,383...34,999,579
Ensembl chr21:34,954,129...34,997,439
G
IGF2R
insulin like growth factor 2 receptor
treatment no_association disease_progression
ISO
ClinVar Annotator: match by term: Hepatocellular carcinoma DNA:loss of heterozygosity,mutations:liver: DNA:loss of heterozygosity:liver
OMIM ClinVar RGD
PMID:9722161 PMID:10347113 PMID:18322954 PMID:25741868 PMID:30720132
RGD:14985219 RGD:14985220 RGD:14985221
NCBI chr13:87,587,717...87,723,795
Ensembl chr13:87,587,907...87,724,116
G
IGFALS
insulin like growth factor binding protein acid labile subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 5:1,698,787...1,704,205
Ensembl chr 5:1,698,978...1,701,972
G
IKBKG
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
treatment
ISO
protein:decreased expression:liver (human)
RGD
PMID:17292824 PMID:22176836 PMID:22922425 PMID:24971483 PMID:25173965 PMID:29551768 More...
RGD:11079569 RGD:153297807 RGD:153297813 RGD:153305943 RGD:153305945 RGD:153305947
NCBI chr X:128,781,975...128,816,039
Ensembl chr X:128,787,785...128,806,083
G
IKZF1
IKAROS family zinc finger 1
ameliorates
ISO
protein:increased expression:liver (human)
RGD
PMID:25301737
RGD:150540326
NCBI chr21:8,398,902...8,500,431
Ensembl chr21:8,402,719...8,484,723
G
IL10
interleukin 10
treatment
ISO
RGD
PMID:23822114 PMID:26890368
RGD:14975171 RGD:7365006
NCBI chr25:22,590,389...22,595,877
Ensembl chr25:22,590,962...22,594,836
G
IL12A
interleukin 12A
susceptibility
ISO
DNA:SNP:3'UTR: rs568408( G>A)(human) associated with hepatitis C;DNA:SNP:3'UTR: rs568408( G>A)(human) associated with hepatitis B; DNA:SNP, haplotype:3′UTR :rs568408(human)
RGD
PMID:20521253 PMID:26631030 PMID:27819525
RGD:25440490 RGD:25440491 RGD:25440501
NCBI chr15:30,887,048...30,896,577
Ensembl chr15:30,887,897...30,894,550
G
IL15RA
interleukin 15 receptor subunit alpha
disease_progression
ISO
mRNA:increased expression:liver (human)
RGD
PMID:35693827
RGD:153344586
NCBI chr 9:6,061,475...6,096,370
Ensembl chr 9:6,061,197...6,096,250
G
IL18
interleukin 18
disease_progression susceptibility severity
ISO
DNA:SNP:promoter:-137G>C(rs187238)(human) associated with hepatitis B, chronic;DNA:SNP:promoter:-607C>A(human) associated with hepatitis C;DNA:SNPs, haplotype:promoter:-607C>A, -137G>C(human)
RGD
PMID:26893476 PMID:27429592 PMID:27470888 PMID:29341496
RGD:11538094 RGD:14695526 RGD:14695540 RGD:14696663
NCBI chr 1:103,485,868...103,511,632
Ensembl chr 1:103,482,083...103,510,150
G
IL18R1
interleukin 18 receptor 1
ISO
mRNA:decreased expression:liver
RGD
PMID:26893476
RGD:11538094
NCBI chr14:6,026,683...6,067,808
Ensembl chr14:6,026,443...6,066,884
G
IL1B
interleukin 1 beta
susceptibility
ISO
DNA:polymorphism:promoter:-31T>C (human)
RGD
PMID:21653279
RGD:7401222
NCBI chr14:15,844,628...15,852,652
Ensembl chr14:15,844,672...15,850,729
G
IL1RAP
interleukin 1 receptor accessory protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr15:84,728,594...84,876,098
Ensembl chr15:84,728,517...84,866,263
G
IL1RN
interleukin 1 receptor antagonist
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr14:16,136,667...16,152,451
Ensembl chr14:16,146,333...16,151,326
G
IL2
interleukin 2
treatment
ISO
RGD
PMID:9449371 PMID:10933975
RGD:14747035 RGD:8693323
NCBI chr 7:69,729,635...69,736,279
Ensembl chr 7:69,730,282...69,734,969
G
IL21
interleukin 21
ISO
associated with hepatitis B;DNA:SNPS, haplotype:(rs13143866, rs2221903, rs907715) (human)
RGD
PMID:25892873
RGD:127285359
NCBI chr 7:69,859,793...69,872,237
Ensembl chr 7:69,863,535...69,872,025
G
IL6
interleukin 6
disease_progression treatment
ISO
mRNA,protein:increased expression:liver, blood serum (mouse) DNA:SNP: :rs2069852 (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17615358 PMID:20818158 PMID:26297436 PMID:26569409 PMID:27022031 PMID:27368337 PMID:29486150 More...
RGD:11344640 RGD:127285672 RGD:14975289
NCBI chr21:35,577,513...35,582,385
Ensembl chr21:35,577,939...35,582,237
G
IL6ST
interleukin 6 cytokine family signal transducer
ISO
RGD
PMID:15780071
RGD:1626706
NCBI chr 4:52,174,893...52,232,475
Ensembl chr 4:52,174,312...52,214,584
G
ING3
inhibitor of growth family member 3
treatment
ISO
RGD
PMID:25156538
RGD:9587823
NCBI chr21:89,772,546...89,802,250
Ensembl chr21:89,772,528...89,802,244
G
INMT
indolethylamine N-methyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr21:27,635,727...27,707,463
Ensembl chr21:27,634,903...27,639,800
G
INPP4B
inositol polyphosphate-4-phosphatase type II B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29415082
NCBI chr 7:88,929,249...89,732,375
Ensembl chr 7:88,979,493...89,461,475
G
INS
insulin
ISO
associated with Chronic Hepatitis C;mRNA:decreased expression:liver (human)
RGD
PMID:33132693
RGD:150340613
NCBI chr 1:1,965,128...1,969,090
G
INSR
insulin receptor
ISO
mRNA, protein:increased expression:liver (human, rat) human cells in a mouse model
RGD
PMID:23633480 PMID:29610518
RGD:14700930 RGD:9685423
NCBI chr 6:6,625,951...6,803,610
Ensembl chr 6:6,630,777...6,803,592
G
IQGAP1
IQ motif containing GTPase activating protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20977743
NCBI chr29:9,363,273...9,485,644
Ensembl chr29:9,362,926...9,485,526
G
IQGAP2
IQ motif containing GTPase activating protein 2
ISO
CTD Direct Evidence: marker/mechanism OMIM:114550
CTD MouseDO
PMID:20977743
NCBI chr 4:70,672,171...70,979,766
Ensembl chr 4:70,672,553...70,979,763
G
IQGAP3
IQ motif containing GTPase activating protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr20:7,286,819...7,334,352
Ensembl chr20:7,286,886...7,333,284
G
IRF2
interferon regulatory factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561517
NCBI chr 7:130,352,809...130,440,485
Ensembl chr 7:130,350,262...130,440,600
G
IRS1
insulin receptor substrate 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:1311924 PMID:23958494
NCBI chr10:112,748,283...112,812,368
G
IRS2
insulin receptor substrate 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16127164
NCBI chr 3:88,045,439...88,076,468
G
ISG15
ISG15 ubiquitin like modifier
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28919514
NCBI chr20:130,419,909...130,421,409
Ensembl chr20:130,419,782...130,421,380
G
ITIH3
inter-alpha-trypsin inhibitor heavy chain 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144
NCBI chr22:14,176,656...14,191,256
Ensembl chr22:14,177,334...14,191,353
G
ITIH4
inter-alpha-trypsin inhibitor heavy chain 4
disease_progression
ISO
associated with hepatitis B;protein:decreased expression:serum
RGD
PMID:24836184
RGD:40903002
NCBI chr22:14,194,979...14,216,180
Ensembl chr22:14,195,701...14,213,603
G
JAG1
jagged canonical Notch ligand 1
ISO
protein:increased expression:liver
RGD
PMID:30660174
RGD:14694832
NCBI chr 2:27,484,699...27,521,108
Ensembl chr 2:27,484,760...27,522,504
G
JAK1
Janus kinase 1
ISO
RGD
PMID:23788652
RGD:150524353
NCBI chr20:68,122,134...68,253,361
Ensembl chr20:68,122,173...68,252,042
G
JAK2
Janus kinase 2
severity treatment exacerbates ameliorates
ISO
protein:increased phosphorylation:liver (mouse) mRNA:decreased expression:liver (human) protein:increased phosphorylation:liver (human) L-JAK2 KO associated with Diseases of the Aged and non-alcoholic fatty liver disease
RGD
PMID:22392353 PMID:22821478 PMID:25420511 PMID:28100771 PMID:29486150 PMID:31393852 More...
RGD:125097525 RGD:127285621 RGD:127285655 RGD:127285672 RGD:127285675 RGD:18182928
NCBI chr12:74,421,243...74,566,766
Ensembl chr12:74,421,016...74,566,710
G
JDP2
Jun dimerization protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20214788
NCBI chr24:52,668,837...52,702,257
Ensembl chr24:52,669,162...52,702,521
G
JUN
Jun proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20214788
NCBI chr20:74,204,481...74,207,835
Ensembl chr20:74,205,542...74,206,546
G
JUND
JunD proto-oncogene, AP-1 transcription factor subunit
ISO
associated with HBV;protein:increased expression:liver (human)
RGD
PMID:15927205
RGD:153297768
NCBI chr 6:16,754,553...16,756,458
Ensembl chr 6:16,755,247...16,756,290
G
KAT2B
lysine acetyltransferase 2B
severity
ISO
protein:decreased expression:liver (human)
RGD
PMID:23643089
RGD:9590314
NCBI chr15:64,769,590...64,885,536
Ensembl chr15:64,770,185...64,886,219
G
KBTBD11
kelch repeat and BTB domain containing 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 8:1,634,347...1,661,024
Ensembl chr 8:1,661,172...1,663,043
G
KCNH1
potassium voltage-gated channel subfamily H member 1
ISO
protein:increased expression:liver (human)
RGD
PMID:17022810
RGD:9693723
NCBI chr25:18,353,356...18,788,472
Ensembl chr25:18,353,482...18,783,592
G
KCNN2
potassium calcium-activated channel subfamily N member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr23:17,595,661...17,735,675
Ensembl chr23:17,598,177...17,735,669
G
KDM1A
lysine demethylase 1A
severity
ISO
mRNA, protein:increased expression:liver (human)
RGD
PMID:23236241
RGD:9681002
NCBI chr20:109,592,761...109,657,885
Ensembl chr20:109,593,074...109,657,839
G
KDM3A
lysine demethylase 3A
ISO
mRNA:increased expression:liver (human)
RGD
PMID:21607773
RGD:9590222
NCBI chr14:20,668,215...20,721,854
Ensembl chr14:20,668,821...20,720,759
G
KDM5C
lysine demethylase 5C
exacerbates
ISO
protein:increased expression:liver (human)
RGD
PMID:26503415
RGD:11530160
NCBI chr X:49,306,472...49,356,151
Ensembl chr X:49,321,173...49,356,100
G
KDM6A
lysine demethylase 6A
ameliorates
ISO
human cells in a mouse model
RGD
PMID:32765772
RGD:150429729
NCBI chr X:42,053,272...42,291,013
Ensembl chr X:42,053,336...42,290,526
G
KDM8
lysine demethylase 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 5:24,907,345...24,927,028
Ensembl chr 5:24,907,657...24,928,995
G
KDR
kinase insert domain receptor
treatment disease_progression
ISO
DNA:SNPs: :rs1870377, rs2071559, rs2305948 (human) associated with alcoholic liver cirrhosis;DNA:SNP: :1416A>T (human) protein:decreased expression:liver protein:increased expression:liver
RGD
PMID:19177438 PMID:23660204 PMID:24445728 PMID:25182707 PMID:25333267
RGD:126848806 RGD:126848810 RGD:126848812 RGD:126848813 RGD:126848814
NCBI chr 7:13,435,059...13,482,236
Ensembl chr 7:13,435,096...13,482,771
G
KIF11
kinesin family member 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:85,858,364...85,923,211
Ensembl chr 9:85,858,381...85,923,819
G
KIF14
kinesin family member 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr25:28,789,952...28,856,713
Ensembl chr25:28,789,614...28,856,570
G
KIF15
kinesin family member 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr22:6,238,804...6,325,804
Ensembl chr22:6,249,567...6,325,510
G
KIF18A
kinesin family member 18A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:37,003,325...37,088,705
Ensembl chr 1:37,003,357...37,088,640
G
KIF18B
kinesin family member 18B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr16:61,455,785...61,478,232
Ensembl chr16:61,456,467...61,478,002
G
KIF1B
kinesin family member 1B
susceptibility severity
ISO
DNA:snp:intron:c.2537+518A>G (rs17401966) (human) mRNA, protein:decreased expression:liver (human)
RGD
PMID:26217094 PMID:27122668
RGD:11052488 RGD:12738461
NCBI chr20:121,393,478...121,567,704
Ensembl chr20:121,395,836...121,546,803
G
KIF20A
kinesin family member 20A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr23:40,848,762...40,857,685
Ensembl chr23:40,849,108...40,857,434
G
KIF23
kinesin family member 23
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr26:14,008,717...14,044,272
Ensembl chr26:14,008,633...14,043,710
G
KIF2C
kinesin family member 2C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr20:88,023,250...88,054,715
Ensembl chr20:88,023,207...88,055,176
G
KIF4A
kinesin family member 4A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr X:60,135,371...60,266,301
G
KIFC1
kinesin family member C1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr17:38,656,517...38,675,056
Ensembl chr17:38,656,246...38,674,470
G
KLF4
KLF transcription factor 4
treatment disease_progression
ISO
RGD
PMID:22677193
RGD:14402023
NCBI chr12:32,045,690...32,050,531
Ensembl chr12:32,045,609...32,050,703
G
KLRF1
killer cell lectin like receptor F1
disease_progression
ISO
mRNA:decreased expression:liver (human)
RGD
PMID:35693827
RGD:153344586
NCBI chr11:9,715,900...9,731,454
Ensembl chr11:9,716,010...9,731,387
G
KMT2A
lysine methyltransferase 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22634756
NCBI chr 1:109,819,748...109,912,763
Ensembl chr 1:109,853,758...109,908,113
G
KMT2B
lysine methyltransferase 2B
ISO
CTD Direct Evidence: marker/mechanism DNA:insertions, translocations:intron:IVS3, multiple (human)
CTD RGD
PMID:18320596 PMID:22634754
RGD:9588597
NCBI chr 6:30,626,723...30,648,204
Ensembl chr 6:30,626,848...30,647,883
G
KMT2C
lysine methyltransferase 2C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22634756
NCBI chr21:120,299,295...120,587,843
Ensembl chr21:120,301,188...120,587,137
G
KRAS
KRAS proto-oncogene, GTPase
induced
ISO
aflatoxin B1 induced:DNA:transversion,transition mutations:cds: ClinVar Annotator: match by term: Hepatocellular cancer
RGD ClinVar
PMID:2278970 PMID:3122217 PMID:8446626 PMID:12460918 PMID:15696205 PMID:16361624 PMID:16434492 PMID:16618717 PMID:18316791 PMID:18794081 PMID:19075190 PMID:19114683 PMID:19679400 PMID:20921462 PMID:20921465 PMID:21228335 PMID:22407852 PMID:22722830 PMID:23325582 PMID:25157968 PMID:26619011 PMID:30891959 More...
RGD:11568697
NCBI chr11:24,963,396...25,010,747
Ensembl chr11:24,973,619...25,005,191
G
KRT18
keratin 18
ISO
OMIM:114550
MouseDO
NCBI chr11:49,073,733...49,081,706
G
LCAT
lecithin-cholesterol acyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 5:59,495,936...59,500,530
Ensembl chr 5:59,497,115...59,500,448
G
LECT2
leukocyte cell derived chemotaxin 2
ameliorates
ISO
human cells in mouse model protein:increased expression:blood serum (human) protein:increased expression:blood serum (mouse)
RGD
PMID:21394108 PMID:24892551
RGD:153323333 RGD:153323335
NCBI chr23:38,696,216...38,705,530
Ensembl chr23:38,696,203...38,705,087
G
LEP
leptin
severity susceptibility
ISO
protein:increased expression:liver (human) DNA:SNP:enhancer:-2548G>A (rs7799039) (human)
RGD
PMID:18573568 PMID:28452232
RGD:15039399 RGD:25330348
NCBI chr21:97,056,913...97,071,161
Ensembl chr21:97,057,529...97,071,220
G
LEPR
leptin receptor
susceptibility
ISO
associated with Hepatitis B, Chronic;DNA:missense mutations:cds:p.Q223R, p.K109R (human)
RGD
PMID:23090836
RGD:21079466
NCBI chr20:67,454,205...67,567,524
Ensembl chr20:67,454,334...67,524,229
G
LETM1
leucine zipper and EF-hand containing transmembrane protein 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23392203
NCBI chr27:46,912,882...46,954,295
Ensembl chr27:46,912,819...46,956,164
G
LIFR
LIF receptor subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 4:37,307,753...37,385,489
Ensembl chr 4:37,314,347...37,362,137
G
LOC103216161
uncharacterized LOC103216161
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:56,448,443...56,467,908
Ensembl chr 2:56,448,392...56,467,712
G
LOC103218526
carbonyl reductase [NADPH] 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21056497
NCBI chr 2:80,096,743...80,099,982
G
LOC103219825
protein patched homolog 1
severity disease_progression
ISO
RGD
PMID:18538319 PMID:22911366
RGD:150523837 RGD:150523842
NCBI chr12:107,580,895...107,656,443
Ensembl chr12:107,590,663...107,652,985
G
LOC103223491
peroxisome proliferator-activated receptor alpha
susceptibility
ISO
associated with hepatitis B;DNA:missense mutation:cds:p.L162V (human)
RGD
PMID:19119483
RGD:15042881
NCBI chr19:28,614,892...28,709,272
Ensembl chr19:28,615,413...28,708,763
G
LOC103224275
glutathione S-transferase Mu 1
no_association susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:deletion:cds (human)
RGD CTD
PMID:7892276 PMID:11859714 PMID:20672314 PMID:20683151
RGD:14700951 RGD:14700979 RGD:7488953
NCBI chr20:23,854,969...23,861,634
G
LOC103226928
aldo-keto reductase family 1 member B1
ISO
protein:increased expression:liver (human) protein:increased expression:liver (rat)
RGD
PMID:19422879 PMID:21683810
RGD:5509919 RGD:8548685
NCBI chr21:103,060,018...103,076,844
Ensembl chr21:103,059,991...103,077,341
G
LOC103229692
solute carrier family 25 member 47
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr24:78,285,089...78,292,562
Ensembl chr24:78,285,593...78,292,773
G
LOC103231165
isocitrate dehydrogenase (NADP(+)) 2
disease_progression
ISO
ClinVar Annotator: match by term: Hepatocellular cancer
RGD ClinVar
PMID:20946881 PMID:21250968 PMID:21596855 PMID:21997850 PMID:22160010 PMID:22397365 PMID:22417203 PMID:22616558 PMID:22898539 PMID:23949315 PMID:24606448 PMID:24716838 PMID:25157968 PMID:26619011 More...
RGD:14985249
NCBI chr29:8,633,429...8,650,744
Ensembl chr29:8,633,715...8,650,657
G
LOC103231897
properdin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr X:44,801,388...44,807,177
Ensembl chr X:44,801,354...44,807,402
G
LOC103233018
liver carboxylesterase 1
disease_progression
ISO
mRNA, protein:decreased expression:liver tumor (human) associated with tumor vascularization; protein:decreased expression:liver tumor (human) protein:decreased expression:liver (human)
RGD
PMID:19658107 PMID:24259486 PMID:30901224
RGD:152995276 RGD:152995279 RGD:152995286
NCBI chr 5:41,710,500...41,745,483
G
LOC103233229
cadherin-1
severity
ISO
DNA:hypermethylation mRNA:increased expression:liver protein:decreased expression:liver
RGD
PMID:17295234 PMID:18837082 PMID:24840851 PMID:30697077
RGD:14402045 RGD:14402046 RGD:14402047 RGD:2289638
NCBI chr 5:58,578,244...58,679,677
Ensembl chr 5:58,578,146...58,679,541
G
LOC103233812
C-type lectin domain family 4 member G
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:7,206,303...7,211,213
Ensembl chr 6:7,206,712...7,209,431
G
LOC103234663
interferon lambda-1
ameliorates
ISO
human protein and cells in mouse model
RGD
PMID:24769671
RGD:126848750
NCBI chr 6:33,901,382...33,904,356
Ensembl chr 6:33,901,801...33,903,894
G
LOC103235252
leukocyte immunoglobulin-like receptor subfamily B member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:46,934,386...46,940,826
G
LOC103241760
ubiquitin-conjugating enzyme E2 E2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27914986
NCBI chr15:67,885,721...68,263,924
G
LOC103242767
C-C motif chemokine 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16284949
NCBI chr16:29,887,799...29,897,664
Ensembl chr16:29,887,883...29,897,544
G
LOC103242912
nucleoside diphosphate kinase A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr16:42,186,039...42,195,608
Ensembl chr16:42,185,260...42,195,616
G
LOC103243413
signal transducer and activator of transcription 5B
exacerbates ameliorates
ISO
protein:increased expression:liver (human) mRNA:increased expression:liver (human)
RGD
PMID:17047057 PMID:31485610
RGD:153298929 RGD:153298932
NCBI chr16:63,997,486...64,070,392
Ensembl chr16:63,997,441...64,070,445
G
LOC103243509
neuroendocrine secretory protein 55
ISO
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma
ClinVar
PMID:1517386 PMID:1594625 PMID:1944469 PMID:2549426 PMID:3720010 PMID:7739708 PMID:8766942 PMID:9626141 PMID:10571700 PMID:11093740 PMID:12727968 PMID:12970318 PMID:15126527 PMID:15952988 PMID:16507630 PMID:16543670 PMID:17873334 PMID:20197676 PMID:21835143 PMID:23403822 PMID:23536913 PMID:23843956 PMID:24855271 PMID:25157968 PMID:25719192 PMID:25741868 PMID:26341786 PMID:26574629 PMID:26619011 PMID:27398169 PMID:27506760 PMID:28492532 PMID:29991465 PMID:30702195 More...
NCBI chr 2:5,233,893...5,303,433
Ensembl chr 2:5,233,874...5,249,192
G
LOC103244924
cyclin-G1
severity disease_progression treatment
ISO
protein:decreased expression:liver (human) protein:increased expression:liver (human) human cells in mouse model
RGD
PMID:19584283 PMID:22835824 PMID:23804702 PMID:24034575 PMID:25431954 PMID:26345095 PMID:27982046 PMID:33543294 More...
RGD:151356922 RGD:151356932 RGD:151356933 RGD:151356967 RGD:151356970 RGD:151356981 RGD:151361198 RGD:151361200
NCBI chr23:65,709,759...65,716,913
Ensembl chr23:65,709,786...65,714,711
G
LOC103244927
hyaluronan mediated motility receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr23:65,732,343...65,765,511
Ensembl chr23:65,732,553...65,765,511
G
LOC103245928
rho GTPase-activating protein 11B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr26:50,246,538...50,269,273
Ensembl chr26:50,245,229...50,269,418
G
LOC103246803
mismatch repair endonuclease PMS2
ISO
ClinVar Annotator: match by term: Hepatocellular carcinoma
ClinVar
NCBI chr28:15,174,359...15,209,962
Ensembl chr28:15,172,100...15,209,852
G
LOC103248467
beta,beta-carotene 9',10'-oxygenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:103,511,730...103,566,526
Ensembl chr 1:103,521,658...103,565,659
G
LOXL3
lysyl oxidase like 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35841383
NCBI chr14:32,722,588...32,745,480
Ensembl chr14:32,725,112...32,745,004
G
LPA
lipoprotein(a)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr13:88,077,041...88,337,256
G
LPAR1
lysophosphatidic acid receptor 1
ISO
RGD
PMID:19000703
RGD:2317680
NCBI chr12:28,502,717...28,669,581
Ensembl chr12:28,503,354...28,669,795
G
LRAT
lecithin retinol acyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 7:101,297,114...101,304,675
Ensembl chr 7:101,297,691...101,302,520
G
LRP1B
LDL receptor related protein 1B
exacerbates
ISO
protein:increased expression:liver (human) DNA:mutations:multiple: (human)
RGD
PMID:33324588 PMID:33391418
RGD:150429776 RGD:150429785
NCBI chr10:25,611,400...27,511,903
Ensembl chr10:25,616,590...26,609,111
G
LRRC1
leucine rich repeat containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr17:18,627,810...18,751,074
Ensembl chr17:18,627,580...18,750,995
G
LRRC56
leucine rich repeat containing 56
ISO
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma
ClinVar
PMID:11150980 PMID:12835555 PMID:16155195 PMID:16170316 PMID:16329078 PMID:16372351 PMID:16443854 PMID:16835863 PMID:16881968 PMID:16969868 PMID:17054105 PMID:17211612 PMID:17384584 PMID:17412879 PMID:17601930 PMID:17979197 PMID:18039947 PMID:18042262 PMID:18247425 PMID:18978862 PMID:19206176 PMID:19213030 PMID:19255327 PMID:19371735 PMID:19382114 PMID:19669404 PMID:19773371 PMID:20301680 PMID:20660566 PMID:20859122 PMID:20937837 PMID:20979192 PMID:21438134 PMID:21495179 PMID:21686750 PMID:21834037 PMID:21850009 PMID:22087699 PMID:22256804 PMID:22317973 PMID:22420426 PMID:22495892 PMID:22499344 PMID:22683711 PMID:22726224 PMID:22926243 PMID:23093928 PMID:23096712 PMID:23406027 PMID:23429430 PMID:23751039 PMID:23884457 PMID:24006476 PMID:24033266 PMID:24129065 PMID:24169525 PMID:24224811 PMID:24390138 PMID:24803665 PMID:25157968 PMID:25326635 PMID:25741868 PMID:25815234 PMID:25914166 PMID:26467025 PMID:26619011 PMID:26778095 PMID:27195699 PMID:27283355 PMID:27444071 PMID:27589201 PMID:28027064 PMID:28139825 PMID:28492532 PMID:29493581 PMID:30055033 PMID:30138938 PMID:30191474 PMID:31222966 PMID:31394527 PMID:31560489 PMID:31564432 PMID:31775759 PMID:32371413 PMID:32732226 PMID:33027564 PMID:33372952 PMID:34008892 PMID:34958143 PMID:168335863 More...
NCBI chr 1:352,131...370,276
Ensembl chr 1:355,982...369,633
G
LRRC59
leucine rich repeat containing 59
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30705370
NCBI chr16:42,931,726...42,949,281
Ensembl chr16:42,932,549...42,947,655
G
LYVE1
lymphatic vessel endothelial hyaluronan receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:54,252,203...54,268,873
Ensembl chr 1:54,253,495...54,269,598
G
LZTR1
leucine zipper like post translational regulator 1
ISO
DNA:missense mutation:cds, liver (human)
RGD
PMID:28622513
RGD:151893487
NCBI chr19:4,917,381...4,935,174
Ensembl chr19:4,918,360...4,933,439
G
MAD2L1
mitotic arrest deficient 2 like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 7:67,351,785...67,360,244
G
MAGEA1
MAGE family member A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr X:127,660,892...127,662,685
Ensembl chr X:127,661,484...127,662,410
G
MAGEA3
MAGE family member A3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr X:127,271,604...127,276,373
G
MAP2K2
mitogen-activated protein kinase kinase 2
exacerbates
ISO
protein:increased expression:liver, cytosol (rat) mRNA:increased expression:liver (human)
RGD
PMID:9397988 PMID:33553243
RGD:150530475 RGD:150530477
NCBI chr 6:3,848,441...3,881,367
Ensembl chr 6:3,848,401...3,881,412
G
MAP2K4
mitogen-activated protein kinase kinase 4
ISO
protein:decreased expression:liver (human)
RGD
PMID:32850377
RGD:150429765
NCBI chr16:11,366,610...11,485,411
Ensembl chr16:11,366,751...11,486,125
G
MAP3K1
mitogen-activated protein kinase kinase kinase 1
exacerbates
ISO
mRNA:decreased expression:liver (human)
RGD
PMID:31310010
RGD:150573714
NCBI chr 4:53,040,731...53,120,784
Ensembl chr 4:53,084,023...53,120,772
G
MAP3K8
mitogen-activated protein kinase kinase kinase 8
ameliorates
ISO
RGD
PMID:26560698
RGD:11342977
G
MAP4K4
mitogen-activated protein kinase kinase kinase kinase 4
severity ameliorates treatment
ISO
human recombinant gene and cell line in a mouse model human cell line in a mouse model
RGD
PMID:21196414 PMID:27010469 PMID:31922225
RGD:151347673 RGD:151347674 RGD:151347839
NCBI chr14:5,391,416...5,579,163
Ensembl chr14:5,391,449...5,583,916
G
MAPK1
mitogen-activated protein kinase 1
ISO
protein:increased expression:liver
RGD
PMID:27468214
RGD:401976278
NCBI chr19:4,246,144...4,352,648
Ensembl chr19:4,246,122...4,353,325
G
MAPK14
mitogen-activated protein kinase 14
treatment exacerbates
ISO
RGD
PMID:23271722 PMID:25216638
RGD:151665347 RGD:151665348
NCBI chr17:36,012,164...36,095,542
Ensembl chr17:36,014,454...36,095,138
G
MAPK8
mitogen-activated protein kinase 8
ameliorates
ISO
protein:decreased phosphorylation:liver (human)
RGD
PMID:33875785
RGD:150340688
NCBI chr 9:43,356,603...43,489,066
Ensembl chr 9:43,356,308...43,393,425
G
MAPT
microtubule associated protein tau
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr16:59,894,400...60,020,723
Ensembl chr16:59,890,221...59,955,612
G
MARCO
macrophage receptor with collagenous structure
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr10:11,329,036...11,389,428
Ensembl chr10:11,329,026...11,388,999
G
MAT1A
methionine adenosyltransferase 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12060674
NCBI chr 9:51,540,162...51,558,076
Ensembl chr 9:51,540,162...51,558,576
G
MBL2
mannose binding lectin 2
severity susceptibility no_association
ISO
associated with hepatitis C;DNA:SNP: :221C>G(rs709620)(human) associated with hepatitis B-related cirrhosis;DNA:SNP: :rs11003123(G>A)(human) associated with viral hepatitis;DNA:polymorphisms:exon: associated with hepatitis B;DNA:SNP:exon: DNA:SNPs:promoter:rs7096206(human) protein:decreased expression:plasma
RGD
PMID:18221301 PMID:21733090 PMID:25787238 PMID:26857650 PMID:27298104 PMID:27557564 More...
RGD:14696813 RGD:14696814 RGD:14696829 RGD:14696833 RGD:14696835 RGD:14696836
NCBI chr 9:78,389,534...78,394,753
Ensembl chr 9:78,389,947...78,396,079
G
MBTPS1
membrane bound transcription factor peptidase, site 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14563831
NCBI chr 5:69,464,064...69,527,588
Ensembl chr 5:69,463,920...69,527,541
G
MBTPS2
membrane bound transcription factor peptidase, site 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14563831
NCBI chr X:20,319,731...20,364,603
Ensembl chr X:20,319,807...20,361,847
G
MCM10
minichromosome maintenance 10 replication initiation factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:13,200,018...13,252,830
Ensembl chr 9:13,204,246...13,253,367
G
MCM2
minichromosome maintenance complex component 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr22:53,419,958...53,452,720
Ensembl chr22:53,420,417...53,444,095
G
MCM7
minichromosome maintenance complex component 7
susceptibility
ISO
associated with hepatitis B;miRNA:increased expression:liver (human) associated with hepatitis B;DNA:SNP:promoter: (rs999885) (human)
RGD
PMID:24416400 PMID:27298561
RGD:15042853 RGD:15042885
NCBI chr28:12,976,487...12,985,354
Ensembl chr28:12,977,013...12,985,898
G
MCM9
minichromosome maintenance 9 homologous recombination repair factor
ISO
OMIM:114550
MouseDO
NCBI chr13:54,945,668...55,069,869
Ensembl chr13:54,945,786...55,070,328
G
MDM2
MDM2 proto-oncogene
susceptibility
ISO
DNA:transversion:promoter:g.-309T>G (human)
RGD
PMID:20019189
RGD:2317357
NCBI chr11:64,434,203...64,465,490
Ensembl chr11:64,434,261...64,469,890
G
ME1
malic enzyme 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147110
NCBI chr13:7,889,211...8,112,793
Ensembl chr13:7,887,984...8,112,533
G
MECP2
methyl-CpG binding protein 2
ISO
mRNA, protein:increased expression:liver CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:11844796 PMID:26189965
RGD:2289670
NCBI chr X:128,445,028...128,519,892
Ensembl chr X:128,453,577...128,455,785
G
MED1
mediator complex subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20007298
NCBI chr16:66,719,393...66,764,902
Ensembl chr16:66,719,423...66,762,896
G
MELK
maternal embryonic leucine zipper kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr12:43,901,840...44,007,855
Ensembl chr12:43,901,551...44,007,266
G
MET
MET proto-oncogene, receptor tyrosine kinase
severity
ISO
protein:increased expression:liver (human) ClinVar Annotator: match by term: Hepatocellular cancer
RGD OMIM ClinVar
PMID:21774103 PMID:21970370 PMID:22703879 PMID:24728327 PMID:25741868 PMID:28259294 PMID:28492532 PMID:29303510 PMID:29641532 More...
RGD:152995524
NCBI chr21:85,370,574...85,486,405
Ensembl chr21:85,397,645...85,488,093
G
MFSD2A
MFSD2 lysolipid transporter A, lysophospholipid
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr20:92,926,217...92,941,191
Ensembl chr20:92,926,067...92,941,159
G
MHC-DPA1
major histocompatibility complex, class II, DP alpha 1
ISO
DNA:hypomethylation: CpG islands:
RGD
PMID:20165882
RGD:14694974
NCBI chr17:39,009,361...39,017,978
G
MHC-DQA1
major histocompatibility complex, class II, DQ alpha 1
susceptibility
ISO
associated with Hepatitis B, Chronic;DNA:SNP: :rs9272105(human) associated with Hepatitis B, Chronic;DNA:SNPs, haplotype: : rs9275572, rs2596542(human)
RGD
PMID:24204805 PMID:30160782
RGD:14398839 RGD:14401561
NCBI chr17:39,422,445...39,428,777
Ensembl chr17:39,420,134...39,428,871
G
MKI67
marker of proliferation Ki-67
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:120,697,183...120,727,039
Ensembl chr 9:120,698,834...120,726,866
G
MLXIPL
MLX interacting protein like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147110
NCBI chr28:9,442,520...9,465,772
G
MME
membrane metalloendopeptidase
ISO
RGD
PMID:8302012
RGD:13801035
NCBI chr15:35,577,460...35,681,730
Ensembl chr15:35,580,714...35,633,914
G
MMP14
matrix metallopeptidase 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33010264
NCBI chr29:23,201,425...23,212,408
Ensembl chr29:23,201,112...23,212,679
G
MMP2
matrix metallopeptidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20084675
NCBI chr 5:41,264,382...41,291,657
Ensembl chr 5:41,264,354...41,291,004
G
MMP9
matrix metallopeptidase 9
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:20084675 PMID:21681821
RGD:8547864
NCBI chr 2:17,867,267...17,874,757
Ensembl chr 2:17,867,177...17,874,712
G
MOGAT2
monoacylglycerol O-acyltransferase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:66,935,212...66,952,446
Ensembl chr 1:66,935,584...66,951,891
G
MPL
MPL proto-oncogene, thrombopoietin receptor
ISO
human cells in mouse model
RGD
PMID:23157389
RGD:126925755
NCBI chr20:89,457,549...89,474,756
Ensembl chr20:89,459,493...89,474,352
G
MPO
myeloperoxidase
disease_progression susceptibility
ISO
associated with liver cirrhosis with Hepatitis C;DNA:SNP:promoter:-463G>A(human) associated with liver cirrhosis; DNA:SNP:promoter:-463G>A( rs2333227)(human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:19731237 PMID:21907168
RGD:26923907 RGD:27095879
NCBI chr16:35,120,194...35,130,851
Ensembl chr16:35,120,581...35,130,671
G
MRO
maestro
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr18:30,149,163...30,177,547
Ensembl chr18:30,166,834...30,181,570
G
MSH3
mutS homolog 3
ISO
ClinVar Annotator: match by term: Hepatocellular cancer
ClinVar
PMID:28492532
NCBI chr 4:74,811,181...75,032,067
Ensembl chr 4:74,811,198...75,032,005
G
MSH5
mutS homolog 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr17:40,260,979...40,283,872
Ensembl chr17:40,261,125...40,282,511
G
MTBP
MDM2 binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29765550
NCBI chr 8:115,023,272...115,109,948
Ensembl chr 8:115,029,029...115,102,088
G
MTDH
metadherin
treatment
ISO
human cells in a mouse model
RGD
PMID:26351209
RGD:11096879
NCBI chr 8:92,563,480...92,641,874
Ensembl chr 8:92,563,550...92,640,231
G
MTHFD2
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
ISO
mRNA:increased expression:liver
RGD
PMID:3878730
RGD:2302305
NCBI chr14:33,063,485...33,080,703
Ensembl chr14:33,064,542...33,080,366
G
MTHFR
methylenetetrahydrofolate reductase
onset susceptibility disease_progression
ISO
DNA:SNP: :1298A>C(human) DNA:SNPs: :677C>T, 1298A>C(human) DNA:SNP: :677C>T(human) DNA:SNP,haplotype: :677C>T, 1298A>C(human)
RGD
PMID:17503006 PMID:17659576 PMID:19035314 PMID:23996892
RGD:14696703 RGD:14696704 RGD:14696707 RGD:14696708
NCBI chr20:119,987,667...120,003,611
Ensembl chr20:119,990,133...120,002,950
G
MTOR
mechanistic target of rapamycin kinase
severity
ISO
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:liver (human)
CTD RGD
PMID:21147110 PMID:25371154
RGD:152995471
NCBI chr20:120,522,667...120,678,988
Ensembl chr20:120,525,737...120,679,020
G
MTRR
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
susceptibility
ISO
DNA:SNP: :66A>G(human)
RGD
PMID:19035314
RGD:14696707
NCBI chr 4:7,461,521...7,493,032
Ensembl chr 4:7,461,526...7,493,840
G
MVK
mevalonate kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147110
NCBI chr11:104,812,882...104,837,089
Ensembl chr11:104,813,846...104,835,517
G
MYBL2
MYB proto-oncogene like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:20,097,179...20,148,998
Ensembl chr 2:20,097,108...20,148,926
G
MYC
MYC proto-oncogene, bHLH transcription factor
severity treatment
ISO
mRNA:increased expression:liver (human) OMIM:114550 mRNA:increased expression:liver (rat) CTD Direct Evidence: marker/mechanism
RGD MouseDO CTD
PMID:9029167 PMID:12029619 PMID:15565109 PMID:21644509 PMID:22076107 PMID:22129741 PMID:22434528 PMID:29698666 More...
RGD:6903288 RGD:7240567 RGD:7240695 RGD:7241004
NCBI chr 8:122,282,989...122,288,392
Ensembl chr 8:122,282,630...122,288,384
G
MYD88
MYD88 innate immune signal transduction adaptor
exacerbates treatment ameliorates
ISO
mRNA:increased expression:liver (human) human gene and cell in a mouse model mouse cell line in a mouse model protein:increased expression:liver (human) human cell line in a mouse model protein, mRNA:decreased expression:liver (human)
RGD
PMID:17615358 PMID:24603331 PMID:26985932 PMID:28370778 PMID:29022910 PMID:31068809 PMID:31074165 PMID:32144747 PMID:33575076 More...
RGD:150520022 RGD:150520169 RGD:150521532 RGD:150521534 RGD:150524327 RGD:150524329 RGD:150524330 RGD:150524334 RGD:150530285
NCBI chr15:1,276,804...1,281,811
Ensembl chr15:1,276,798...1,281,166
G
NAT2
N-acetyltransferase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 8:16,451,144...16,494,961
Ensembl chr 8:16,493,749...16,494,621
G
NBN
nibrin
ISO
ClinVar Annotator: match by term: Hepatocellular cancer
ClinVar
PMID:9590180 PMID:9590181 PMID:9620777 PMID:10398434 PMID:10799436 PMID:10848790 PMID:10852373 PMID:11093281 PMID:11279524 PMID:11953735 PMID:12123493 PMID:12505263 PMID:12833396 PMID:12845677 PMID:14973119 PMID:15185344 PMID:15279809 PMID:16033915 PMID:16544999 PMID:17103455 PMID:18606567 PMID:18940477 PMID:19635536 PMID:19908051 PMID:20444919 PMID:22131123 PMID:22293976 PMID:22373003 PMID:22491912 PMID:22941933 PMID:23317186 PMID:24033266 PMID:24113799 PMID:25485873 PMID:25741868 PMID:25980754 PMID:26083025 PMID:26467025 PMID:26822949 PMID:26845104 PMID:27150568 PMID:27616075 PMID:28492532 PMID:28873162 PMID:29368341 PMID:29419426 PMID:30426508 PMID:31173646 PMID:32295079 PMID:33050356 PMID:33471974 PMID:33471991 PMID:33840814 PMID:34072463 PMID:34072659 PMID:34544220 PMID:35309086 More...
NCBI chr 8:85,017,807...85,069,219
Ensembl chr 8:85,015,752...85,069,028
G
NCAPG
non-SMC condensin I complex subunit G
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr27:32,380,722...32,413,659
Ensembl chr27:32,377,575...32,413,494
G
NCAPH
non-SMC condensin I complex subunit H
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr14:755,840...792,053
Ensembl chr14:755,897...792,154
G
NCOA2
nuclear receptor coactivator 2
exacerbates
ISO
RGD
PMID:22556267 PMID:28273073
RGD:153002573 RGD:153002576
NCBI chr 8:65,855,232...66,151,733
Ensembl chr 8:65,855,235...66,040,947
G
NDC80
NDC80 kinetochore complex component
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr18:61,835,027...61,882,660
Ensembl chr18:61,835,064...61,881,627
G
NEIL3
nei like DNA glycosylase 3
disease_progression
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver (human)
CTD RGD
PMID:28284560 PMID:35693827
RGD:153344586
NCBI chr 7:123,408,582...123,462,475
Ensembl chr 7:123,409,363...123,462,411
G
NEK2
NIMA related kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr25:17,816,929...17,847,348
Ensembl chr25:17,829,546...17,842,463
G
NF2
NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor
disease_progression
ISO
protein:decreased expression:liver DNA, protein:SNP, increased expression:intron, liver
RGD
PMID:26443326 PMID:27289045 PMID:29130106
RGD:11076529 RGD:150530489 RGD:150530504
NCBI chr19:12,474,479...12,572,144
Ensembl chr19:12,474,468...12,572,250
G
NFE2L1
NFE2 like bZIP transcription factor 1
ISO
OMIM:114550
MouseDO
NCBI chr16:68,449,601...68,463,030
Ensembl chr16:68,449,898...68,461,190
G
NFE2L2
NFE2 like bZIP transcription factor 2
ISO
ClinVar Annotator: match by term: Hepatocellular carcinoma
ClinVar
PMID:26619011 PMID:29018201
NCBI chr10:62,789,647...62,825,651
Ensembl chr10:62,790,124...62,825,339
G
NFKB1
nuclear factor kappa B subunit 1
disease_progression treatment
ISO
associated with Chronic Hepatitis B;DNA:insertion/deletion:3'utr: -94ins/delATTG (rs28720239) (human)
RGD
PMID:19797428 PMID:25999787
RGD:152177911 RGD:40400751
NCBI chr 7:50,589,494...50,711,472
Ensembl chr 7:50,589,856...50,711,498
G
NFKBIA
NFKB inhibitor alpha
disease_progression susceptibility
ISO
CTD Direct Evidence: therapeutic associated with Chronic Hepatitis B;DNA:SNPs,haplotype:3'utr,promoter: 826C>T,881A>G (rs2233406,rs3138053) (human) associated with hepatitis B;DNA:SNP:promoter:-826C>T (rs2233406) (human)
CTD RGD
PMID:19797428 PMID:22022477 PMID:25223483
RGD:40400751 RGD:40902986
NCBI chr24:12,211,619...12,216,185
Ensembl chr24:12,210,281...12,214,854
G
NKX3-1
NK3 homeobox 1
treatment
ISO
human gene in a mouse model mRNA:decreased expression:liver
RGD
PMID:28972178
RGD:14401599
NCBI chr 8:21,792,069...21,797,258
Ensembl chr 8:21,791,422...21,796,319
G
NLRC3
NLR family CARD domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30081150
NCBI chr 5:3,241,552...3,262,763
Ensembl chr 5:3,242,242...3,262,261
G
NLRC5
NLR family CARD domain containing 5
ISO
protein:increased expression:liver
RGD
PMID:27338800
RGD:15003194
NCBI chr 5:42,942,875...43,035,043
Ensembl chr 5:42,974,300...43,035,351
G
NNMT
nicotinamide N-methyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:105,650,178...105,708,441
Ensembl chr 1:105,690,085...105,713,010
G
NOS2
nitric oxide synthase 2
treatment
ISO
RGD
PMID:25999787
RGD:152177911
NCBI chr16:21,533,011...21,576,645
Ensembl chr16:21,533,484...21,574,257
G
NOTCH3
notch receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:13,762,570...13,803,676
Ensembl chr 6:13,761,512...13,793,359
G
NR0B2
nuclear receptor subfamily 0 group B member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23811326
NCBI chr20:105,850,328...105,853,076
Ensembl chr20:105,850,598...105,853,060
G
NR1H2
nuclear receptor subfamily 1 group H member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147110
NCBI chr 6:43,438,428...43,445,190
Ensembl chr 6:43,437,950...43,446,063
G
NR1H4
nuclear receptor subfamily 1 group H member 4
ISO
mRNA:splice variant(s):liver (human) OMIM:114550 intestinally expressed human gene in mouse model CTD Direct Evidence: marker/mechanism
RGD MouseDO CTD
PMID:23213087 PMID:23811326 PMID:24954587 PMID:25496033
RGD:14696796 RGD:14928330 RGD:14928334
NCBI chr11:95,792,428...95,877,989
Ensembl chr11:95,792,996...95,878,293
G
NRAS
NRAS proto-oncogene, GTPase
disease_progression severity
ISO
human gene in mouse model ClinVar Annotator: match by term: Hepatocellular cancer mRNA, protein:increased expression:liver (mouse, human)
RGD ClinVar
PMID:1654209 PMID:2278970 PMID:2674680 PMID:3122217 PMID:6587382 PMID:8120410 PMID:10821536 PMID:12460918 PMID:12727991 PMID:14508525 PMID:15899789 PMID:16273091 PMID:16291983 PMID:16434492 PMID:17699718 PMID:18390968 PMID:18633438 PMID:18668139 PMID:18948947 PMID:19075190 PMID:19657110 PMID:19880792 PMID:19966803 PMID:20130576 PMID:20149136 PMID:20179705 PMID:20406486 PMID:20619739 PMID:20736745 PMID:21107323 PMID:21305640 PMID:21576590 PMID:21729679 PMID:21829508 PMID:21993994 PMID:22407852 PMID:22499344 PMID:22718121 PMID:22761467 PMID:22773810 PMID:23076151 PMID:23392294 PMID:23400451 PMID:23414587 PMID:23515407 PMID:23538902 PMID:23569304 PMID:23614898 PMID:24006476 PMID:24033266 PMID:24148783 PMID:24370118 PMID:24671188 PMID:25157968 PMID:25348872 PMID:25695684 PMID:25741868 PMID:26619011 PMID:26821351 PMID:27050078 PMID:28492532 PMID:28780248 PMID:30685691 More...
RGD:14696775 RGD:14696793
NCBI chr20:18,953,273...18,966,002
Ensembl chr20:18,953,883...18,961,931
G
NRG1
neuregulin 1
disease_progression
ISO
mRNA:increased expression:liver (human) associated with hepatitis C;mRNA:altered expression:liver (human
RGD
PMID:17393520 PMID:27514687
RGD:39456104 RGD:39456110
NCBI chr 8:29,745,984...30,862,140
Ensembl chr 8:30,635,803...30,856,487
G
NRP1
neuropilin 1
disease_progression
ISO
protein:decreased expression:liver
RGD
PMID:25333267
RGD:126848812
NCBI chr 9:32,474,787...32,632,746
Ensembl chr 9:32,474,309...32,633,101
G
NUF2
NUF2 component of NDC80 kinetochore complex
disease_progression treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:28284560 PMID:30653265 PMID:31933938
RGD:28867240 RGD:28912742
NCBI chr25:65,462,608...65,493,242
Ensembl chr25:65,462,603...65,493,246
G
NUSAP1
nucleolar and spindle associated protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr26:41,624,507...41,667,568
Ensembl chr26:41,624,894...41,667,548
G
OIT3
oncoprotein induced transcript 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:58,338,703...58,378,492
Ensembl chr 9:58,337,958...58,377,734
G
OLFML2A
olfactomedin like 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr12:13,334,339...13,368,610
Ensembl chr12:13,335,805...13,451,675
G
OLFML2B
olfactomedin like 2B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr20:2,053,696...2,094,142
Ensembl chr20:2,053,852...2,094,126
G
ORC1
origin recognition complex subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr20:80,540,331...80,571,989
Ensembl chr20:80,542,532...80,572,237
G
OTC
ornithine transcarbamylase
severity
ISO
mRNA:altered expression:liver tumor (human)
RGD
PMID:30901224
RGD:152995286
NCBI chr X:35,494,334...35,570,923
Ensembl chr X:35,494,287...35,570,845
G
PAFAH1B1
platelet activating factor acetylhydrolase 1b regulatory subunit 1
disease_progression
ISO
mRNA,protein:decreased expression:liver:
RGD
PMID:21569763
RGD:12790589
NCBI chr16:2,270,126...2,293,705
Ensembl chr16:2,270,085...2,296,825
G
PAMR1
peptidase domain containing associated with muscle regeneration 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:29,732,311...29,833,646
Ensembl chr 1:29,774,155...29,833,117
G
PARK7
Parkinsonism associated deglycase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr20:123,776,084...123,808,031
Ensembl chr20:123,776,297...123,798,434
G
PARP1
poly(ADP-ribose) polymerase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18695907
NCBI chr25:3,350,798...3,405,040
G
PBK
PDZ binding kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 8:25,921,124...25,943,349
Ensembl chr 8:25,921,133...25,943,062
G
PCK1
phosphoenolpyruvate carboxykinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144 PMID:28284560
NCBI chr 2:6,550,806...6,556,499
Ensembl chr 2:6,549,652...6,556,478
G
PCLAF
PCNA clamp associated factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr26:19,140,901...19,155,488
Ensembl chr26:19,140,843...19,155,730
G
PCNA
proliferating cell nuclear antigen
treatment
ISO
protein:increased expression:liver:
RGD
PMID:23219601 PMID:25999787
RGD:10448993 RGD:152177911
NCBI chr 2:32,936,600...32,953,635
Ensembl chr 2:32,948,196...32,953,991
G
PDCD1
programmed cell death 1
disease_progression
ISO
associated with hepatitis B associated with hepatitis B;DNA:SNP: : +8669 A>G (human)
RGD
PMID:21912640 PMID:27034168
RGD:40818257 RGD:41410800
NCBI chr10:127,877,383...127,886,234
Ensembl chr10:127,878,554...127,886,088
G
PDGFB
platelet derived growth factor subunit B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20506153
NCBI chr19:21,865,792...21,888,068
Ensembl chr19:21,863,768...21,886,395
G
PDGFRL
platelet derived growth factor receptor like
ISO
ClinVar Annotator: match by term: Hepatocellular carcinoma
OMIM ClinVar
PMID:7898930
NCBI chr 8:15,671,827...15,739,396
Ensembl chr 8:15,671,425...15,738,199
G
PDIA3
protein disulfide isomerase family A member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr26:39,273,982...39,300,170
Ensembl chr26:39,272,997...39,349,966
G
PDK4
pyruvate dehydrogenase kinase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28003426
NCBI chr21:53,445,607...53,458,729
Ensembl chr21:53,445,457...53,460,776
G
PFAS
phosphoribosylformylglycinamidine synthase
ISO
protein:increased activity:hepatoma (rat) protein:increased expression:liver
RGD
PMID:6722784
RGD:5135276
NCBI chr16:7,618,952...7,639,700
Ensembl chr16:7,623,817...7,638,594
G
PFN2
profilin 2
disease_progression
ISO
mRNA:increased expression:liver (human)
RGD
PMID:35693827
RGD:153344586
NCBI chr15:40,718,892...40,726,731
G
PGD
phosphogluconate dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144
NCBI chr20:121,359,854...121,380,934
G
PGK1
phosphoglycerate kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr X:67,072,029...67,093,881
G
PHB1
prohibitin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr16:69,805,968...69,816,792
Ensembl chr16:69,806,923...69,816,754
G
PHF6
PHD finger protein 6
exacerbates
ISO
mRNA:increased expression:liver (human)
RGD
PMID:30888215 PMID:31329335
RGD:155260288 RGD:155260308
NCBI chr X:109,531,700...109,595,136
Ensembl chr X:109,531,726...109,593,854
G
PHLDA1
pleckstrin homology like domain family A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr11:71,621,536...71,630,051
G
PIK3CA
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
treatment susceptibility severity no_association
ISO
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma DNA:SNPs: :rs17849071,rs17849079(human) DNA:mutations:exons: DNA:mutation:exon:
OMIM ClinVar RGD
PMID:15016963 PMID:15254419 PMID:15520168 PMID:15608678 PMID:15647370 PMID:15805248 PMID:15930273 PMID:16331247 PMID:16906227 PMID:16930767 PMID:17376864 PMID:17673550 PMID:18676830 PMID:18725974 PMID:19029981 PMID:19223544 PMID:19366826 PMID:19513541 PMID:19903786 PMID:20453058 PMID:20593314 PMID:20619739 PMID:21078999 PMID:21430269 PMID:21558396 PMID:21824802 PMID:22162582 PMID:22162589 PMID:22209294 PMID:22271473 PMID:22357840 PMID:22370636 PMID:22658544 PMID:22729222 PMID:22729223 PMID:22729224 PMID:23066039 PMID:23100325 PMID:23408298 PMID:23888070 PMID:23946963 PMID:24033266 PMID:24265155 PMID:24559322 PMID:24673525 PMID:24782230 PMID:25157968 PMID:25599672 PMID:25681199 PMID:25741868 PMID:25880439 PMID:25999787 PMID:26266975 PMID:26266985 PMID:26619011 PMID:26627007 PMID:26637981 PMID:26822237 PMID:26823876 PMID:26851524 PMID:27126994 PMID:27626068 PMID:27631024 PMID:28151489 PMID:28425981 PMID:28492532 PMID:29446767 PMID:29661094 PMID:29758562 PMID:29988677 PMID:30063105 PMID:30376034 PMID:30543347 PMID:31536475 PMID:31775759 PMID:32778138 PMID:34008892 PMID:34496175 PMID:34568242 PMID:34606700 PMID:36474027 PMID:37667289 PMID:37712948 More...
RGD:11556371 RGD:14402404 RGD:14402405 RGD:152177911
NCBI chr15:10,218,034...10,304,874
Ensembl chr15:10,218,805...10,294,316
G
PIK3CB
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
treatment
ISO
RGD
PMID:25999787
RGD:152177911
NCBI chr15:51,705,585...51,885,848
Ensembl chr15:51,775,733...51,889,238
G
PIK3R1
phosphoinositide-3-kinase regulatory subunit 1
treatment
ISO
RGD
PMID:25999787 PMID:31801250
RGD:151893509 RGD:152177911
NCBI chr 4:64,321,296...64,406,188
Ensembl chr 4:64,321,078...64,406,519
G
PIK3R2
phosphoinositide-3-kinase regulatory subunit 2
treatment
ISO
RGD
PMID:25999787
RGD:152177911
NCBI chr 6:16,620,673...16,637,511
Ensembl chr 6:16,621,606...16,636,937
G
PIK3R3
phosphoinositide-3-kinase regulatory subunit 3
treatment
ISO
RGD
PMID:25999787
RGD:152177911
NCBI chr20:86,651,692...86,748,670
Ensembl chr20:86,651,520...86,745,116
G
PINX1
PIN2 (TERF1) interacting telomerase inhibitor 1
disease_progression
ISO
associated with Chronic Hepatitis B; DNA:SNP::rs1469557(human)
RGD
PMID:27221889
RGD:152977752
NCBI chr 8:8,259,537...8,336,586
Ensembl chr 8:8,259,692...8,336,603
G
PITPNM3
PITPNM family member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr16:5,830,107...5,934,979
Ensembl chr16:5,834,088...5,916,697
G
PITX1
paired like homeodomain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr23:37,807,486...37,820,540
Ensembl chr23:37,807,378...37,813,948
G
PKM
pyruvate kinase M1/2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144
NCBI chr26:11,224,332...11,255,538
G
PKMYT1
protein kinase, membrane associated tyrosine/threonine 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 5:2,712,423...2,722,122
Ensembl chr 5:2,712,448...2,716,661
G
PKP1
plakophilin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr25:28,083,358...28,129,356
Ensembl chr25:28,081,983...28,128,173
G
PLAC8
placenta associated 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 7:31,471,166...31,496,053
Ensembl chr 7:31,470,774...31,489,432
G
PLAU
plasminogen activator, urokinase
ISO
OMIM:114550
MouseDO
NCBI chr 9:57,452,904...57,459,345
Ensembl chr 9:57,452,761...57,459,286
G
PLCG1
phospholipase C gamma 1
ameliorates
ISO
human cell line in a mouse model
RGD
PMID:30623526
RGD:151356937
NCBI chr 2:22,599,547...22,638,394
G
PLK1
polo like kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 5:21,388,957...21,408,574
Ensembl chr 5:21,396,204...21,410,718
G
PLK4
polo like kinase 4
sexual_dimorphism
ISO
DNA:hypermethylation:promoter
RGD
PMID:21324136
RGD:27226690
NCBI chr 7:75,005,468...75,023,768
Ensembl chr 7:75,006,431...75,023,730
G
PLOD3
procollagen-lysine,2-oxoglutarate 5-dioxygenase 3
treatment
ISO
mRNA, protein:increased expression:liver (human)
RGD
PMID:29059470
RGD:155791679
NCBI chr28:11,962,394...11,974,206
Ensembl chr28:11,962,286...11,975,228
G
PLVAP
plasmalemma vesicle associated protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:15,857,945...15,879,022
Ensembl chr 6:15,857,947...15,879,058
G
PLXDC1
plexin domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr16:67,015,482...67,102,761
Ensembl chr16:67,016,829...67,106,635
G
PML
PML nuclear body scaffold
ameliorates disease_progression exacerbates
ISO
mRNA:increased expression:liver (mouse) protein:increased expression:liver (human) associated with hepatitis C
RGD
PMID:11511788 PMID:26118777 PMID:31144474
RGD:41404685 RGD:41404687 RGD:41404690
NCBI chr26:9,441,998...9,494,949
Ensembl chr26:9,451,112...9,494,931
G
PNPLA3
patatin like phospholipase domain containing 3
ISO
associated with Hepatitis C, Chronic;DNA:SNP: :rs738409 (p.I148M) (human)
RGD
PMID:21319195
RGD:14981585
NCBI chr19:26,435,302...26,458,368
Ensembl chr19:26,435,599...26,462,210
G
PNPT1
polyribonucleotide nucleotidyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr14:51,211,385...51,267,706
Ensembl chr14:51,211,118...51,267,098
G
POLG
DNA polymerase gamma, catalytic subunit
susceptibility
ISO
DNA:SNPs:introns: (rs1061316, rs758130) (human)
RGD
PMID:28457473
RGD:15039387
NCBI chr29:7,864,319...7,881,577
Ensembl chr29:7,863,277...7,882,068
G
PON1
paraoxonase 1
disease_progression
ISO
mRNA:decreased expression:liver (human)
RGD
PMID:35693827
RGD:153344586
NCBI chr21:53,713,434...53,739,658
Ensembl chr21:53,714,012...53,739,875
G
POT1
protection of telomeres 1
disease_progression
ISO
associated with hepatitis B;DNA:SNP: :rs7784168(human)
RGD
PMID:23907815
RGD:152975963
NCBI chr21:93,572,139...93,688,374
Ensembl chr21:93,571,272...93,655,869
G
PPARA
peroxisome proliferator activated receptor alpha
susceptibility
ISO
associated with hepatitis B;DNA:missense mutation:cds:p.L162V (human)
RGD
PMID:19119483
RGD:15042881
G
PPARG
peroxisome proliferator activated receptor gamma
severity
ISO
CTD Direct Evidence: therapeutic protein:decreased expression:liver
CTD RGD
PMID:16374840 PMID:27451128
RGD:14694822
NCBI chr22:48,262,743...48,407,415
Ensembl chr22:48,275,600...48,407,418
G
PPAT
phosphoribosyl pyrophosphate amidotransferase
ISO
protein:increased activity:hepatoma (rat)
RGD
PMID:6327016
RGD:5135035
NCBI chr 7:12,201,434...12,242,418
Ensembl chr 7:12,191,784...12,243,488
G
PPP1R1A
protein phosphatase 1 regulatory inhibitor subunit 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15010824
NCBI chr11:50,695,896...50,704,191
Ensembl chr11:50,696,032...50,704,219
G
PPP1R9A
protein phosphatase 1 regulatory subunit 9A
onset
ISO
protein:increased expression:liver (rat)
RGD
PMID:20935162
RGD:10002734
NCBI chr21:53,744,202...54,129,709
Ensembl chr21:53,747,857...54,127,005
G
PPP1R9B
protein phosphatase 1 regulatory subunit 9B
severity
ISO
mRNA, protein:decreased expression:liver (human)
RGD
PMID:23591196
RGD:10043803
NCBI chr16:43,188,400...43,205,621
Ensembl chr16:43,188,022...43,205,680
G
PPP4R3C
protein phosphatase 4 regulatory subunit 3C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr X:25,913,708...25,917,148
G
PRC1
protein regulator of cytokinesis 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr29:8,866,919...8,895,832
Ensembl chr29:8,866,969...8,894,691
G
PRDM1
PR/SET domain 1
disease_progression
ISO
associated with hepatitis B; associated with hepatitis B;DNA:SNP: :rs1010273(human)
RGD
PMID:31100710 PMID:31376415
RGD:150530465 RGD:150530466
NCBI chr13:67,695,436...67,719,487
Ensembl chr13:67,695,309...67,718,931
G
PRDX1
peroxiredoxin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27517622
NCBI chr20:87,267,026...87,277,634
Ensembl chr20:87,267,044...87,279,978
G
PRDX2
peroxiredoxin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 6:11,484,452...11,489,067
Ensembl chr 6:11,481,784...11,489,051
G
PRDX6
peroxiredoxin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr25:55,706,920...55,719,196
Ensembl chr25:55,706,885...55,718,665
G
PREX2
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2
exacerbates
ISO
protein:increased expression:liver (human) mRNA:increased expression:liver (human) mRNA:decreased expression:liver (human)
RGD
PMID:25151370 PMID:28000796 PMID:28205209 PMID:31776854
RGD:151665185 RGD:151665186 RGD:151665188 RGD:151665343
NCBI chr 8:63,781,892...64,061,222
Ensembl chr 8:63,781,948...64,060,864
G
PRKN
parkin RBR E3 ubiquitin protein ligase
severity
ISO
protein:decreased expression:liver (human)
RGD
PMID:28862485
RGD:13432206
NCBI chr13:88,856,056...90,329,379
G
PRL
prolactin
onset
ISO
protein:increased expression:serum (human)
RGD
PMID:22392353
RGD:125097525
NCBI chr17:49,922,750...49,938,084
Ensembl chr17:49,928,321...49,938,631
G
PROM1
prominin 1
ISO
mRNA:increased expression:liver (mouse)
RGD
PMID:26569409
RGD:11344640
NCBI chr27:34,093,699...34,243,630
Ensembl chr27:34,129,532...34,243,778
G
PTEN
phosphatase and tensin homolog
severity treatment exacerbates
ISO
associated with hepatitis B;protein:decreased expression:liver (human) OMIM:114550 CTD Direct Evidence: marker/mechanism associated with hepatitis C, liver cirrhosis;protein:decreased expression:liver (human)
RGD MouseDO CTD
PMID:12115563 PMID:12673720 PMID:27022031 PMID:29303510 PMID:30690477 PMID:31801250 More...
RGD:127285591 RGD:127285603 RGD:127285610 RGD:151893509 RGD:152995524
NCBI chr 9:81,308,058...81,412,386
Ensembl chr 9:81,309,099...81,409,146
G
PTGS2
prostaglandin-endoperoxide synthase 2
treatment susceptibility severity
ISO
mRNA,protein:decreased expression:liver CTD Direct Evidence: marker/mechanism DNA:SNP:promoter:-1195A>G (rs689466) (human) protein:increased expression:liver, cytosol
RGD CTD
PMID:11872629 PMID:12024111 PMID:14563831 PMID:15800977 PMID:16374840 PMID:17510421 PMID:18373278 PMID:24720952 PMID:24759835 PMID:25999787 More...
RGD:14695010 RGD:14695011 RGD:14695012 RGD:152177911 RGD:2300283
NCBI chr25:42,733,535...42,742,463
Ensembl chr25:42,734,771...42,742,429
G
PTH1R
parathyroid hormone 1 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr22:8,287,877...8,309,736
Ensembl chr22:8,289,398...8,311,256
G
PTK2
protein tyrosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:14578863 PMID:17203219
RGD:2292584
NCBI chr 8:134,897,511...135,246,300
G
PTPN13
protein tyrosine phosphatase non-receptor type 13
disease_progression susceptibility
ISO
DNA:SNP: :p.Y2081D(human)
RGD
PMID:16489062 PMID:26801674
RGD:152176666 RGD:152599190
NCBI chr 7:34,974,028...35,200,214
Ensembl chr 7:34,974,082...35,200,293
G
PTPRB
protein tyrosine phosphatase receptor type B
disease_progression
ISO
mRNA:decreased expression:liver (human)
RGD
PMID:30237408
RGD:151361293
NCBI chr11:66,095,445...66,222,402
Ensembl chr11:66,101,038...66,221,982
G
PTTG1
PTTG1 regulator of sister chromatid separation, securin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr23:62,781,184...62,787,832
G
PYCARD
PYD and CARD domain containing
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17471463
NCBI chr 5:27,892,332...27,894,386
Ensembl chr 5:27,889,230...27,893,697
G
PYGL
glycogen phosphorylase L
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2885971
NCBI chr24:27,987,676...28,030,919
Ensembl chr24:27,987,649...28,030,869
G
PZP
PZP alpha-2-macroglobulin like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr11:8,963,883...9,023,148
Ensembl chr11:8,963,461...9,014,957
G
RAC1
Rac family small GTPase 1
exacerbates
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:liver (human) mRNA:increased expression:liver (human)
CTD RGD
PMID:18506888 PMID:20522449 PMID:33482578
RGD:153298967 RGD:153350129
NCBI chr28:15,583,609...15,610,753
Ensembl chr28:15,583,516...15,610,328
G
RACGAP1
Rac GTPase activating protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr11:46,218,987...46,260,477
Ensembl chr11:46,220,090...46,254,602
G
RAD21
RAD21 cohesin complex component
susceptibility exacerbates treatment
ISO
associated with hepatitis c, liver cirrhosis;mRNA:increased expression:liver (human) protein:increased expression:liver (human) human cells in a mouse model
RGD
PMID:28434945 PMID:30698808 PMID:32596342 PMID:33251678
RGD:150520026 RGD:150520029 RGD:150520030 RGD:150520035
NCBI chr 8:111,486,356...111,515,641
Ensembl chr 8:111,486,048...111,507,729
G
RAD50
RAD50 double strand break repair protein
ISO
ClinVar Annotator: match by term: Hepatocellular carcinoma
ClinVar
PMID:16385572 PMID:18281469 PMID:19409520 PMID:24894818 PMID:25452441 PMID:25741868 PMID:26467025 PMID:28492532 PMID:29961768 PMID:31159747 PMID:31589614 PMID:32295079 More...
NCBI chr23:35,375,206...35,458,801
Ensembl chr23:35,375,305...35,458,622
G
RAD52
RAD52 homolog, DNA repair protein
onset susceptibility
ISO
mRNA,protein:increased expression:liver (human) associated with hepatitis B;DNA:SNP:3'utr: (rs7963551) (human)
RGD
PMID:24729511 PMID:31719794
RGD:151361199 RGD:151361207
NCBI chr11:893,984...989,119
Ensembl chr11:895,292...927,430
G
RAD54L
RAD54 like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr20:86,510,616...86,542,426
Ensembl chr20:86,507,248...86,542,663
G
RARA
retinoic acid receptor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18026104
NCBI chr16:65,817,849...65,866,862
Ensembl chr16:65,817,757...65,866,878
G
RB1
RB transcriptional corepressor 1
treatment
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:12029619 PMID:14961299 PMID:33841550
RGD:152998960
NCBI chr 3:26,220,783...26,393,671
Ensembl chr 3:26,220,803...26,394,546
G
RBM10
RNA binding motif protein 10
disease_progression
ISO
mRNA:decreased expression:liver
RGD
PMID:32572914
RGD:151356975
NCBI chr X:44,339,653...44,373,509
Ensembl chr X:44,339,877...44,373,339
G
RCAN1
regulator of calcineurin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:78,561,212...78,658,023
Ensembl chr 2:78,562,795...78,571,498
G
RECQL
RecQ like helicase
disease_progression
ISO
protein:increased expression:liver
RGD
PMID:18422747
RGD:2317370
NCBI chr11:21,334,601...21,366,943
Ensembl chr11:21,331,584...21,366,979
G
RET
ret proto-oncogene
severity
ISO
protein:increased expression:liver (human) ClinVar Annotator: match by term: Hepatocellular carcinoma
RGD ClinVar
PMID:7784092 PMID:7845675 PMID:7911697 PMID:9111992 PMID:9242375 PMID:9263528 PMID:11230481 PMID:12116277 PMID:14715928 PMID:15184865 PMID:15855933 PMID:16736292 PMID:17047083 PMID:17097365 PMID:18062802 PMID:25157968 PMID:25810047 PMID:26046350 PMID:28350084 PMID:28492532 PMID:29656518 More...
RGD:150340602
NCBI chr 9:38,746,088...38,798,773
Ensembl chr 9:38,769,170...38,796,712
G
RGN
regucalcin
ISO
protein:decreased expression:liver
RGD
PMID:21683810
RGD:5509919
NCBI chr X:44,282,825...44,299,027
Ensembl chr X:44,285,601...44,299,258
G
RICTOR
RPTOR independent companion of MTOR complex 2
severity
ISO
mRNA, protein:increased expression:liver (human)
RGD
PMID:25371154 PMID:29303510
RGD:152995471 RGD:152995524
NCBI chr 4:37,758,531...37,885,323
Ensembl chr 4:37,762,901...37,873,766
G
RIT1
Ras like without CAAX 1
ameliorates
ISO
human cells in mouse model
RGD
PMID:31247273
RGD:152999016
NCBI chr20:7,965,944...7,979,396
Ensembl chr20:7,966,057...7,976,819
G
RND3
Rho family GTPase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr10:35,877,147...35,897,318
Ensembl chr10:35,877,153...35,897,286
G
RNF157
ring finger protein 157
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr16:45,438,603...45,536,270
Ensembl chr16:45,438,672...45,538,600
G
RNF43
ring finger protein 43
exacerbates
ISO
human cells in a mouse model
RGD
PMID:23136185
RGD:151361219
NCBI chr16:34,981,126...35,046,478
Ensembl chr16:34,980,922...35,045,107
G
RNF6
ring finger protein 6
disease_progression
ISO
RGD
PMID:30496760
RGD:151665757
NCBI chr 3:5,461,053...5,471,268
Ensembl chr 3:5,462,126...5,468,555
G
ROBO1
roundabout guidance receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr22:97,178,093...98,363,647
Ensembl chr22:98,222,891...98,363,219
G
RPS6
ribosomal protein S6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147110
NCBI chr12:60,353,800...60,357,797
Ensembl chr12:60,353,817...60,357,759
G
RPS6KA3
ribosomal protein S6 kinase A3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561517
NCBI chr X:18,614,664...18,730,591
Ensembl chr X:18,620,159...18,730,581
G
RRM1
ribonucleotide reductase catalytic subunit M1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18230555
NCBI chr 1:62,606,112...62,649,979
Ensembl chr 1:62,604,486...62,650,200
G
RRM2
ribonucleotide reductase regulatory subunit M2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18230555 PMID:28284560
NCBI chr14:97,512,690...97,519,734
Ensembl chr14:97,512,832...97,521,932
G
RSPO3
R-spondin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr13:46,530,423...46,606,900
Ensembl chr13:46,530,355...46,606,730
G
RTKN
rhotekin
ISO
mRNA:increased expression:liver
RGD
PMID:27922690
RGD:19165144
NCBI chr14:32,835,660...32,851,799
Ensembl chr14:32,837,546...32,855,912
G
RTP3
receptor transporter protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17693185
NCBI chr22:7,925,733...7,930,132
Ensembl chr22:7,926,804...7,931,187
G
RUNX3
RUNX family transcription factor 3
ISO
CTD Direct Evidence: marker/mechanism mRNA:decreased expression:liver
CTD RGD
PMID:17094378 PMID:28458013
RGD:126775147
NCBI chr20:107,769,244...107,802,154
Ensembl chr20:107,736,683...107,802,307
G
RXRA
retinoid X receptor alpha
ISO
ClinVar Annotator: match by term: Hepatocellular carcinoma
ClinVar
PMID:26619011
NCBI chr12:3,704,129...3,814,707
Ensembl chr12:3,699,923...3,814,678
G
S100A9
S100 calcium binding protein A9
disease_progression
ISO
mRNA:increased expression:liver (human)
RGD
PMID:35693827
RGD:153344586
NCBI chr20:10,391,965...10,395,216
Ensembl chr20:10,391,934...10,394,720
G
SARDH
sarcosine dehydrogenase
severity
ISO
mRNA:altered expression:liver tumor (human)
RGD
PMID:30901224
RGD:152995286
NCBI chr12:4,397,312...4,469,890
Ensembl chr12:4,397,539...4,469,562
G
SAV1
salvador family WW domain containing protein 1
ISO
OMIM:114550
MouseDO
NCBI chr24:27,710,256...27,747,638
Ensembl chr24:27,711,970...27,747,647
G
SCAP
SREBF chaperone
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14563831
NCBI chr22:8,821,809...8,887,538
Ensembl chr22:8,818,980...8,850,202
G
SCD
stearoyl-CoA desaturase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147110
NCBI chr 9:93,380,812...93,398,860
Ensembl chr 9:93,380,914...93,398,912
G
SERPINA1
serpin family A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:6258829 PMID:21472284
NCBI chr24:72,158,521...72,171,139
Ensembl chr24:72,156,784...72,163,500
G
SERPINA4
serpin family A member 4
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:19709125
NCBI chr24:72,345,566...72,356,257
Ensembl chr24:72,347,261...72,356,416
G
SERPINB5
serpin family B member 5
disease_progression
ISO
associated with hepatitis B;
RGD
PMID:26296971
RGD:11520929
NCBI chr18:16,256,700...16,284,410
Ensembl chr18:16,256,552...16,283,764
G
SERPINF1
serpin family F member 1
ISO
associated with Human Viral Hepatitis, liver cirrhosis;protein:increased expression:serum (human)
RGD
PMID:27748324
RGD:27226704
NCBI chr16:1,408,453...1,424,197
G
SET
SET nuclear proto-oncogene
ISO
ClinVar Annotator: match by term: Hepatocellular carcinoma
ClinVar
PMID:26822237
NCBI chr12:9,446,265...9,453,991
G
SF3B1
splicing factor 3b subunit 1
treatment disease_progression
ISO
ClinVar Annotator: match by term: Hepatocellular carcinoma mRNA, protein:increased expression:liver
RGD ClinVar
PMID:23634996 PMID:26619011 PMID:33038489
RGD:126790494
NCBI chr10:82,901,908...82,952,094
Ensembl chr10:82,899,079...82,952,071
G
SF3B2
splicing factor 3b subunit 2
ISO
ClinVar Annotator: match by term: Hepatocellular carcinoma
ClinVar
PMID:26619011
NCBI chr 1:8,189,636...8,207,024
Ensembl chr 1:8,189,446...8,207,020
G
SF3B4
splicing factor 3b subunit 4
severity treatment
ISO
mRNA, protein:increased expression:liver (human) mRNA, protein:increased expression:liver(human) human cells in mouse model mRNA, protein:increased expression:liver (rat)
RGD
PMID:29059470 PMID:30391496
RGD:155791679 RGD:155804298
G
SFN
stratifin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr20:105,902,481...105,904,313
Ensembl chr20:105,902,974...105,903,720
G
SFRP1
secreted frizzled related protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 8:39,243,775...39,289,050
Ensembl chr 8:39,243,780...39,288,984
G
SH3GL1
SH3 domain containing GRB2 like 1, endophilin A2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33838155
NCBI chr 6:4,090,800...4,130,566
Ensembl chr 6:4,091,359...4,130,578
G
SHC1
SHC adaptor protein 1
ISO
protein:increased expression, increased phosphorylation:hepatocyte
RGD
PMID:15375560
RGD:1643188
NCBI chr20:8,854,189...8,866,406
Ensembl chr20:8,858,458...8,866,610
G
SHH
sonic hedgehog signaling molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26189965
NCBI chr21:123,929,937...123,942,451
Ensembl chr21:123,932,900...123,942,395
G
SIK2
salt inducible kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34491613
NCBI chr 1:102,944,171...103,070,973
Ensembl chr 1:102,944,281...103,068,823
G
SIX1
SIX homeobox 1
severity
ISO
protein:increased expression:liver (human)
RGD
PMID:17008870
RGD:11561961
NCBI chr24:37,840,399...37,855,801
Ensembl chr24:37,840,309...37,845,192
G
SKA1
spindle and kinetochore associated complex subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr18:30,562,320...30,579,966
Ensembl chr18:30,560,284...30,579,938
G
SKA3
spindle and kinetochore associated complex subunit 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 3:32,645...57,771
G
SKP2
S-phase kinase associated protein 2
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:liver
CTD RGD
PMID:12717389 PMID:19533683
RGD:2315050
NCBI chr 4:35,009,114...35,040,518
Ensembl chr 4:35,009,076...35,042,632
G
SLC22A1
solute carrier family 22 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr13:87,744,600...87,780,846
Ensembl chr13:87,745,023...87,781,073
G
SLC26A6
solute carrier family 26 member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr22:10,035,676...10,046,274
Ensembl chr22:10,035,478...10,045,304
G
SLC2A1
solute carrier family 2 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8364915
NCBI chr20:89,974,567...90,007,977
Ensembl chr20:90,002,030...90,008,033
G
SLC2A2
solute carrier family 2 member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8364915
NCBI chr15:18,434,370...18,466,331
Ensembl chr15:18,434,916...18,467,352
G
SLC38A1
solute carrier family 38 member 1
ameliorates disease_progression
ISO
RGD
PMID:26389641
RGD:151361140
NCBI chr11:42,415,986...42,502,794
Ensembl chr11:42,421,910...42,472,838
G
SLC5A5
solute carrier family 5 member 5
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15347726 PMID:15520214
NCBI chr 6:16,346,361...16,367,833
G
SLC7A5
solute carrier family 7 member 5
ameliorates disease_progression
ISO
mRNA:increased expression:liver
RGD
PMID:7532544 PMID:23696029 PMID:26389641
RGD:151361140 RGD:151361280 RGD:634202
NCBI chr 5:73,229,953...73,269,801
Ensembl chr 5:73,229,951...73,269,754
G
SLCO1B3
solute carrier organic anion transporter family member 1B3
disease_progression exacerbates
ISO
protein:decreased expression:liver (human) mRNA,protein:decreased expression:liver (human)
RGD
PMID:21626360 PMID:32534581
RGD:152995417 RGD:152995423
NCBI chr11:20,637,429...20,760,577
Ensembl chr11:20,648,582...20,761,161
G
SLIT2
slit guidance ligand 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19100240
NCBI chr27:29,650,589...30,020,105
Ensembl chr27:29,650,337...29,803,612
G
SMAD2
SMAD family member 2
ISO
RGD
PMID:18971187
RGD:12880056
NCBI chr18:33,017,138...33,105,320
Ensembl chr18:33,017,492...33,104,606
G
SMAD4
SMAD family member 4
disease_progression
ISO
protein:decreased expression:liver protein:increased expression:liver:
RGD
PMID:18971187 PMID:22799322 PMID:23922662 PMID:29924446
RGD:12880056 RGD:18182921 RGD:21066341 RGD:21066342
NCBI chr18:29,894,157...29,951,445
Ensembl chr18:29,897,621...29,934,478
G
SMAD7
SMAD family member 7
ISO
mRNA:increased expression:liver (human)
RGD
PMID:25602745
RGD:14401589
NCBI chr18:31,993,543...32,024,088
Ensembl chr18:31,993,681...32,024,850
G
SMARCA4
SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4
ISO
DNA:SNPs: :rs11879293, rs2072382 (human)
RGD
PMID:24556940
RGD:127285650
NCBI chr 6:9,943,162...10,044,476
G
SMARCB1
SWI/SNF related BAF chromatin remodeling complex subunit B1
disease_progression
ISO
mRNA:decreased expression:liver
RGD
PMID:27111394
RGD:127285647
NCBI chr19:6,902,985...6,945,111
Ensembl chr19:6,902,951...6,944,784
G
SMARCC1
SWI/SNF related BAF chromatin remodeling complex subunit C1
ameliorates
ISO
mRNA, protein:increased expression:liver (human)
RGD
PMID:32514535
RGD:151347860
NCBI chr22:8,987,936...9,167,689
Ensembl chr22:8,987,012...9,134,946
G
SMC3
structural maintenance of chromosomes 3
exacerbates
ISO
mRNA:increased editing:cds:p.K96R,p.Q103R(human)
RGD
PMID:29996118
RGD:156430111
NCBI chr 9:103,506,779...103,543,836
Ensembl chr 9:103,506,689...103,545,523
G
SMG9
SMG9 nonsense mediated mRNA decay factor
severity
ISO
RGD
PMID:34456727
RGD:155882446
NCBI chr 6:37,253,023...37,277,536
Ensembl chr 6:37,250,791...37,277,557
G
SMO
smoothened, frizzled class receptor
disease_progression
ISO
DNA:SNP: :rs3824 (human)
RGD
PMID:25944162
RGD:150340548
NCBI chr21:97,788,955...97,814,549
Ensembl chr21:97,788,624...97,814,709
G
SNAI1
snail family transcriptional repressor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35841383
NCBI chr 2:13,988,059...13,993,780
Ensembl chr 2:13,988,024...13,993,746
G
SNRPE
small nuclear ribonucleoprotein polypeptide E
ISO
human gene in a mouse model
RGD
PMID:21688285
RGD:10768833
NCBI chr25:25,474,620...25,483,427
G
SNW1
SNW domain containing 1
severity
ISO
protein:increased expression:liver (human)
RGD
PMID:23696020
RGD:11035253
NCBI chr24:54,976,597...55,020,051
Ensembl chr24:54,977,083...55,019,988
G
SNX27
sorting nexin 27
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36029209
NCBI chr20:11,997,768...12,083,929
Ensembl chr20:11,998,527...12,083,528
G
SOAT1
sterol O-acyltransferase 1
exacerbates
ISO
associated with hepatitis B;protein:increased expression:liver (human)
RGD
PMID:30814741
RGD:126925204
NCBI chr25:49,998,197...50,061,433
Ensembl chr25:50,001,910...50,061,173
G
SOAT2
sterol O-acyltransferase 2
ISO
RGD
PMID:16274362
RGD:1581190
NCBI chr11:49,214,295...49,228,268
Ensembl chr11:49,215,034...49,228,244
G
SOCS1
suppressor of cytokine signaling 1
treatment
ISO
associated with liver cirrhosis;DNA:altered methylation:liver: DNA:hypermethylation:CpG island, 5'untranslated region:
RGD
PMID:14614012 PMID:15235874 PMID:18843197 PMID:22318090
RGD:150573687 RGD:150573689 RGD:150573700 RGD:150573703
NCBI chr 5:10,731,866...10,733,745
Ensembl chr 5:10,732,350...10,732,991
G
SOCS2
suppressor of cytokine signaling 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr11:88,964,805...88,971,147
Ensembl chr11:88,966,940...88,971,515
G
SOCS3
suppressor of cytokine signaling 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16831601
NCBI chr16:70,353,099...70,356,401
Ensembl chr16:70,354,746...70,355,423
G
SOD1
superoxide dismutase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33010264
NCBI chr 2:60,461,219...60,472,999
G
SOD2
superoxide dismutase 2
disease_progression susceptibility
ISO
associated with liver cirrhosis; DNA:SNP:cds:p.Ala16Val(rs1799725)(human) protein:increased expression:saliva CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:15869407 PMID:16767786 PMID:18760346 PMID:19731237 PMID:21472284 PMID:27221200 PMID:31041878 PMID:33010264 More...
RGD:1581242 RGD:26923907 RGD:26923955 RGD:27095881
NCBI chr13:87,284,537...87,297,998
Ensembl chr13:87,280,686...87,297,974
G
SOX30
SRY-box transcription factor 30
disease_progression exacerbates
ISO
RGD
PMID:30312695
RGD:151660341
NCBI chr23:60,013,384...60,038,682
Ensembl chr23:60,014,046...60,037,997
G
SPAG9
sperm associated antigen 9
ISO
associated with Human Viral Hepatitis
RGD
PMID:29344208
RGD:30296654
NCBI chr16:42,224,565...42,384,160
Ensembl chr16:42,224,697...42,384,749
G
SPC25
SPC25 component of NDC80 kinetochore complex
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr10:54,390,300...54,423,478
Ensembl chr10:54,403,157...54,423,245
G
SPOCK1
SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1
ameliorates
ISO
human cells in mouse model
RGD
PMID:30710422
RGD:153344549
NCBI chr23:39,676,750...40,192,565
Ensembl chr23:39,676,558...39,965,037
G
SPOP
speckle type BTB/POZ protein
exacerbates
ISO
mRNA:decreased expression:liver (human) human cells in mouse model
RGD
PMID:26156804 PMID:33209975
RGD:11074965 RGD:153298924
NCBI chr16:69,990,554...70,073,241
G
SPP1
secreted phosphoprotein 1
disease_progression
ISO
mRNA:increased expression:liver (human)
RGD
PMID:16047475 PMID:35693827
RGD:153344586 RGD:1581375
NCBI chr 7:36,337,165...36,344,927
Ensembl chr 7:36,338,386...36,344,407
G
SPRTN
SprT-like N-terminal domain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25261934
NCBI chr25:68,599,377...68,620,568
Ensembl chr25:68,599,780...68,620,621
G
SRC
SRC proto-oncogene, non-receptor tyrosine kinase
disease_progression
ISO
RGD
PMID:9581679
RGD:150521543
NCBI chr 2:26,344,480...26,367,448
Ensembl chr 2:26,343,450...26,367,776
G
SREBF1
sterol regulatory element binding transcription factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14563831 PMID:21147110
NCBI chr16:16,847,603...16,874,239
Ensembl chr16:16,845,491...16,859,554
G
SREBF2
sterol regulatory element binding transcription factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147110
NCBI chr19:24,364,725...24,439,851
Ensembl chr19:24,364,911...24,440,014
G
SRF
serum response factor
ISO
RGD
PMID:9570363
RGD:1581428
NCBI chr17:28,983,161...28,993,465
Ensembl chr17:28,983,002...28,992,995
G
SRPX
sushi repeat containing protein X-linked
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
G
SRSF1
serine and arginine rich splicing factor 1
ISO
mRNA:increased expression:liver (human)
RGD
PMID:23633480
RGD:9685423
NCBI chr16:35,392,573...35,396,815
Ensembl chr16:35,392,873...35,394,982
G
SRSF2
serine and arginine rich splicing factor 2
disease_progression treatment
ISO
RGD
PMID:28082404 PMID:29278882 PMID:32372053
RGD:150429663 RGD:150429666 RGD:150429692
NCBI chr16:44,945,193...44,948,496
Ensembl chr16:44,945,200...44,946,438
G
ST6GAL1
ST6 beta-galactoside alpha-2,6-sialyltransferase 1
ISO
protein:increased activity:liver:
RGD
PMID:9331085
RGD:10043141
NCBI chr15:81,205,121...81,346,089
Ensembl chr15:81,239,631...81,349,173
G
STAB2
stabilin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr11:98,780,148...98,953,871
Ensembl chr11:98,779,921...98,954,913
G
STAT1
signal transducer and activator of transcription 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22488367
NCBI chr10:76,492,859...76,537,689
Ensembl chr10:76,492,533...76,533,393
G
STAT3
signal transducer and activator of transcription 3
ISO
protein:increased phosphorylation:liver (mouse)
RGD
PMID:28100771
RGD:127285675
NCBI chr16:63,877,884...63,957,894
Ensembl chr16:63,922,862...63,957,984
G
STAT4
signal transducer and activator of transcription 4
susceptibility
ISO
Hepatitis B, Chronic; DNA:SNP: intron 3: (rs7574865) (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:23242368 PMID:26745093
RGD:11553302
NCBI chr10:76,553,626...76,708,540
Ensembl chr10:76,553,606...76,674,928
G
STAT5A
signal transducer and activator of transcription 5A
ameliorates
ISO
RGD
PMID:28100771
RGD:127285675
NCBI chr16:63,959,265...63,986,627
Ensembl chr16:63,960,515...63,985,026
G
STC2
stanniocalcin 2
disease_progression
ISO
mRNA:increased expression:liver (human)
RGD
PMID:35693827
RGD:153344586
NCBI chr23:75,475,020...75,489,727
Ensembl chr23:75,475,022...75,488,678
G
STIM1
stromal interaction molecule 1
ISO
mRNA:increased expression:liver (human)
RGD
PMID:23211538
RGD:152995401
NCBI chr 1:62,651,472...62,865,992
Ensembl chr 1:62,651,290...62,865,986
G
STMN1
stathmin 1
disease_progression
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:28284560 PMID:28982915
RGD:21408578
NCBI chr20:106,866,719...106,873,314
Ensembl chr20:106,868,838...106,874,403
G
TACC3
transforming acidic coiled-coil containing protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr27:47,021,970...47,045,571
Ensembl chr27:47,021,965...47,045,223
G
TAGLN2
transgelin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr20:4,024,948...4,032,361
Ensembl chr20:4,024,775...4,032,526
G
TALDO1
transaldolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19436114
NCBI chr 1:553,475...569,935
Ensembl chr 1:553,458...573,546
G
TATDN1
TatD DNase domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 8:119,055,356...119,103,328
Ensembl chr 8:119,052,415...119,102,839
G
TBX3
T-box transcription factor 3
disease_progression severity ameliorates
ISO
protein:increased expression:liver (human) human cells in mouse model
RGD
PMID:22811581 PMID:26922018 PMID:29295731 PMID:30578408 PMID:33577921
RGD:151361112 RGD:151361114 RGD:151361122 RGD:151361123 RGD:151361132
NCBI chr11:109,952,100...109,966,328
Ensembl chr11:109,952,054...109,965,065
G
TCF19
transcription factor 19
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr17:41,310,999...41,319,268
Ensembl chr17:41,311,005...41,319,042
G
TCIM
transcriptional and immune response regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 8:38,146,171...38,147,526
Ensembl chr 8:38,146,241...38,146,561
G
TEDC2
tubulin epsilon and delta complex 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 5:2,338,246...2,343,171
Ensembl chr 5:2,338,341...2,342,825
G
TEP1
telomerase associated protein 1
susceptibility disease_progression
ISO
DNA:SNP:intron:rs1760893(human) associated with hepatitis B;DNA:SNPs: :rs1713449,rs1760898, rs872072 (human)
RGD
PMID:23907815 PMID:27305982
RGD:152975963 RGD:152977750
NCBI chr29:20,880,255...20,928,874
Ensembl chr29:20,883,678...20,923,313
G
TERT
telomerase reverse transcriptase
no_association disease_progression susceptibility treatment
ISO
associated with hepatitis B;DNA:SNP: :rs13167280 (human) ClinVar Annotator: match by term: Hepatocellular carcinoma DNA:SNPs::rs2736098(human) DNA:mutations, polymorphisms:promoter,intron, exon:rs2736100,rs2736098(human) DNA:mutations:promoter: DNA:SNP,mutations:promoter:rs2853669 (-245T >C), (-124C > T),(-146C > T)human
RGD ClinVar
PMID:17175353 PMID:19184104 PMID:23000435 PMID:23907815 PMID:25123086 PMID:25339005 PMID:25741868 PMID:26575952 PMID:28416747 PMID:28492532 PMID:28677271 More...
RGD:11564803 RGD:14696767 RGD:14696768 RGD:14696769 RGD:14696770 RGD:150530496 RGD:152975963
NCBI chr 4:1,082,894...1,119,373
Ensembl chr 4:1,083,384...1,117,468
G
TET1
tet methylcytosine dioxygenase 1
ISO
protein:decreased expression:liver
RGD
PMID:23671639
RGD:9586747
NCBI chr 9:62,709,800...62,843,322
Ensembl chr 9:62,712,484...62,837,138
G
TET2
tet methylcytosine dioxygenase 2
ameliorates disease_progression severity
ISO
human cells in mouse model mRNA:decreased expression:liver (human) mRNA, protein:increased expression:liver (human) mRNA, protein:decreased expression:liver (human)
RGD
PMID:26366235 PMID:29331390 PMID:30070373 PMID:33097695
RGD:150429595 RGD:150429597 RGD:150429684 RGD:150429689
NCBI chr 7:53,193,824...53,326,813
Ensembl chr 7:53,193,941...53,326,942
G
TFPI2
tissue factor pathway inhibitor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17464989 PMID:28284560
NCBI chr21:55,134,921...55,139,862
Ensembl chr21:55,135,198...55,140,801
G
TFRC
transferrin receptor
ISO
mRNA:increased expression:liver
RGD
PMID:16953838
RGD:2292036
NCBI chr15:91,102,153...91,134,994
Ensembl chr15:91,102,817...91,135,584
G
TGFA
transforming growth factor alpha
ISO
CTD Direct Evidence: marker/mechanism associated with Diabetes Mellitus, Experimental
CTD RGD
PMID:9029167 PMID:9060843 PMID:15565109
RGD:2317471
NCBI chr14:36,545,641...36,654,213
Ensembl chr14:36,545,875...36,648,237
G
TGFB1
transforming growth factor beta 1
ISO
mRNA:increased expression:liver (mouse) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:9029167 PMID:28100771
RGD:127285675
NCBI chr 6:35,651,583...35,674,387
Ensembl chr 6:35,648,677...35,674,365
G
TGFB2
transforming growth factor beta 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33010264
NCBI chr25:11,163,651...11,259,868
Ensembl chr25:11,163,100...11,258,470
G
TGFBR2
transforming growth factor beta receptor 2
ISO
mRNA, protein:decreased expression:liver
RGD
PMID:14585397
RGD:1601598
NCBI chr15:75,112,903...75,200,263
Ensembl chr15:75,112,561...75,197,711
G
TGM3
transglutaminase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:54,189,888...54,236,714
Ensembl chr 2:54,189,902...54,221,973
G
TH
tyrosine hydroxylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 1:1,969,194...1,977,263
Ensembl chr 1:1,966,460...1,977,218
G
THY1
Thy-1 cell surface antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:110,787,213...110,791,536
Ensembl chr 1:110,783,877...110,791,569
G
TICRR
TOPBP1 interacting checkpoint and replication regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr29:8,117,198...8,171,956
G
TIMD4
T cell immunoglobulin and mucin domain containing 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr23:59,320,120...59,381,965
Ensembl chr23:59,319,749...59,355,100
G
TK1
thymidine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr16:70,186,103...70,200,689
Ensembl chr16:70,186,767...70,200,610
G
TLR2
toll like receptor 2
susceptibility
ISO
associated with Hepatitis C, Chronic;DNA:deletion:promoter:-196 to -174(human)
RGD
PMID:21500195 PMID:22859216 PMID:27183918
RGD:15090813 RGD:15090815 RGD:18337266
NCBI chr 7:100,239,533...100,565,955
Ensembl chr 7:100,258,441...100,260,795
G
TLR3
toll like receptor 3
disease_progression
ISO
RGD
PMID:23197495
RGD:21079421
NCBI chr 7:131,991,068...132,014,366
Ensembl chr 7:131,991,029...132,016,232
G
TLR4
toll like receptor 4
susceptibility
ISO
DNA:SNP: :rs1057317(human) DNA:SNPs, haplotype: :multiples CTD Direct Evidence: marker/mechanism protein:increased expression:liver:
RGD CTD
PMID:21559380 PMID:25179842 PMID:27022031 PMID:28578348
RGD:14700552 RGD:14700557 RGD:14700558
NCBI chr12:21,873,762...21,885,562
Ensembl chr12:21,871,773...21,885,515
G
TLR7
toll like receptor 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24990399
NCBI chr X:11,348,520...11,372,132
G
TMEM70
transmembrane protein 70
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27914986
NCBI chr 8:69,576,786...69,582,478
Ensembl chr 8:69,576,808...69,583,308
G
TNF
tumor necrosis factor
disease_progression
ISO
mRNA, protein:increased expression:liver, blood serum (mouse) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:26569409 PMID:26890368 PMID:27022031
RGD:11344640 RGD:14975171
G
TNFAIP3
TNF alpha induced protein 3
sexual_dimorphism ameliorates
ISO
mRNA,protein:increased expression:liver (human) protein:decreased expression:liver (human) mRNA:decreased expression:liver (human)
RGD
PMID:26538215 PMID:27253414 PMID:29190981 PMID:32015333
RGD:151347600 RGD:151347604 RGD:151347618 RGD:151347622
NCBI chr13:35,537,103...35,553,396
Ensembl chr13:35,537,102...35,549,197
G
TNFSF10
TNF superfamily member 10
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17326159
NCBI chr15:16,934,982...16,953,155
Ensembl chr15:16,934,962...16,954,860
G
TNFSF9
TNF superfamily member 9
ISO
RGD
PMID:17325342
RGD:2317348
NCBI chr 6:6,131,157...6,136,345
Ensembl chr 6:6,131,571...6,135,463
G
TNIK
TRAF2 and NCK interacting kinase
disease_progression
ISO
protein:increased phosphorylation:liver, nucleus (human)
RGD
PMID:25160513
RGD:151347837
NCBI chr15:18,011,137...18,403,676
Ensembl chr15:18,011,170...18,399,981
G
TONSL
tonsoku like, DNA repair protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 8:138,641,514...138,657,429
Ensembl chr 8:138,641,575...138,656,673
G
TOP2A
DNA topoisomerase II alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr16:65,761,391...65,792,041
Ensembl chr16:65,761,416...65,792,701
G
TP53
tumor protein p53
treatment
ISO
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma | ClinVar Annotator: match by term: LIVER CELL CARCINOMA
RGD ClinVar OMIM
PMID:253702 PMID:960674 PMID:1349102 PMID:1349175 PMID:1359493 PMID:1565143 PMID:1565144 PMID:1569604 PMID:1591732 PMID:1631137 PMID:1631151 PMID:1672732 PMID:1673792 PMID:1679237 PMID:1683921 PMID:1686725 PMID:1849234 PMID:1915267 PMID:1918170 PMID:1975675 PMID:1978757 PMID:1999338 PMID:2046748 PMID:2259385 PMID:2531845 PMID:2554494 PMID:2654466 PMID:4122735 PMID:6736287 PMID:7478555 PMID:7565304 PMID:7651740 PMID:7707106 PMID:7718482 PMID:7732013 PMID:7737263 PMID:7750099 PMID:7761089 PMID:7783166 PMID:7791795 PMID:7881428 PMID:7885831 PMID:7887414 PMID:7969167 PMID:8001119 PMID:8023157 PMID:8062826 PMID:8080050 PMID:8099841 PMID:8118819 PMID:8164043 PMID:8242631 PMID:8242752 PMID:8276238 PMID:8308926 PMID:8336941 PMID:8344492 PMID:8364550 PMID:8401536 PMID:8402598 PMID:8423216 PMID:8425176 PMID:8464896 PMID:8479749 PMID:8527048 PMID:8550239 PMID:8631304 PMID:8633021 PMID:8649776 PMID:8718514 PMID:8825920 PMID:8829627 PMID:8829653 PMID:8843196 PMID:8869100 PMID:9047394 PMID:9049183 PMID:9049184 PMID:9150393 PMID:9218725 PMID:9242456 PMID:9268986 PMID:9290701 PMID:9364015 PMID:9399658 PMID:9399838 PMID:9405613 PMID:9407971 PMID:9472631 PMID:9482117 PMID:9525742 PMID:9546439 PMID:9569050 PMID:9572492 PMID:9598730 PMID:9607760 PMID:9627118 PMID:9632751 PMID:9662334 PMID:9667734 PMID:9704930 PMID:9825943 PMID:9839505 PMID:9891044 PMID:10064694 PMID:10089074 PMID:10229196 PMID:10366100 PMID:10411893 PMID:10432928 PMID:10519380 PMID:10557074 PMID:10567903 PMID:10589545 PMID:10616528 PMID:10629033 PMID:10713666 PMID:10753186 PMID:10754498 PMID:10761705 PMID:10797439 PMID:10802655 PMID:10864200 PMID:10871862 PMID:10914716 PMID:10922393 PMID:11051239 PMID:11051241 PMID:11101847 PMID:11139324 PMID:11152481 PMID:11180592 PMID:11313981 PMID:11315715 PMID:11370630 PMID:11403041 PMID:11429705 PMID:11479205 PMID:11494139 PMID:11590071 PMID:11593407 PMID:11668501 PMID:11782540 PMID:11793474 PMID:11896595 PMID:11900253 PMID:11904319 PMID:11920788 PMID:11920959 PMID:12007217 PMID:12034820 PMID:12076704 PMID:12124823 PMID:12406399 PMID:12506399 PMID:12509279 PMID:12567188 PMID:12619118 PMID:12672316 PMID:12695689 PMID:12700230 PMID:12726864 PMID:12779080 PMID:12782597 PMID:12792784 PMID:12826609 PMID:12885464 PMID:12901974 PMID:12909720 PMID:12917626 PMID:14559903 PMID:14584079 PMID:14673037 PMID:14743206 PMID:15004724 PMID:15017592 PMID:15037740 PMID:15060172 PMID:15077194 PMID:15161705 PMID:15221755 PMID:15308588 PMID:15355915 PMID:15381368 PMID:15390294 PMID:15541116 PMID:15564800 PMID:15580553 PMID:15607980 PMID:15607981 PMID:15611505 PMID:15703170 PMID:15722483 PMID:15781620 PMID:15825182 PMID:15850016 PMID:15925506 PMID:15951970 PMID:15958617 PMID:15977174 PMID:15982667 PMID:16000567 PMID:16199549 PMID:16206219 PMID:16209708 PMID:16247456 PMID:16258005 PMID:16288208 PMID:16322298 PMID:16337994 PMID:16401470 PMID:16474844 PMID:16489069 PMID:16494995 PMID:16508005 PMID:16551709 PMID:16633321 PMID:16682957 PMID:16736287 PMID:16741917 PMID:16754663 PMID:16778209 PMID:16818505 PMID:16827139 PMID:16861262 PMID:16964264 PMID:16969106 PMID:17015838 PMID:17170001 PMID:17308077 PMID:17311302 PMID:17390010 PMID:17401428 PMID:17417627 PMID:17427234 PMID:17530187 PMID:17535973 PMID:17540308 PMID:17541742 PMID:17567834 PMID:17572079 PMID:17599946 PMID:17606709 PMID:17636407 PMID:17638920 PMID:17724467 PMID:17875924 PMID:17881637 PMID:17974978 PMID:17999388 PMID:18208484 PMID:18307025 PMID:18391940 PMID:18453682 PMID:18477611 PMID:18511570 PMID:18555592 PMID:18628487 PMID:18685109 PMID:18689542 PMID:18818522 PMID:18937320 PMID:19012332 PMID:19101993 PMID:19127115 PMID:19147582 PMID:19171880 PMID:19336573 PMID:19367287 PMID:19367569 PMID:19378321 PMID:19405127 PMID:19454241 PMID:19462533 PMID:19468865 PMID:19521721 PMID:19556618 PMID:19681600 PMID:19711436 PMID:19714490 PMID:19834951 PMID:19850740 PMID:19881536 PMID:19913028 PMID:19930417 PMID:20013323 PMID:20028212 PMID:20113312 PMID:20118236 PMID:20127978 PMID:20128691 PMID:20182602 PMID:20234365 PMID:20308654 PMID:20407015 PMID:20436704 PMID:20505364 PMID:20506564 PMID:20516128 PMID:20520810 PMID:20522432 PMID:20538734 PMID:20586629 PMID:20589832 PMID:20593220 PMID:20689556 PMID:20693561 PMID:20805372 PMID:20878954 PMID:20972454 PMID:21056685 PMID:21059199 PMID:21080251 PMID:21113594 PMID:21115975 PMID:21118481 PMID:21159183 PMID:21187651 PMID:21232794 PMID:21305319 PMID:21343334 PMID:21356188 PMID:21445056 PMID:21483000 PMID:21484931 PMID:21514416 PMID:21519010 PMID:21535297 PMID:21552135 PMID:21561095 PMID:21590121 PMID:21601526 PMID:21619694 PMID:21626334 PMID:21665182 PMID:21672450 PMID:21674059 PMID:21747090 PMID:21761402 PMID:22006311 PMID:22052707 PMID:22090360 PMID:22110706 PMID:22114072 PMID:22186996 PMID:22198284 PMID:22233476 PMID:22265402 PMID:22319594 PMID:22427690 PMID:22484423 PMID:22553421 PMID:22553460 PMID:22666503 PMID:22672556 PMID:22698404 PMID:22703879 PMID:22710932 PMID:22713868 PMID:22729912 PMID:22744426 PMID:22768918 PMID:22811390 PMID:22822097 PMID:22862161 PMID:22869713 PMID:22887876 PMID:22899716 PMID:22915647 PMID:22919068 PMID:22923379 PMID:22955915 PMID:22983585 PMID:22999923 PMID:23028800 PMID:23031740 PMID:23161690 PMID:23172776 PMID:23246812 PMID:23259501 PMID:23263379 PMID:23265383 PMID:23315175 PMID:23334668 PMID:23406775 PMID:23484829 PMID:23538418 PMID:23612969 PMID:23624782 PMID:23625637 PMID:23630318 PMID:23667202 PMID:23713777 PMID:23792586 PMID:23887774 PMID:23894400 PMID:23939625 PMID:23950206 PMID:23967324 PMID:24033266 PMID:24038938 PMID:24065105 PMID:24122735 PMID:24307375 PMID:24381225 PMID:24382691 PMID:24384472 PMID:24395441 PMID:24487413 PMID:24501221 PMID:24573247 PMID:24590827 PMID:24603336 PMID:24641375 PMID:24651012 PMID:24651015 PMID:24677579 PMID:24702488 PMID:24728327 PMID:24744791 PMID:24810334 PMID:24835218 PMID:24857548 PMID:24940547 PMID:25059482 PMID:25119136 PMID:25123297 PMID:25131192 PMID:25157968 PMID:25186627 PMID:25256166 PMID:25293557 PMID:25294809 PMID:25326637 PMID:25339994 PMID:25381062 PMID:25404506 PMID:25433984 PMID:25503501 PMID:25504633 PMID:25516983 PMID:25525159 PMID:25584008 PMID:25584637 PMID:25612911 PMID:25619955 PMID:25634208 PMID:25691460 PMID:25741868 PMID:25757876 PMID:25765855 PMID:25787918 PMID:25896519 PMID:25925845 PMID:25927356 PMID:25945745 PMID:25952993 PMID:25980754 PMID:26014290 PMID:26024390 PMID:26066407 PMID:26205489 PMID:26225655 PMID:26230955 PMID:26270727 PMID:26271412 PMID:26332594 PMID:26425688 PMID:26467025 PMID:26497680 PMID:26554828 PMID:26556299 PMID:26580448 PMID:26585234 PMID:26619011 PMID:26628864 PMID:26641009 PMID:26659639 PMID:26681312 PMID:26718964 PMID:26781615 PMID:26786923 PMID:26787237 PMID:26818906 PMID:26822237 PMID:26845104 PMID:26878390 PMID:26911350 PMID:26976419 PMID:27022024 PMID:27050224 PMID:27077130 PMID:27146902 PMID:27149858 PMID:27153395 PMID:27179933 PMID:27189670 PMID:27276561 PMID:27276934 PMID:27328919 PMID:27374712 PMID:27458004 PMID:27463065 PMID:27489289 PMID:27493922 PMID:27501770 PMID:27516001 PMID:27523101 PMID:27533082 PMID:27557517 PMID:27616075 PMID:27621308 PMID:27622479 PMID:27680515 PMID:27683180 PMID:27714481 PMID:27724982 PMID:27730344 PMID:27813088 PMID:27873457 PMID:27895058 PMID:27911860 PMID:27959731 PMID:27993330 PMID:28135145 PMID:28152038 PMID:28160093 PMID:28166194 PMID:28176830 PMID:28271309 PMID:28279309 PMID:28349240 PMID:28356770 PMID:28369373 PMID:28453743 PMID:28472496 PMID:28477316 PMID:28492532 PMID:28664506 PMID:28724667 PMID:28772286 PMID:28802053 PMID:28861920 PMID:28873162 PMID:28949402 PMID:28975465 PMID:29025599 PMID:29058119 PMID:29070607 PMID:29076966 PMID:29126202 PMID:29300620 PMID:29324801 PMID:29470806 PMID:29478780 PMID:29489754 PMID:29581140 PMID:29752822 PMID:29753700 PMID:29785153 PMID:29958926 PMID:29979965 PMID:30076369 PMID:30093976 PMID:30107044 PMID:30128536 PMID:30152528 PMID:30216591 PMID:30224644 PMID:30287823 PMID:30299350 PMID:30311369 PMID:30318520 PMID:30322717 PMID:30327374 PMID:30352134 PMID:30374176 PMID:30450585 PMID:30546832 PMID:30583724 PMID:30630526 PMID:30675318 PMID:30709381 PMID:30720243 PMID:30816478 PMID:30840781 PMID:30918304 PMID:31016814 PMID:31050713 PMID:31105275 PMID:31119730 PMID:31121848 PMID:31127191 PMID:31159747 PMID:31168460 PMID:31206626 PMID:31212162 PMID:31296311 PMID:31300551 PMID:31321604 PMID:31494577 PMID:31533767 PMID:31559875 PMID:31742824 PMID:31748977 PMID:31775759 PMID:31881331 PMID:31882575 PMID:31983162 PMID:32000721 PMID:32019277 PMID:32126783 PMID:32156018 PMID:32164171 PMID:32179180 PMID:32187361 PMID:32295079 PMID:32318955 PMID:32371905 PMID:32401780 PMID:32475984 PMID:32658383 PMID:32817165 PMID:32885271 PMID:32888145 PMID:32899294 PMID:32906206 PMID:32959997 PMID:32980694 PMID:33087929 PMID:33138793 PMID:33163847 PMID:33208383 PMID:33245408 PMID:33257846 PMID:33300245 PMID:33332384 PMID:33372952 PMID:33407742 PMID:33471991 PMID:33633026 PMID:33635883 PMID:33674644 PMID:33818021 PMID:33840814 PMID:33841550 PMID:34026625 PMID:34088725 PMID:34240179 PMID:34266904 PMID:34299313 PMID:34308366 PMID:34503094 PMID:34529667 PMID:34675114 PMID:34709361 PMID:34793666 PMID:34805717 PMID:34994652 PMID:35033608 PMID:35043155 PMID:35127508 PMID:35802772 PMID:35820297 PMID:35938033 PMID:35974385 PMID:36008825 PMID:36168441 PMID:36219266 PMID:36309086 PMID:36329109 PMID:36988593 More...
RGD:152998960
NCBI chr16:7,047,686...7,065,567
Ensembl chr16:7,045,146...7,066,223
G
TP73
tumor protein p73
treatment exacerbates
ISO
human cells in a mouse model mRNA:increased expression:liver (human) protein:decreased phosphorylation:liver (human)
RGD
PMID:14760085 PMID:19664633 PMID:25371988 PMID:27359056 PMID:31429776
RGD:151347579 RGD:151347592 RGD:151347593 RGD:151347594 RGD:151347596
NCBI chr20:127,958,002...128,035,792
Ensembl chr20:127,958,809...128,013,691
G
TPX2
TPX2 microtubule nucleation factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:36,131,907...36,191,254
Ensembl chr 2:36,134,760...36,191,425
G
TRAF7
TNF receptor associated factor 7
treatment
ISO
mRNA:increased expression:liver
RGD
PMID:31730901
RGD:151356961
NCBI chr 5:2,051,247...2,072,763
Ensembl chr 5:2,059,349...2,071,297
G
TRAIP
TRAF interacting protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr22:11,220,152...11,262,942
Ensembl chr22:11,233,996...11,262,830
G
TRIM24
tripartite motif containing 24
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18026104
NCBI chr21:107,166,180...107,291,897
Ensembl chr21:107,166,395...107,295,736
G
TRIP13
thyroid hormone receptor interactor 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 4:737,214...760,263
Ensembl chr 4:737,263...760,171
G
TROAP
trophinin associated protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr11:45,552,369...45,560,134
Ensembl chr11:45,553,251...45,560,123
G
TSC1
TSC complex subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21499249
NCBI chr12:5,195,604...5,249,042
Ensembl chr12:5,195,675...5,244,157
G
TSC2
TSC complex subunit 2
severity
ISO
protein:decreased expression:liver (human)
RGD
PMID:24119083
RGD:21079731
NCBI chr 5:1,946,534...1,985,168
Ensembl chr 5:1,946,927...1,987,682
G
TSLP
thymic stromal lymphopoietin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr23:14,419,820...14,423,331
G
TST
thiosulfate sulfurtransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr19:19,716,295...19,724,712
Ensembl chr19:19,716,180...19,724,589
G
TTC36
tetratricopeptide repeat domain 36
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:109,912,976...109,917,097
G
TTK
TTK protein kinase
disease_progression
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver (human)
CTD RGD
PMID:28284560 PMID:35693827
RGD:153344586
NCBI chr13:4,738,849...4,779,563
Ensembl chr13:4,738,959...4,780,627
G
TTR
transthyretin
disease_progression
ISO
protein:decreased expression:blood serum (human) protein:increased expression:blood serum (rat) protein:increased expression:blood serum (human)
RGD
PMID:16240287 PMID:28876464 PMID:29534342
RGD:151356736 RGD:151664602 RGD:151665161
NCBI chr18:49,124,302...49,131,495
Ensembl chr18:49,124,121...49,131,399
G
TXNIP
thioredoxin interacting protein
ISO
OMIM:114550
MouseDO
NCBI chr20:12,756,145...12,759,853
Ensembl chr20:12,756,053...12,761,177
G
TYMS
thymidylate synthetase
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:deletion:3'UTR:1494del6(human)
CTD RGD
PMID:17659576 PMID:18019677 PMID:18230555
RGD:14696708
NCBI chr18:60,030,640...60,043,297
Ensembl chr18:60,030,658...60,041,856
G
UACA
uveal autoantigen with coiled-coil domains and ankyrin repeats
ISO
OMIM:114550
MouseDO
NCBI chr26:12,693,208...12,792,900
Ensembl chr26:12,749,774...12,795,279
G
UBD
ubiquitin D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144
NCBI chr17:43,061,243...43,065,135
Ensembl chr17:43,061,826...43,064,869
G
UBE2C
ubiquitin conjugating enzyme E2 C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:18,069,525...18,073,597
G
UBE2T
ubiquitin conjugating enzyme E2 T
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr25:27,069,971...27,084,360
Ensembl chr25:27,070,240...27,081,749
G
UBR5
ubiquitin protein ligase E3 component n-recognin 5
treatment
ISO
RGD
PMID:32087767
RGD:151665344
NCBI chr 8:97,104,325...97,257,317
Ensembl chr 8:97,103,220...97,257,440
G
UCHL1
ubiquitin C-terminal hydrolase L1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18666234
NCBI chr27:9,074,961...9,086,606
Ensembl chr27:9,074,923...9,086,517
G
UHRF1
ubiquitin like with PHD and ring finger domains 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:4,592,362...4,642,179
Ensembl chr 6:4,592,919...4,642,445
G
UMPS
uridine monophosphate synthetase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18230555
NCBI chr22:56,081,897...56,097,164
Ensembl chr22:56,082,103...56,097,105
G
UROC1
urocanate hydratase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr22:54,497,373...54,536,295
Ensembl chr22:54,499,487...54,535,862
G
USP2
ubiquitin specific peptidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147110
NCBI chr 1:110,733,097...110,760,119
Ensembl chr 1:110,734,737...110,742,186
G
USP4
ubiquitin specific peptidase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35841383
NCBI chr22:10,672,920...10,735,374
Ensembl chr22:10,672,388...10,732,104
G
VASN
vasorin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25826090
NCBI chr 5:4,052,239...4,063,884
G
VAV1
vav guanine nucleotide exchange factor 1
ISO
mRNA:decreased expression:liver
RGD
PMID:2064726
RGD:2306008
NCBI chr 6:6,337,255...6,415,851
G
VCAM1
vascular cell adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22922871
NCBI chr20:32,616,425...32,635,903
Ensembl chr20:32,615,333...32,635,862
G
VDR
vitamin D receptor
susceptibility
ISO
associated with Hepatitis B, Chronic;DNA:SNP: :rs2228570(human) ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma associated with alcoholic liver cirrhosis;DNA:haplotype::
RGD ClinVar
PMID:20572305 PMID:24033266 PMID:25541958 PMID:25741868 PMID:28492532
RGD:14402025 RGD:14402026
NCBI chr11:44,062,198...44,126,295
Ensembl chr11:44,065,457...44,166,684
G
VEGFA
vascular endothelial growth factor A
treatment susceptibility disease_progression
ISO
associated with liver cirrhosis; protein:increased expression:serum: DNA:SNP: :2578C>A (human) associated with liver cirrhosis; protein:increased expression:platelet, liver: protein:increased expression:liver DNA:polymorphism:promoter:-2578C>A (rs699947)(human)
RGD
PMID:16835748 PMID:18392108 PMID:18544126 PMID:24445728 PMID:25999787 PMID:26930285 PMID:27338800 PMID:28147320 More...
RGD:11527070 RGD:126848814 RGD:15003194 RGD:15003196 RGD:15003200 RGD:15014783 RGD:15036790 RGD:152177911
NCBI chr17:28,377,959...28,394,508
G
VEGFC
vascular endothelial growth factor C
ISO
associated with liver cirrhosis; protein:increased expression:liver:
RGD
PMID:18544126
RGD:15003200
NCBI chr 7:122,772,539...122,893,486
Ensembl chr 7:122,772,182...122,893,512
G
VHL
von Hippel-Lindau tumor suppressor
disease_progression
ISO
RGD
PMID:31321740
RGD:155882550
NCBI chr22:46,184,621...46,203,065
Ensembl chr22:46,184,756...46,204,428
G
VIPR1
vasoactive intestinal peptide receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr22:3,950,129...3,984,849
Ensembl chr22:3,950,193...3,984,948
G
VSIG4
V-set and immunoglobulin domain containing 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr X:55,963,007...55,982,929
Ensembl chr X:55,962,866...55,981,287
G
WDR62
WD repeat domain 62
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:30,964,219...31,010,692
Ensembl chr 6:30,964,319...31,011,403
G
WDR76
WD repeat domain 76
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr26:39,178,407...39,222,005
Ensembl chr26:39,176,535...39,223,993
G
WNT2
Wnt family member 2
susceptibility
ISO
associated with hepatitis B;DNA:SNP: :rs4730775(human)
RGD
PMID:28328801
RGD:14402040
NCBI chr21:85,955,517...86,005,664
Ensembl chr21:85,955,145...86,001,730
G
WRAP53
WD repeat containing antisense to TP53
ISO
RNA:increased expression:liver:
RGD
PMID:26551349
RGD:11096781
NCBI chr16:7,065,531...7,085,590
Ensembl chr16:7,066,333...7,085,625
G
XDH
xanthine dehydrogenase
ISO
protein:decreased activity:tumor (rat)
RGD
PMID:179860
RGD:5135059
NCBI chr14:76,084,693...76,162,840
Ensembl chr14:76,085,368...76,163,936
G
XPO1
exportin 1
ameliorates exacerbates treatment
ISO
human cell line in a mouse model mRNA:increased expression:liver (human)
RGD
PMID:25030088 PMID:27013579 PMID:31371628
RGD:151665796 RGD:151667433 RGD:151667441
NCBI chr14:45,428,279...45,487,965
Ensembl chr14:45,432,619...45,488,723
G
XPO5
exportin 5
severity
ISO
DNA:snp, haplotype:3' utr:c.*659A>C (rs11077) (human)
RGD
PMID:24676133
RGD:11041737
NCBI chr17:28,585,317...28,637,045
Ensembl chr17:28,585,536...28,635,519
G
XRCC1
X-ray repair cross complementing 1
susceptibility severity disease_progression no_association
ISO
DNA:missense mutation:cds:p.R399Q (rs25487) (human) DNA:SNPs:exon 9, exon 15: c.910A>G, c.1686C>G (human) associated with Chronic Hepatitis C;DNA:SNP:exon 14: c.1517G>C, p.506G>A (human) DNA:SNP:exon 13: c.1471G>A, p.E491K (human) DNA:SNPs:cds: 194C>T, 280A>G (human) associated with Hepatitis C, Chronic;DNA:missense mutation:cds:p.R399Q (human) associated with hepatitis B;DNA:missense mutation, haplotype:cds:p.R399Q (human) DNA:SNPs:exons:c.1254C>T, c.1517G>C (human) DNA:silent mutation, missense mutation:cds:c.1161G>A, c.1779C>G (p.L387L, p.S593R) (human) DNA:missense mutations:cds:c.482C>T, c.1178G>A (p.P161L, p.R393H) (human) DNA:missense mutation:cds:c.1804C>A (p.G506A) (human) DNA:missense mutation:cds:p.R399Q (28152G>A) (rs25487) (human) DNA:missense mutations:cds:p.R194W, p.R280H, p.R399Q (human) associated with Hepatitis C, Chronic;DNA:missense mutation:cds:p.R194W (human)
RGD
PMID:14519756 PMID:19194663 PMID:22502666 PMID:23454624 PMID:23493666 PMID:23534753 PMID:23984316 PMID:24446299 PMID:24526467 PMID:24570146 PMID:24634229 PMID:26918371 PMID:28058700 PMID:28927037 PMID:29682247 PMID:29935355 PMID:32334466 More...
RGD:14696702 RGD:14696772 RGD:14696773 RGD:14985238 RGD:14985240 RGD:14985242 RGD:14985243 RGD:15014789 RGD:15014790 RGD:15014791 RGD:15014792 RGD:15036794 RGD:15036797 RGD:150530503 RGD:150530624 RGD:150540332 RGD:150540333
NCBI chr 6:37,062,149...37,095,138
Ensembl chr 6:37,060,439...37,095,094
G
YAP1
Yes1 associated transcriptional regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29698666
NCBI chr 1:93,479,478...93,605,340
Ensembl chr 1:93,479,135...93,606,808
G
YTHDF2
YTH N6-methyladenosine RNA binding protein F2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28104805
NCBI chr20:104,041,657...104,078,705
Ensembl chr20:104,040,679...104,078,484
G
YWHAZ
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta
severity
ISO
RGD
PMID:27811373
RGD:14700875
NCBI chr 8:95,786,197...95,821,270
Ensembl chr 8:95,788,305...95,819,197
G
ZC3H12D
zinc finger CCCH-type containing 12D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34545456
NCBI chr13:22,152,938...22,195,470
Ensembl chr13:22,158,259...22,194,514
G
ZFHX3
zinc finger homeobox 3
disease_progression severity
ISO
associated with Chronic Hepatitis B;protein:decreased expression:blood serum (human) human cell line in a mouse model
RGD
PMID:20534899 PMID:32277050
RGD:151361162 RGD:151361169
NCBI chr 5:55,912,325...56,174,010
Ensembl chr 5:55,907,983...56,085,112
G
ZFP36
ZFP36 ring finger protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:34,011,073...34,013,665
Ensembl chr 6:34,011,031...34,013,870
G
ZIC2
Zic family member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 3:78,631,556...78,637,422
Ensembl chr 3:78,631,530...78,636,548
G
ZIC4
Zic family member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr15:43,285,711...43,309,197
Ensembl chr15:43,291,014...43,309,187
G
ZIC5
Zic family member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 3:78,611,133...78,629,616
Ensembl chr 3:78,615,177...78,621,446
G
ZNF23
zinc finger protein 23
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21965783
NCBI chr 5:54,578,420...54,609,302
G
ZWINT
ZW10 interacting kinetochore protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:74,912,070...74,915,920
Ensembl chr 9:74,912,093...74,915,926
G
IDH1
isocitrate dehydrogenase (NADP(+)) 1
disease_progression
ISO
DNA:polymorphism: :rs12478635(human) DNA:misssense mutation:cds:p.Arg132Cys(human)
RGD
PMID:25355558 PMID:28403884
RGD:14974227 RGD:14974228
NCBI chr10:94,021,002...94,039,997
Ensembl chr10:94,020,818...94,039,975
G
LEP
leptin
ISO
mRNA:increased expression:liver:
RGD
PMID:20723213
RGD:14696785
NCBI chr21:97,056,913...97,071,161
Ensembl chr21:97,057,529...97,071,220
G
LEPR
leptin receptor
ISO
mRNA:increased expression:liver
RGD
PMID:20723213
RGD:14696785
NCBI chr20:67,454,205...67,567,524
Ensembl chr20:67,454,334...67,524,229
G
LOC103231165
isocitrate dehydrogenase (NADP(+)) 2
disease_progression
ISO
DNA:polymorphism: :rs11632348(human)
RGD
PMID:25355558
RGD:14974228
NCBI chr29:8,633,429...8,650,744
Ensembl chr29:8,633,715...8,650,657
G
TERT
telomerase reverse transcriptase
disease_progression
ISO
mRNA:increased expression:liver:
RGD
PMID:20723213 PMID:28460432
RGD:14696783 RGD:14696785
NCBI chr 4:1,082,894...1,119,373
Ensembl chr 4:1,083,384...1,117,468
G
ALDOB
aldolase, fructose-bisphosphate B
ISO
protein:increased activity:liver (rat)
RGD
PMID:8264573
RGD:2313432
NCBI chr12:37,993,367...38,021,693
Ensembl chr12:38,007,265...38,021,258
G
APOBEC1
apolipoprotein B mRNA editing enzyme catalytic subunit 1
ISO
RGD
PMID:9633945
RGD:10755510
NCBI chr11:7,696,571...7,700,424
Ensembl chr11:7,696,259...7,700,643
G
CBX7
chromobox 7
ISO
RGD
PMID:22214847
RGD:9587356
NCBI chr19:21,776,618...21,798,525
Ensembl chr19:21,775,931...21,798,309
G
CDKN1A
cyclin dependent kinase inhibitor 1A
ISO
protein:increased expression:liver
RGD
PMID:23890812
RGD:13792775
NCBI chr17:35,445,668...35,454,334
Ensembl chr17:35,445,223...35,454,342
G
COL1A1
collagen type I alpha 1 chain
onset
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:21295105
RGD:5130894
NCBI chr16:43,134,648...43,152,313
Ensembl chr16:43,134,779...43,150,930
G
EIF4G2
eukaryotic translation initiation factor 4 gamma 2
ISO
RGD
PMID:9633945
RGD:10755510
NCBI chr 1:54,017,587...54,029,491
Ensembl chr 1:54,017,696...54,028,843
G
H2AFX
histone H2AX
treatment
ISO
RGD
PMID:23474136
RGD:8693737
NCBI chr 1:110,466,692...110,468,776
Ensembl chr 1:110,467,775...110,468,206
G
HSPA4
heat shock protein family A (Hsp70) member 4
ISO
protein:increased expression:liver (rat)
RGD
PMID:22213170
RGD:5686872
NCBI chr23:35,862,817...35,917,490
Ensembl chr23:35,862,814...35,918,287
G
IL10
interleukin 10
treatment
ISO
RGD
PMID:25168696
RGD:11049493
NCBI chr25:22,590,389...22,595,877
Ensembl chr25:22,590,962...22,594,836
G
KMT5C
lysine methyltransferase 5C
disease_progression
ISO
protein:decreased expression:liver
RGD
PMID:16497704
RGD:9586726
NCBI chr 6:47,942,100...47,950,364
Ensembl chr 6:47,944,197...47,949,693
G
MAP2K3
mitogen-activated protein kinase kinase 3
ISO
RGD
PMID:24233520
RGD:7495808
NCBI chr16:19,396,377...19,427,617
Ensembl chr16:19,396,452...19,427,652
G
MET
MET proto-oncogene, receptor tyrosine kinase
onset
ISO
mRNA, protein:increased expression:neoplastic liver (rat)
RGD
PMID:11956651
RGD:2317546
NCBI chr21:85,370,574...85,486,405
Ensembl chr21:85,397,645...85,488,093
G
MTHFR
methylenetetrahydrofolate reductase
onset
ISO
mRNA:decreased expression:liver (rat)
RGD
PMID:22213190
RGD:6893663
NCBI chr20:119,987,667...120,003,611
Ensembl chr20:119,990,133...120,002,950
G
NQO1
NAD(P)H quinone dehydrogenase 1
ISO
RGD
PMID:24418717
RGD:11035219
NCBI chr 5:57,676,547...57,695,434
Ensembl chr 5:57,675,981...57,716,599
G
TTPA
alpha tocopherol transfer protein
ISO
mRNA:decreased expression:liver
RGD
PMID:9178827
RGD:1600436
NCBI chr 8:58,952,685...58,979,083
Ensembl chr 8:58,950,626...58,978,258
G
TUT4
terminal uridylyl transferase 4
ISO
human cells in a mouse model
RGD
PMID:24056962
RGD:11530012
NCBI chr20:80,395,484...80,522,442
Ensembl chr20:80,395,581...80,523,671
G
ABCA1
ATP binding cassette subfamily A member 1
severity
ISO
mRNA:decreased expression:liver (mouse)
RGD
PMID:30580964
RGD:24922199
NCBI chr12:34,587,123...34,734,936
Ensembl chr12:34,587,118...34,731,642
G
ABCB11
ATP binding cassette subfamily B member 11
ISO
mRNA:decreased expression:liver
RGD
PMID:29651702
RGD:14402411
NCBI chr10:54,458,283...54,575,943
Ensembl chr10:54,459,377...54,575,059
G
ACOT12
acyl-CoA thioesterase 12
ISO
RGD
PMID:2566591
RGD:13831129
NCBI chr 4:75,398,361...75,543,933
Ensembl chr 4:75,469,424...75,535,267
G
ADAM28
ADAM metallopeptidase domain 28
ISO
mRNA:increased expression:liver
RGD
PMID:32782619
RGD:153297784
NCBI chr 8:22,424,260...22,483,878
Ensembl chr 8:22,430,579...22,488,257
G
ALDH2
aldehyde dehydrogenase 2 family member
ISO
DNA:missense mutation:cds:p.E487K (mouse)
RGD
PMID:26150517
RGD:14696779
NCBI chr11:107,019,015...107,060,784
Ensembl chr11:107,019,111...107,060,374
G
ATM
ATM serine/threonine kinase
ameliorates
ISO
RGD
PMID:19919837
RGD:150340702
NCBI chr 1:99,653,208...99,786,889
Ensembl chr 1:99,653,139...99,791,520
G
CCND1
cyclin D1
disease_progression
ISO
protein:increased expression:liver (rat)
RGD
PMID:11797828
RGD:151356973
NCBI chr 1:4,909,616...4,922,272
Ensembl chr 1:4,907,353...4,922,357
G
CCND2
cyclin D2
disease_progression
ISO
RGD
PMID:30308939
RGD:151665105
NCBI chr11:4,307,419...4,339,003
Ensembl chr11:4,307,401...4,333,661
G
CCNE1
cyclin E1
disease_progression
ISO
protein:increased expression:liver (rat)
RGD
PMID:11797828
RGD:151356973
NCBI chr 6:24,879,923...24,888,985
G
CHUK
component of inhibitor of nuclear factor kappa B kinase complex
ISO
human cells in mouse model
RGD
PMID:27367027
RGD:153305911
NCBI chr 9:93,219,374...93,263,077
Ensembl chr 9:93,219,383...93,262,700
G
GPT
glutamic--pyruvic transaminase
treatment
ISO
RGD
PMID:22922605
RGD:14975251
NCBI chr 8:138,716,802...138,721,421
Ensembl chr 8:138,718,767...138,721,251
G
GPT2
glutamic--pyruvic transaminase 2
treatment
ISO
RGD
PMID:22922605
RGD:14975251
NCBI chr 5:32,743,850...32,791,299
Ensembl chr 5:32,744,065...32,791,479
G
HRAS
HRas proto-oncogene, GTPase
ISO
DNA:missense mutations:cds:p.Q61L, p.Q61K, p.Q61R (mouse)
RGD
PMID:9142214
RGD:14688053
NCBI chr 1:343,613...345,782
Ensembl chr 1:343,506...346,637
G
IKBKB
inhibitor of nuclear factor kappa B kinase subunit beta
ISO
human cells in mouse model
RGD
PMID:27367027
RGD:153305911
NCBI chr 8:40,267,532...40,325,282
Ensembl chr 8:40,268,079...40,326,381
G
IKBKG
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
ISO
human cells in mouse model
RGD
PMID:27367027
RGD:153305911
NCBI chr X:128,781,975...128,816,039
Ensembl chr X:128,787,785...128,806,083
G
IL10
interleukin 10
ISO
RGD
PMID:30610790
RGD:14975253
NCBI chr25:22,590,389...22,595,877
Ensembl chr25:22,590,962...22,594,836
G
JAG1
jagged canonical Notch ligand 1
treatment
ISO
miRNA:decreased expression:liver
RGD
PMID:25311838
RGD:14694834
NCBI chr 2:27,484,699...27,521,108
Ensembl chr 2:27,484,760...27,522,504
G
JAK2
Janus kinase 2
severity
ISO
human cell line in a mouse model
RGD
PMID:27788478
RGD:18182929
NCBI chr12:74,421,243...74,566,766
Ensembl chr12:74,421,016...74,566,710
G
KRT18
keratin 18
severity
ISO
associated with fatty liver disease
RGD
PMID:27689336
RGD:18337485
NCBI chr11:49,073,733...49,081,706
G
LOC103233018
liver carboxylesterase 1
treatment
ISO
RGD
PMID:27523631
RGD:152995275
NCBI chr 5:41,710,500...41,745,483
G
LOC103233229
cadherin-1
ISO
mRNA:increased expression:liver (mouse)
RGD
PMID:25319454
RGD:152995431
NCBI chr 5:58,578,244...58,679,677
Ensembl chr 5:58,578,146...58,679,541
G
MAPK14
mitogen-activated protein kinase 14
exacerbates
ISO
RGD
PMID:17468757
RGD:151665350
NCBI chr17:36,012,164...36,095,542
Ensembl chr17:36,014,454...36,095,138
G
PCNA
proliferating cell nuclear antigen
disease_progression
ISO
protein:increased expression:liver (rat)
RGD
PMID:11797828
RGD:151356973
NCBI chr 2:32,936,600...32,953,635
Ensembl chr 2:32,948,196...32,953,991
G
PIK3CA
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
susceptibility
ISO
RGD
PMID:20583210
RGD:14402407
NCBI chr15:10,218,034...10,304,874
Ensembl chr15:10,218,805...10,294,316
G
SETD2
SET domain containing 2, histone lysine methyltransferase
ISO
protein:decreased expression:liver (human)
RGD
PMID:26172293
RGD:11530741
NCBI chr22:8,421,178...8,567,221
Ensembl chr22:8,420,960...8,567,201
G
SLCO1B1
solute carrier organic anion transporter family member 1B1
disease_progression
ISO
mRNA:decreased expression:liver (human)
RGD
PMID:21625523
RGD:152995425
NCBI chr11:20,992,353...21,091,761
Ensembl chr11:21,001,655...21,093,278
G
SLCO1B3
solute carrier organic anion transporter family member 1B3
ISO
mRNA:decreased expression:liver (mouse)
RGD
PMID:25319454
RGD:152995431
NCBI chr11:20,637,429...20,760,577
Ensembl chr11:20,648,582...20,761,161
G
SLCO2B1
solute carrier organic anion transporter family member 2B1
disease_progression
ISO
mRNA:decreased expression:liver (human)
RGD
PMID:21625523
RGD:152995425
NCBI chr 1:66,375,924...66,430,804
Ensembl chr 1:66,376,299...66,433,055
G
XRCC1
X-ray repair cross complementing 1
severity
ISO
mRNA:increased expression:liver (human)
RGD
PMID:30088263
RGD:15036795
NCBI chr 6:37,062,149...37,095,138
Ensembl chr 6:37,060,439...37,095,094
G
ATP7B
ATPase copper transporting beta
ISO
RGD
PMID:11509115
RGD:1302456
NCBI chr 3:29,817,712...29,899,302
Ensembl chr 3:29,816,860...29,899,077
G
DDR2
discoidin domain receptor tyrosine kinase 2
ameliorates
ISO
DNA:deletion:exons:
RGD
PMID:24293323
RGD:150429711
NCBI chr20:1,298,636...1,451,872
Ensembl chr20:1,299,574...1,359,674
G
HMBS
hydroxymethylbilane synthase
sexual_dimorphism
ISO
Protein:increased activity:liver (rat)
RGD
PMID:1781034
RGD:25440495
NCBI chr 1:110,457,799...110,466,361
Ensembl chr 1:110,457,537...110,466,095
G
HRAS
HRas proto-oncogene, GTPase
ISO
DNA:hypomethylation
RGD
PMID:3345576
RGD:14694848
NCBI chr 1:343,613...345,782
Ensembl chr 1:343,506...346,637
G
IL10
interleukin 10
ISO
DNA:SNP:promoter:-592C>A (rs1800872) (human)
RGD
PMID:28763918
RGD:14975157
NCBI chr25:22,590,389...22,595,877
Ensembl chr25:22,590,962...22,594,836
G
NRAS
NRAS proto-oncogene, GTPase
ISO
mRNA:increased expression:liver (human)
RGD
PMID:3018923
RGD:14975106
NCBI chr20:18,953,273...18,966,002
Ensembl chr20:18,953,883...18,961,931
G
PDCD10
programmed cell death 10
ISO
protein:increased expression:liver (human)
RGD
PMID:32186778
RGD:401827111
NCBI chr15:21,697,366...21,748,760
Ensembl chr15:21,706,675...21,749,470
G
BRAF
B-Raf proto-oncogene, serine/threonine kinase
severity
ISO
associated with skin melanoma;DNA:missense mutations:cds: associated with colorectal cancer;DNA:missense mutations:cds:pV599E,p.V600E (human) associated with colorectal cancer;DNA:mutation:cds: associated with colorectal cancer;DNA:missense mutation:cds:p.V600E (human) associated with colorectal cancer;DNA:mutations:multiple
RGD
PMID:22331825 PMID:23010994 PMID:26775732 PMID:27737491 PMID:28787433
RGD:11554843 RGD:14696791 RGD:15039394 RGD:18337264 RGD:18337265
NCBI chr21:109,495,525...109,690,261
G
CCL2
C-C motif chemokine ligand 2
disease_progression
ISO
associated with colorectal cancer
RGD
PMID:27058904
RGD:14995463
NCBI chr16:27,763,354...27,765,437
Ensembl chr16:27,763,555...27,765,416
G
CCL5
C-C motif chemokine ligand 5
treatment
ISO
associated with Animal Mammary Neoplasms;
RGD
PMID:15692764
RGD:14995455
NCBI chr16:29,351,214...29,361,317
G
CCND2
cyclin D2
ISO
associated with colorectal cancer;protein:increased expression:colorectum
RGD
PMID:19508551
RGD:151665111
NCBI chr11:4,307,419...4,339,003
Ensembl chr11:4,307,401...4,333,661
G
CD44
CD44 molecule (IN blood group)
ISO
associated with Breast Neoplasm;protein:increased expression:liver
RGD
PMID:17991717
RGD:2289349
NCBI chr 1:30,039,854...30,132,646
Ensembl chr 1:30,039,749...30,132,416
G
CHD4
chromodomain helicase DNA binding protein 4
ameliorates
ISO
associated with human colon adenocarcinoma cells in a mouse model
RGD
PMID:28486105
RGD:153323299
NCBI chr11:6,603,820...6,641,278
Ensembl chr11:6,602,694...6,640,351
G
CXCL10
C-X-C motif chemokine ligand 10
treatment
ISO
associated with colon carcinoma;
RGD
PMID:30381616
RGD:27095891
NCBI chr 7:24,526,657...24,529,193
Ensembl chr 7:24,526,680...24,529,130
G
CXCL12
C-X-C motif chemokine ligand 12
ameliorates
ISO
associated with colorectal cancer; human cells in mouse model
RGD
PMID:30789971
RGD:151893289
NCBI chr 9:40,005,580...40,020,513
Ensembl chr 9:40,011,439...40,020,494
G
CXCL8
C-X-C motif chemokine ligand 8
ISO
associated with colorectal cancer; human colon adenocarcinoma cells in a mouse model
RGD
PMID:29679563
RGD:26884358
NCBI chr 7:22,202,497...22,205,730
Ensembl chr 7:22,202,527...22,204,068
G
CXCR4
C-X-C motif chemokine receptor 4
ameliorates
ISO
associated with colorectal cancer; human cells in mouse model human cells in mouse model; associated with colorectal cancer
RGD
PMID:29436696 PMID:30789971
RGD:151893289 RGD:152023643
NCBI chr10:20,336,470...20,340,308
Ensembl chr10:20,336,247...20,340,309
G
DAXX
death domain associated protein
exacerbates
ISO
associated with pancreatic endocrine carcinoma;DNA:mutations:CDS:multiple (human) associated with colon cancer; mRNA:decreased expression:liver (human) associated with neuroendocrine tumor;DNA:mutations:CDS:multiple (human)
RGD
PMID:30339629 PMID:30342802 PMID:31942198
RGD:152025194 RGD:152025199 RGD:152025203
NCBI chr17:38,754,227...38,758,714
Ensembl chr17:38,754,280...38,759,071
G
DDR1
discoidin domain receptor tyrosine kinase 1
treatment
ISO
human cells in mouse model; nilotinib mRNA:increased expression:liver (mouse)
RGD
PMID:29438985 PMID:30666650 PMID:33110221
RGD:151347537 RGD:151347685 RGD:151347840
NCBI chr17:41,564,271...41,583,404
Ensembl chr17:41,564,992...41,575,682
G
DDR2
discoidin domain receptor tyrosine kinase 2
ameliorates
ISO
associated with colon carcinoma associated with melanoma;
RGD
PMID:21701781 PMID:22071959
RGD:150429701 RGD:150429713
NCBI chr20:1,298,636...1,451,872
Ensembl chr20:1,299,574...1,359,674
G
DOCK6
dedicator of cytokinesis 6
ameliorates
ISO
associated with stomach cancer;
RGD
PMID:29587866
RGD:155791564
NCBI chr 6:10,133,688...10,191,995
G
FBXW7
F-box and WD repeat domain containing 7
disease_progression
ISO
associated with colorectal cancer;
RGD
PMID:28846828
RGD:21408566
NCBI chr 7:98,894,261...99,105,955
Ensembl chr 7:98,892,504...99,106,084
G
FGFR1
fibroblast growth factor receptor 1
ISO
associated with colorectal cancer;mRNA:increased expression:colorectal mucosa:
RGD
PMID:19082464
RGD:25330357
NCBI chr 8:36,426,116...36,485,683
Ensembl chr 8:36,427,110...36,485,508
G
FOSL2
FOS like 2, AP-1 transcription factor subunit
ISO
human cells in mouse model
RGD
PMID:30114390
RGD:153344554
NCBI chr14:79,201,128...79,222,363
Ensembl chr14:79,201,649...79,222,373
G
GPC3
glypican 3
ISO
protein:increased expression:blood serum (human)
RGD
PMID:28801286
RGD:243065135
NCBI chr X:108,688,706...109,143,653
G
HMBS
hydroxymethylbilane synthase
ISO
associated with colon adenocarcinoma;protein:decreased activity:liver(rat)
RGD
PMID:1386052
RGD:25440496
NCBI chr 1:110,457,799...110,466,361
Ensembl chr 1:110,457,537...110,466,095
G
IL2
interleukin 2
treatment
ISO
associated with Colorectal Neoplasms, Carcinoma, Hepatocellular; associated with colon carcinoma
RGD
PMID:9354462 PMID:11591892
RGD:14928215 RGD:8663446
NCBI chr 7:69,729,635...69,736,279
Ensembl chr 7:69,730,282...69,734,969
G
IQSEC1
IQ motif and Sec7 domain ArfGEF 1
ISO
human cells in mouse model
RGD
PMID:22662237
RGD:153344589
NCBI chr22:48,873,240...49,050,666
Ensembl chr22:48,872,925...49,050,625
G
LOC103244924
cyclin-G1
treatment
ISO
human cells in mouse model
RGD
PMID:10910035
RGD:151356987
NCBI chr23:65,709,759...65,716,913
Ensembl chr23:65,709,786...65,714,711
G
MAP2K7
mitogen-activated protein kinase kinase 7
ISO
associated with colon cancer;protein:increased expression:colon (human)
RGD
PMID:24533778
RGD:155259116
NCBI chr 6:7,355,387...7,365,944
Ensembl chr 6:7,355,434...7,364,398
G
MPL
MPL proto-oncogene, thrombopoietin receptor
exacerbates severity
ISO
associated with pancreatic ductal adenocarcinoma; human cells in mouse model associated with pancreatic cancer; protein:increased expression:liver, pancreas (human) associated with colorectal carcinoma;protein:increased expression:colorectum (human)
RGD
PMID:23747337 PMID:30770989
RGD:126925751 RGD:126925752
NCBI chr20:89,457,549...89,474,756
Ensembl chr20:89,459,493...89,474,352
G
NRAS
NRAS proto-oncogene, GTPase
susceptibility
ISO
associated with melanoma;DNA:mutations: exons (human) human gene in a mouse model;DNA:missense mutations:cds:p.G12V, p.Q61K (human) associated with colorectal cancer;DNA:mutations:exons (human)
RGD
PMID:26799184 PMID:28011498 PMID:28787433
RGD:14696774 RGD:14696791 RGD:14696792
NCBI chr20:18,953,273...18,966,002
Ensembl chr20:18,953,883...18,961,931
G
PTPRB
protein tyrosine phosphatase receptor type B
treatment
ISO
mouse tumor cells in mouse recipient
RGD
PMID:31348125
RGD:151660353
NCBI chr11:66,095,445...66,222,402
Ensembl chr11:66,101,038...66,221,982
G
RICTOR
RPTOR independent companion of MTOR complex 2
disease_progression
ISO
mRNA:increased expression:liver (human)
RGD
PMID:30404068
RGD:152995463
NCBI chr 4:37,758,531...37,885,323
Ensembl chr 4:37,762,901...37,873,766
G
RNF43
ring finger protein 43
ISO
associated with colorectal adenocarcinoma;mRNA:increased expression:liver (human)
RGD
PMID:28789449
RGD:151361221
NCBI chr16:34,981,126...35,046,478
Ensembl chr16:34,980,922...35,045,107
G
SLC3A2
solute carrier family 3 member 2
severity
ISO
associated with colon adenocarcinoma
RGD
PMID:11745822
RGD:151361130
NCBI chr 1:11,011,351...11,050,494
Ensembl chr 1:11,008,120...11,050,298
G
SLC7A5
solute carrier family 7 member 5
severity
ISO
associated with colon cancer associated with colon adenocarcinoma
RGD
PMID:11718450 PMID:11745822
RGD:151361129 RGD:151361130
NCBI chr 5:73,229,953...73,269,801
Ensembl chr 5:73,229,951...73,269,754
G
SMAD4
SMAD family member 4
treatment
ISO
associated with colorectal carcinoma; DNA:mutations: : associated with colorectal carcinoma;protein:decreased expression:colorectum:
RGD
PMID:17390050 PMID:29551247
RGD:18937000 RGD:21066338
NCBI chr18:29,894,157...29,951,445
Ensembl chr18:29,897,621...29,934,478
G
SOX30
SRY-box transcription factor 30
ameliorates
ISO
RGD
PMID:29739711
RGD:151660333
NCBI chr23:60,013,384...60,038,682
Ensembl chr23:60,014,046...60,037,997
G
SRC
SRC proto-oncogene, non-receptor tyrosine kinase
disease_progression
ISO
associated with colon cancer;protein:increased activity:colon
RGD
PMID:7678609
RGD:150521542
NCBI chr 2:26,344,480...26,367,448
Ensembl chr 2:26,343,450...26,367,776
G
VEGFA
vascular endothelial growth factor A
ISO
associated with colorectal carcinoma;mRNA,protein:increased expression:liver:
RGD
PMID:22156924
RGD:15014782
NCBI chr17:28,377,959...28,394,508
G
PRKACA
protein kinase cAMP-activated catalytic subunit alpha
susceptibility
ISO
RGD
PMID:28923495
RGD:151347843
NCBI chr 6:12,743,752...12,759,155
G
SPRTN
SprT-like N-terminal domain
ISO
ClinVar Annotator: match by term: Progeroid features-hepatocellular carcinoma predisposition syndrome | ClinVar Annotator: match by term: Ruijs-Aalfs syndrome
OMIM ClinVar
PMID:12503110 PMID:25261934 PMID:25741868
NCBI chr25:68,599,377...68,620,568
Ensembl chr25:68,599,780...68,620,621
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all